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Abstract 
Melastatin-related transient receptor potential 2 (TRPM2) channel is a Ca2+-permeable 
cation channel that is gated by ADP-ribose (ADPR) and also activated by reactive oxygen 
species (ROS) such as H2O2.  TRPM2 channel are shown to be critically involved in several 
physiological and pathological cell processes.  
Previous studies have reported inhibition of the human TRPM2 channel by extracellular 
acidic pH.  However, the underlying mechanism is not fully understood.  In the present study, 
I performed patch-clamp recordings to examine the effect of extracellular acidic pH on 
ADPR-induced currents in HEK293 cells heterogeneously expressing human TRPM2 (hTRPM2) 
or mouse TRPM2 (mTRPM2) channels. The results showed that the inhibition was 
substantially reversible upon brief exposure to acidic pH but became irreversible after 
prolonged exposure, supporting the mechanism in which protons bind to and inhibit the 
open TRPM2 channel and the proton-binding induces further conformational changes 
leading to channel inactivation.  Furthermore, the mTRPM2 channel exhibited a lower 
sensitivity to, and slower kinetics of, inhibition, than the hTRPM2 channel.  A residue in the 
pore region (His-995 in hTRPM2 and Gln-992 in mTRPM2) had a crucial role in determining 
such species differences. 
The pharmacology of the TRPM2 channel is poor, with no specific inhibitor.  Here, I 
examined the effects of 48 hit compounds identified from screening chemical libraries on 
hTRPM2 channels expressed in HEK293 cells.  Four compounds inhibited H2O2-induced Ca2+-
response with a micromolar to submicromolar potency and abolished ADPR-induced 
currents at 10 µM, indicating that they act as TRPM2 channel inhibitors.   
The TRPM2 channel was reported to be functionally expressed in macrophage cells, but its 
role in mediating ROS-induced Ca2+ signalling and cell death is largely unclear.  This study 
examined the contribution and mechanism of the TRPM2 channel in H2O2-induced Ca2+-
responses and cell death in RAW264.7 and differentiated THP-1 macrophage cells and 
peritoneal macrophage cells isolated from TRPM2+/+ and TRPM2-/- mice.  The results showed 
that TRPM2 channels operated as cell surface Ca2+-permeable channels and constituted the 
principal Ca2+ signalling mechanism, but played a limited role in cell death. 
In summary, the results from my study provided useful information to advance the 
understanding of the pharmacology and functional roles of the TRPM2 channels.    
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1.1 TRP channel superfamily 
The transient receptor potential (TRP) channel was originally identified in a genetic study of 
the photoreceptors in the fruitfly Drosophila (Hardie and Minke, 1992).  In contrast with the 
persistent receptor potential response in the wild-type (WT) fly to constant bright light, a 
spontaneous mutant fly showed a transient receptor potential response and named the trp 
mutant (Cosens and Manning, 1969, Minke et al., 1975, Hardie and Minke, 1992).  The 
responsible trp gene was identified later by molecular cloning, and the encoded TRP protein 
was shown as a membrane protein located in the membrane of photoreceptor cells 
(Montell and Rubin, 1989).  Subsequent studies further demonstrated that the TRP protein 
formed a Ca2+-permeable channel (Montell and Goodman, 1989, Hardie and Minke, 1992).  
Up to now, 28 homologues of the Drosophila TRP proteins in mammalian cells have been 
identified, and constitute a large superfamily that can be divided into 6 subfamilies based on 
their amino acid sequence homology.  These subfamilies are TRPC (classical), TRPM 
(melastatin), TRPV (vanilloid), TRPA (ankyrin), TRPML (mucolipin) and TRPP (polycystin) 
(Pedersen et al., 2005) (Fig. 1.1).  According to their homology to the Drosophila TRP, the 
mammalian TRPs can also be broadly categorized into two groups (Fig. 1.2).  The proteins of 
the TRPC, TRPV, TRPM, TRPA subfamilies show high amino acid relatedness with the 
Drosophila TRP and constitute group 1, while the proteins of the TRPP and TRPML 
subfamilies exhibit low sequence homology to the Drosophila TRP and form group 2 
(Venkatachalam and Montell, 2007).  All members of the TRP superfamily share a similar 
membrane topology, having intracellular C- and N-terminus, six transmembrane segments 
(S1-S6), and a re-entrant loop between the S5 and S6 that forms the ion-permeating pore 
(Montell, 2005, Pedersen et al., 2005, Venkatachalam and Montell, 2007) (Fig. 1.2). 
The second member of the TRPM subfamily, TRPM2, is the major topic of my study.  In the 
following sections, I will first provide a brief overview of all the other TRP channels and 
present a more detailed discussion of our current knowledge regarding the TRPM2 channel. 
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Figure 1.1 The family tree of the mammalian TRP channel proteins 
The tree shows the homology of human TRP proteins.  The mouse TRPC2 protein is  
shown, as the gene encoding the human TRPC2 is a pseudogene (Nilius et al., 2007). (The 
permission for using this figure in a thesis, which has been verified on the website of 
Copyright Clearance Center’s RightsLink™, is not required.) 
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Figure 1.2 Schematic representation of the main structural features of the members of the 
six mammalian TRP channel subfamilies 
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1.1.1 TRPC subfamily 
There are seven mammalian TRPC members, TRPC1-7 (Fig. 1.1).  As illustrated for TRPC1 in 
Fig. 1.2, these proteins have multiple ankyrin repeats, 33-residue motifs forming helix-loop-
helix and mediating protein-protein interactions, in the N-terminus.  There is a TRP domain 
adjacent to the intracellular part of S6, which is composed of 23-25 highly conserved 
residues.  Two coiled-coil domains locate in the N- and C-terminus, respectively.  The coiled-
coil domain is composed of a-helix forming heptad repeats (abcdefg), in which residues at 
positions a and d are preferentially hydrophobic and mediate protein-protein interactions 
(Cohen and Parry, 1990). 
TRPCs have been cloned from human (Nagamine et al., 1998) and rodents (Xu et al., 2001, 
Nakayama et al., 2006).  They are extensively expressed in tissues and cells, such as brain 
(Sossey-Alaoui et al., 1999, Nagamine et al., 1998), heart (Nakayama et al., 2006), testis 
(Sutton et al., 2004), spleen (Uehara, 2005), vascular smooth muscle (Wang et al., 2004), 
kidney (Wissenbach et al., 2000), liver (Chen and Barritt, 2003) and endothelial cells (Wang 
et al., 2009).  Among of them, TRPC3, TRPC4 and TRPC5, are distributed in abundance in 
neurons (Lee-Kwon et al., 2005, Crousillac et al., 2003, Riccio et al., 2009, Sossey-Alaoui et 
al., 1999, Davare et al., 2009).  
All TRPC channels are Ca2+ permeable cationic channels and activated by phospholipase C 
(PLC) signal transduction pathway.  Activation of PLC by G-protein coupled receptors (GPCR) 
results in hydrolysis of membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP2) into 
inositol 1,4,5-trisphosphate (IP3), an agonist for the IP3 receptor that is located on the 
endoplasmic reticulum (ER) and mediates Ca2+ release from the ER, and diacylglycerol (DAG), 
a physiological activator of protein kinase C (PKC). 
The TRPC1 channel has been proposed as a candidate of store-operated channel (SOC).  It 
can be activated by Ca2+ depletion in the ER as a result of activation of the IP3 receptor.  
Furthermore, associating with STIM1 (stromal interaction molecule 1) and Orai1 (calcium 
release-activated calcium channel protein 1), TRPC1 can modulate the store-operated 
Orai1/STIM1-mediated Ca2+ entry (SOCE) (Worley et al., 2007). 
23 
 
The TRPC4 and TRPC5 proteins have high sequence homology (64%) (Ramsey et al., 2006).  
They can form homotetramers which are regarded as receptor-operated channels (ROC) 
that can be stimulated by activation of GPCRs and receptor tyrosine kinase (RTK) (Odell et 
al., 2005, Schaefer et al., 2000, Plant and Schaefer, 2003).  In addition, TRPC4 and TRPC5 
proteins can also assemble heteromeric channels with each other, and also with TRPC1 and 
TRPC3 proteins (Plant and Schaefer, 2003, Poteser et al., 2006).  The TRPC4 channels are 
involved in vasodilatation (Plant and Schaefer, 2003) and neurotransmitter release (Munsch 
et al., 2003), meanwhile the TRPC5 channels are shown to play a role in cardiovascular 
remodeling (Nath et al., 2009) and metabolic syndrome (Wuensch et al., 2010). 
The TRPC3, TRPC6 and TRPC7 share 70–80% sequence homology with each other (Hofmann 
et al., 1999).  All of them can be stimulated by DAG (Kiselyov et al., 1998, Philipp et al., 1998, 
Venkatachalam et al., 2003, Lievremont et al., 2005, Hofmann et al., 1999).  The TRPC3 
channel also couples with the IP3 receptor after its conformational change caused by 
binding with IP3 and calmodulin.  Thus, it is involved in modulating depletion of intracellular 
Ca2+ store in the ER and SOCE, and is likely to depolarize the membrane potential and 
further activate the voltage-gated Ca2+ (Cav) channels (Groschner and Rosker, 2005).  The 
TRPC6 channel activity can be modulated by redox (Graham et al., 2010), phosphorylation 
by PKC (Bousquet et al., 2010) and Src (sarcoma) family PTK (Hisatsune et al., 2004), and 
activation of GPCRs (Cayouette et al., 2004).  There are many lines of evidence to support 
the involvement of the TRPC6 channel in promoting neuron survival (Du et al., 2010) and 
controlling contraction of smooth muscles and vessels (Ding et al., 2011, Monet et al., 2012).  
The TRPC7 channels can be modulated by cGMP (cyclic guanosine monophosphate)-
dependent protein kinase and are involved in mediating carbachol-induced Ca2+ influx 
(Yuasa et al., 2011).  However, the physiological function of the TRPC7 channel is still poorly 
understood.  
The TRPC2 is unique among the TRPCs, as the full-length genes have only been identified 
from rodents and bovine (Zufall, 2005).  In mice, TRPC2 is expressed in brain, testis and 
sperm, and is important in regulating sexual and social behaviors of the animals (Zufall et al., 
2005).  However, in human, the complete TRPC2 gene is lost and the remnants form a 
pseudogene (Yildirim and Birnbaumer, 2007, Lof et al., 2011). 
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1.1.2 TRPV subfamily 
There are six members, TRPV1-6, in the TRPV subfamily (Fig. 1.1).  The TRPVs contain 
multiple ankyrin repeats in the intracellular N-terminal region, and a TRP domain in the 
proximal part of the C-terminus, similar to the TRPCs (Fig. 1.2).  The TRPV1 and TRPV4 
proteins, but not other TRPVs, contain a C-terminal coiled-coil domain (Tominaga and 
Tominaga, 2005, Nilius et al., 2003b).  
The TRPV1-4 proteins are abundantly expressed in neuronal tissues, including hippocampus 
(Planells-Cases et al., 2005), cerebral cortex (Pingle et al., 2007), hypothalamus (Planells-
Cases et al., 2005), midbrain (Smith et al., 2002), dorsal root ganglion (DRG) (Derbenev et al., 
2004, Derbenev et al., 2006, Xing and Li, 2007), trigeminal ganglion (TG) (Derbenev et al., 
2004) and nodose ganglion (Derbenev et al., 2006, Planells-Cases et al., 2005, Pingle et al., 
2007), as well in other types of cells, such as granulocytes, macrophages, endothelial cells 
(Strotmann et al., 2000, Liedtke, 2006), keratinocytes and smooth muscle cells (Muraki et al., 
2003, Montell et al., 2002, Beech et al., 2004). 
The TRPV1-4 channels show remarkable thermo-sensitivity (Smith et al., 2002, Caterina et 
al., 1997, Peier et al., 2002b).  Among them, the TRPV1 and TRPV2 channels respond to 
noxious heat (>42°C), while the TRPV3 and TRPV4 channels are stimulated by non-painful 
warm temperature (25°C-42°C).   
In physiological conditions, the TRPV1 channels are stimulated by heat at approximate 43°C, 
whereas the threshold is reduced to body temperature in inflammatory conditions, since 
pro-inflammatory factors, such as macrophage-chemoattractant protein-1 (MCP-1), IL 
(interleukin)-1β, IL-6 and TNF-α (tumor necrosis factor-α), can all enhance the sensitivity of 
the TRPV1 channel to heat (Okada et al., 2011, Zhang et al., 2005, Caterina et al., 2000, 
Bishnoi et al., 2011).  Besides heat, the TRPV1 channel can be activated by capsaicin 
(Tominaga et al., 1998) and extracellular acidic pH (<6.0) (Jordt et al., 2000).  It plays a 
critical role in nociception and thermo-sensing (Caterina et al., 2000, Walker et al., 2003).  
The TRPV2 channel responds to noxious heat or temperature of higher than 52°C (Caterina 
et al., 1997).  Activation of the TRPV2 channel by chemical ligands shows striking species 
specificity.  For instance, 2-aminoethoxydiphenyl borate (2-APB) potently activates the 
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rodent TRPV2 channel, but does not activate the human TRPV2 channel at concentrations 
up to 1 mM (Neeper et al., 2007, Hu et al., 2004).  Several studies show that the TRPV2 
channel activity is up-regulated after tissue injury or inflammation, suggesting its role in pain 
sensation (Frederick et al., 2007, Shimosato et al., 2005). 
The TRPV3 and TRPV4 channels respond to moderate temperatures in the range of 34°C-
38°C (Smith et al., 2002, Xu et al., 2002) and 27°C-34°C (Guler et al., 2002), respectively.  
TRPV3 can also be activated by 2-APB and camphor (Vogt-Eisele et al., 2007).  Intriguingly, 
the TRPV3 channel activation by warm temperature or 2-APB results in a biphasic response.  
The first phase shows a gradual increase in the TRPV3 channel currents, followed by the 
second phase characterized by an abrupt enhancement in the current amplitude and loss of 
the outward rectification (Hu et al., 2004, Chung et al., 2005).  Besides heat, the TRPV4 
channel can be activated by hypotonic cell swelling (Nilius et al., 2003b, Vriens et al., 2005), 
and chemical stimuli, such as anandamide and arachidonic acid (Watanabe et al., 2003, 
Nilius et al., 2003b, Nilius et al., 2004). 
The TRPV5 and TRPV6 channels were initially named ECaC1 (epithelial Ca2+ channel 1) and 
ECaC2, respectively.  They have been identified in kidney (Nijenhuis et al., 2003), small 
intestine (van de Graaf et al., 2006), placenta (Bernucci et al., 2006), pancreas, brain and 
rectum (Hoenderop et al., 2000).  Distinct from other members of the TRP superfamily, the 
TRPV5 and TRPV6 channels exhibit strong inward rectification and a high Ca2+ selectivity 
with the PCa (permeability of Ca2+) /PNa value being over 100 (Nilius et al., 2000, Nilius et al., 
2001a, Vennekens et al., 2000).  The TRPV5 and TRPV6 channels are constitutively active 
(den Dekker et al., 2003).  The most efficient blockers of the TRPV5 channels are ruthenium 
red and econazole (Nilius et al., 2001b).  The TRPV5 channel also can be blocked by 
extracellular divalent cations, including Pb2+, Cu2+, Zn2+, Co2+ and Fe2+, with IC50 (the half 
maximal inhibitory concentration) values between 1-10 µM (Nilius et al., 2001b).  The TRPV6 
channel is inhibited by ruthenium red with the potency approximate 100-fold lower than 
that for TRPV5.  In addition, Mg2+ inhibits TRPV5 and TRPV6 channels from both extracellular 
and intracellular sides and in a voltage-dependent manner (Nilius, 2007).  The TRPV5 and 
TRPV6 channels are thought to contribute to Ca2+ absorption/reabsorption in kidney and 
intestine (Nijenhuis et al., 2005, Hoenderop et al., 2003, Hoenderop et al., 2005). 
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1.1.3 TRPA subfamily 
The TRPA1 protein is the sole member of the TRPA subfamily (Fig. 1.1).  The protein contains 
14 ankyrin repeats in the intracellular N-terminal domain (Fig. 1.2).  TRPA1 mRNA 
expression is detected in several tissues, but the functional TRPA1 channel is only observed 
in sensory neurons such as DRG and TG (Kobayashi et al., 2005, Story et al., 2003), and hair 
cells of the inner ear (Nagata et al., 2005, Corey et al., 2004).  The TRPA1 channel can be 
activated by cold temperature (Bandell et al., 2004, Story et al., 2003) as well as a variety of 
pungent chemicals, such as mustard oil, allicin, wasabi and acrolein (Bandell et al., 2004).  
Intracellular Ca2+ can also stimulate the TRPA1 channel (Zurborg et al., 2007, Doerner et al., 
2007).  The contribution of the TRPA1 channel in cold sensation is still disputable.  Some 
groups have shown that exogenously expressed TRPA1 channels are activated by noxious 
cold (<15°C) (Bandell et al., 2004, Story et al., 2003) and that the cold sensitivity is reduced 
to very low temperatures (-10°C) in the TRPA1-deficient mice in tail flick test, in which the 
mice flick tail when they feels pain caused by cold (Karashima et al., 2009).  However, other 
groups have failed to observe such changes in the cold sensitivity (Bautista et al., 2006, 
Karashima et al., 2009). 
1.1.4 TRPM subfamily 
The TRPM subfamily is composed of eight members, TRPM1-8 (Fig. 1.1).  Like the TRPC 
proteins, they all contain a TRP domain and a coiled-coil domain in the C-terminus (Fig. 1.2).  
Unique to the TRPM proteins is the presence of four highly homologous regions among the 
TRPM subfamily (thus called TRPM-homology regions) in the N-terminus that bear no 
sequence homology to any other known proteins (Eisfeld and Luckhoff, 2007). 
The TRPM1, TRPM3-5, and TRPM7-8 channels have been identified in various tissues, such 
as kidney (Grimm et al., 2003), DRG neurons (Babes et al., 2004, Kobayashi et al., 2005), lung 
epithelia (Sabnis et al., 2008), pancreas (Wagner et al., 2008), retina (Schmidt, 2009), 
vascular smooth muscles (Naylor et al., 2010) and testis (De Blas et al., 2005).  In contrast, 
the TRPM6 channel is almost exclusively expressed in epithelial cells (Chubanov et al., 2004, 
Wolf et al., 2010).  
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The TRPM1 protein forms an outwardly-rectifying non-selective cation channel (Oancea et 
al., 2009).  This channel has been shown to mediate synaptic transmission in rod bipolar 
cells of the retina and probably contribute to production of melanin pigment (Devi et al., 
2009).  Loss of the functional TRPM1 channels results in melanomas and night blindness in 
human (Duncan et al., 1998, Venkatachalam et al., 2006).  
The TRPM3 channel is a Ca2+ permeable non-selective cation channel that exhibits 
constitutive activity and strong outward rectification (Naylor et al., 2010, Oberwinkler et al., 
2005).  The TRPM3 channel activity can be increased by extracellular pregnenolone sulphate, 
osmolarity and Ca2+ depletion in the ER (Naylor et al., 2010, Wagner et al., 2008).  The 
TRPM3 channel has been shown to contribute to renal Ca2+ homeostasis and steroid-
induced insulin secretion from pancreatic β-cells (Lee et al., 2003, Wagner et al., 2008).  
The TRPM4 and TRPM5 channels exhibit similar channel activation and ion permeation 
properties.  Different from other TRP or TRPM channels, they are monovalent cation-
selective and are impermeable to divalent cations such as Ca2+ but they can be activated by 
intracellular Ca2+ (>1 µM).  However, the TRPM4 channel can be inactivated in the constant 
presence of intracellular Ca2+ (Nilius et al., 2003a).  The TRPM4 and TRPM5 channels are also 
activated by IP3-triggered Ca2+ depletion in the ER (Hofmann et al., 2003, Perez et al., 2002), 
positive membrane potential (Hofmann et al., 2003, Liman, 2007) and heat (Talavera et al., 
2005).  Both TRPM4 and TRPM5 channels contribute to generation of action potential in 
atria cardiomyocytes and taste cells (Hofmann et al., 2003, Simard et al., 2013).  The TRPM4 
channel has been shown to play an important role in determining dendritic cell migration 
(Barbet et al., 2008), and the TRPM5 channel contributes in taste, such as sweet, bitter and 
umami (Hofmann et al., 2003, Liu and Liman, 2003, Talavera et al., 2005).  
The TRPM6 and TRPM7 proteins show high sequence homology, and both form non-
selective cation channels with substantial Mg2+-permeability.  The TRPM6 channel currents 
are characterized by strong outward rectification.  The channel can be inhibited by internal 
Mg2+ (Gwanyanya et al., 2004), ATP (Thebault et al., 2008) and acidic pH (Gwanyanya et al., 
2004).  The TRPM7 channel is constitutively active, and can be inhibited by internal MgATP 
(Mishra et al., 2009) and acidic pH (Gwanyanya et al., 2004).  The TRPM6 and TRPM7 
channels play an important role in Mg2+ homeostasis (Bodding, 2007, Nijenhuis et al., 2006), 
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and be also involved in cell apoptosis (Nadler et al., 2001), adhesion (Su et al., 2006), and 
migration (Kuras et al., 2012) as well as detrusor smooth muscle contraction (Nomoto et al., 
2008). 
TRPM8 is present in many cells and tissues, including sperm and prostate (Henshall et al., 
2003, Tsavaler et al., 2001).  The TRPM8 channel can be activated by low temperature with 
a threshold of about 25°C, and a variety of cooling compounds, such as menthol, icilin and 
eucalyptol (Behrendt et al., 2004, Brauchi et al., 2004).  Menthol and icilin show a high 
potency with an EC50 (the concentration evoking half of the maximal effects) of 80 µM and 
0.36 µM, respectively (McKemy et al., 2002, Peier et al., 2002a).  The sensitivity of the 
TRPM8 channel to cold or menthol can be increased by inflammatory factors such as 
bradykinin and prostaglandin E2 (Linte et al., 2007, Premkumar et al., 2005).  TRPM8 has 
been shown to be involved in cool sensing and cold nociception as well as inflammatory 
process (Premkumar et al., 2005, Tsukimi et al., 2005, Marchand et al., 2005). 
1.1.5 TRPML subfamily 
Three proteins, TRPML1-3, make up the TRPML subfamily (Fig. 1.1).  The TRPML proteins 
contain a large serine lipase active site on the large loop between the S1 and S2 (Fig. 1.2).  
The function of this domain is still unclear, but it has been speculated that it may regulate 
membrane remodeling (LaPlante et al., 2011).  In contrast with the TRPs in group 1, the 
TRPMLs contain no coiled-coil domain, ankyrin repeats and the TRP domain (Montell, 2005) 
(Fig. 1.2).  Perhaps most distinctively, the TRPMLs form non-selective cation channels in the 
membranes of lysosome.    
TRPML1, also named mucolipin (MLN) 1, is the founding member of TRPML subfamily.  It 
was cloned during a genetic study searching for the gene responsible for mucolipidosis type 
IV (MLIV), a childhood neurodegenerative disease (Bargal et al., 2000).  The TRPML1 channel 
is located in the late lysosomes and endosomes, and appears to be involved in lysosome 
formation and recycling (Campbell and Fares, 2010, LaPlante et al., 2011, Piper and Luzio, 
2004).  Mutations of the TRPML1 proteins lead to the MLIV.  To date, at least 15 mutations 
are identified in the human TRPML1 gene (Dong et al., 2008, Sun et al., 2000). 
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TRPML2, also called MLN2, is abundantly expressed in the endosome and lysosome, and can 
be detected at a lower level in the plasma membranes (Venkatachalam et al., 2006).  The 
heterogeneously expressed TRPML2 channel is constitutively active and characterized by 
inward rectification.  The TRPML2 channel has been reported to be involved in trafficking 
and regulation of Arf6 (ADP-ribosylation factor 6) -associated pathway as well as cell 
apoptosis (Karacsonyi et al., 2007, Lev et al., 2010).  
TRPML3, also called MLN3, shows a broad tissue expression, including skin (Bargal et al., 
2002), stereocilia and inner ear (Atiba-Davies and Noben-Trauth, 2007, Di Palma et al., 2002, 
Kim et al., 2008).  The TRPML3 proteins are localized in the membranes of the early- and 
late-endosomes, lysosome, as well as on the cell surface (Kim et al., 2009).  The TRPML3 
channel is an inwardly-rectifying non-selective cation channel and inhibited by extracellular 
pH (Kim et al., 2008).  TRPML3 has been reported to play a role in regulating cargo 
trafficking along the endosomal pathway and autophagy (Kim et al., 2009, Martina et al., 
2009).  Mutations in the TRPML3 channel have been reported to result in embryonic 
lethality and deafness (Noben-Trauth, 2011).  
1.1.6 TRPP subfamily 
TRPP proteins are identified in the search for the gene(s) responsible to the autosomal 
dominant polycystic kidney diseases (ADPKDs) (Mochizuki et al., 1996).  ADPKDs are mainly 
caused by mutations in two separate genes, pkd1 and pkd2.  Pkd1 encodes PKD-1 protein 
(polycystic kidney disease protein 1), and pkd2 encodes TRPP2 protein.  The PKD-1 protein is 
a large integral plasma membrane protein that has 11 transmembrane segments and an 
extracellular N-terminus and an intracellular C-terminus.  The function of PKD-1 is not fully 
understood.  Several lines of independent evidence support that PKD-1 binds with TRPP2 to 
form a hetero-multimeric ion channel complex that plays a critical role in kidney 
development. 
The TRPP2 protein is a member of the TRPP subfamily (Fig. 1.1).  It is expressed in many 
tissues, including kidney, liver and pancreatic cysts (Gattone et al., 2002).  The TRPP2 
protein contains a coiled-coil domain in the C-terminus, but no ankyrin repeats and no TRP 
domain. Similar to TRPMLs, the TRPP2 protein contains a large domain between the S1 and 
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S2 (Zhu et al., 2011, Feng et al., 2011) (Fig. 1.2) The TRPP2 protein is located in the plasma 
membrane and the membrane of the ER, and form a Ca2+ permeable non-selective cation 
channel (Inoue et al., 2006).  The channel responds to activation of GPCRs and RTKs 
(Foggensteiner et al., 2000), and mechanical stimuli, such as fluid shear stress (Nauli et al., 
2003).  It is well known that mutations of TRPP2 contribute to ADPKD.  However, there is 
still a lack of knowledge of the physiological function of the TRPP2 channels.  
Two TRPP2 homologues, TRPP3 and TRPP5, have been identified to date.  The TRPP3 
channel has been detected in numerous tissues, such as retina (Nomura et al., 1998), brain 
(Wu et al., 1998), hair cell (Huang et al., 2006) and taste receptor cells in the tongue 
(Ishimaru et al., 2006, LopezJimenez et al., 2006).  The TRPP3 channel is a Ca2+-activated 
non-selective cation channel and responds to extracellular hypo-osmotic solutions and 
extracellular acidification (Murakami et al., 2005).  The TRPP3 channel plays a role in sour 
tasting (Ishimaru et al., 2006, LopezJimenez et al., 2006) and development of retina 
(Nomura et al., 1998).  The TRPP5 channel is expressed in testis, brain and kidney (Guo et al., 
2000), and could be involved in spermiogenesis, cell proliferation and apoptosis (Chen et al., 
2008, Xiao et al., 2010).  However, the role of the TRPP5 channel in the physiological 
processes is still far from being understood (Xiao et al., 2010).  
  
31 
 
1.2 TRPM2 channels 
1.2.1 Molecular cloning and cellular/ tissue distribution 
TRPM2, previously named TRPC7 (Nagamine et al., 1998) or long TRPC2 (LTRPC2) (Perraud 
et al., 2001), is the second member of the TRPM subfamily (Fig. 1.1).  The genes encoding 
TRPM2 protein have been cloned from human (Nagamine et al., 1998), rat (Kraft et al., 2004) 
and mouse (Okada et al., 1999).  The predicted full-length human, rat and mouse TRPM2 
proteins have 1503, 1508 and 1506 amino acid residues, respectively (Fig.1.3), with a 
molecular weight of approximately 170 kDa (Hill et al., 2006, Nagamine et al., 1998).  The 
human TRPM2 (hTRPM2) gene is located in the chromosome 21q22.3, composed of 32 
exons, and spanning approximately 90 kb (Nagamine et al., 1998).   
An early study using Northern blotting and reverse transcription-polymerase chain reaction 
(RT-PCR) showed that TRPM2 mRNA of approximate 6.5 kb is abundantly expressed in many 
regions in the brain, including cerebral cortex, occipital pole, frontal lobe, amygdala, 
caudate nucleus and hippocampus (Nagamine et al., 1998).  To date, both TRPM2 mRNA 
and protein have been revealed in several other types of cells, such as neutrophil 
granulocytes (Heiner et al., 2003), microglia (Fonfria et al., 2006), monocyte cells 
(Yamamoto et al., 2008), pancreatic β-cells (Togashi et al., 2006, Uchida and Tominaga, 2011) 
and endothelial cells (Hecquet et al., 2008, Hill et al., 2006, Wehrhahn et al., 2010). 
Furthermore, using patch clamp recording and fluorescent Ca2+ imaging, functional 
expression of the TRPM2 channels has been identified in various types of cells, such as 
hippocampal neurons (Olah et al., 2009, Perraud et al., 2001), striatal neurons (Perraud et 
al., 2001), DRG neurons (Naziroglu et al., 2011), peritoneal macrophages (Kashio et al., 
2012), microglia (Fonfria et al., 2006, Hill et al., 2006, Kraft et al., 2004), T lymphocytes (Beck 
et al., 2006, Magnone et al., 2012), neutrophil granulocytes (Beck et al., 2006, Heiner et al., 
2003), pancreatic β-cells (Togashi et al., 2006, Uchida and Tominaga, 2011) and endothelial 
cells (Hecquet et al., 2008, Hill et al., 2006, Wehrhahn et al., 2010). 
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1.2.2 Molecular or structural properties 
As shown in Fig. 1.4, TRPM2 subunit contains six transmembrane segments, a pore-forming 
region between the S5 and S6, and intracellular N- and C-terminus like all other members of 
the TRP superfamily.  The functional TRPM2 channel is homo-tetrameric, composed of four 
subunits.  The results from a study using transmission electron microscopy shows a bell-
shaped three-dimensional structure of the tetrameric TRPM2 channel with 18 nm in width 
and 25 nm in height (Maruyama et al., 2007).  The extracellular part of this bell-shaped 
molecule is small, dense and dome-like; while the intracellular part is large, sparse and 
double-layered. 
The N-terminus of the TRPM2 protein (amino acid residues 1-730) contains an IQ-like motif, 
comprising of amino acid residues 406–416 (Tong et al., 2006).  The N-terminus also 
contains a coiled-coil domain, which is located in the amino acid sequence from residues 
654-681 (Mei and Jiang, 2009) (Fig. 1.3 and Fig. 1.4).  The significant noticeable variation 
between TRPM2 and other TRP proteins or the unique feature of the TRPM2 proteins is that 
the C-terminus (amino acid residues 1236-1503) has an enzyme domain, which shares 39% 
homology to the NUDT9 (Nudix (nucleoside diphosphate linked moiety X)-type motif 9) 
ADPR (adenosine diphosphate ribose) hydrolases and thus is termed the NUDT9-H domain 
(Shen et al., 2003).  This domain serves as a binding site for ADPR and confers specific 
activation of the TRPM2 channels by ADPR.  The C-terminus of TRPM2 protein also contains 
a coiled-coil domain (amino acid residues 1171-1200) and a highly conserved TRP domain 
(amino acid residues 1062-1067) (Sumoza-Toledo and Penner, 2011) (Fig. 1.3 and Fig. 1.4). 
1.2.2.1 Functional properties of the TRPM2 channels 
The TRPM2 channel currents exhibit a linear current-voltage (I-V) relationship.  The reversal 
potential in physiological solutions is about 0 mV, indicating that the TRPM2 channel is non-
selective and permeable to cations such as Na+, K+ and Ca2+.  The relative permeability, 
PK/PNa and PCa/PNa, is about 1.1 and 0.9, respectively (Xia et al., 2008), although a much 
higher PCa/PNa value of 5.83 has also been reported (Togashi et al., 2006).  According to the 
results of single-channel patch clamp recording, the conductance of the single TRPM2 
channel is 50-80 pS (Inamura et al., 2003, Perraud et al., 2001, Sano et al., 2001, Kraft et al., 
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2004).  The single-channel recordings also show sustained channel opening that can last up 
to minutes (Kraft et al., 2004, Perraud et al., 2001, Sano et al., 2001). 
There are several amino acid residues and segments that have been demonstrated to be 
involved in determining the TRPM2 channel functional properties.  A previous study using 
site-directed mutagenesis in our lab demonstrated that Glu-960, Gln-981, Asp-987, and Glu-
1022 in the pore-forming loop contribute to the gating and divalent cation permeation of 
the hTRPM2 channel (Fig. 1.4).  Whole-cell recordings in this study showed that mutation of 
Glu-960 eliminates the channel activation by ADPR.  The reduction in ADPR-induced currents 
was also observed in the D987E and E1022A mutant channels.  Further experiments 
revealed augmentation of the Ca2+ permeability by Q981E and D987E mutations, as well as 
the increase in Mg2+ permeability by E1022A mutation (Xia et al., 2008).  Another site-
directed mutagenesis study reported that substitution of two conserved Cys residues, Cys-
996 and Cys-1008 in the pore region of the hTRPM2 channel (Fig.1.4) by Ala or Ser 
dramatically reduced or completely abolished ADPR-induced currents.  Furthermore, Biotin 
labeling and co-immunoprecipitation analysis showed no change in total protein expression, 
membrane trafficking and localization, or subunit interactions.  These results suggest an 
essential role of these two Cys residues in the channel function (Mei et al., 2006a).  The 
TRPM2 channel currents decline in the continuous or prolonged exposure to ADPR, a 
phenomenon called current rundown, often observed in the inside-out configuration of 
patch-clamp recording.  Such current rundown is presumably due to irreversible inactivation 
of the TRPM2 channels through conformational changes in the pore region.  Consistent with 
this hypothesis, a recent study has demonstrated that, in the TRPM2 pore region, insertion 
of a Leu residue between residues 983 and 984 and substitution of Gly-984 and Tyr-985 
residues (Fig. 1.4) with Asp and Glu present in the corresponding pore region of the TRPM5 
channel, which showed no current rundown, almost completely abolished the rundown of 
the TRPM2 channel currents (Toth and Csanady, 2012). 
1.2.2.2 Channel assembly 
As described above, a coiled-coil domain is located in the C-terminus of the TRPM2 protein 
(Fig. 1.4), and its sequence is presented in Fig. 1.3.  This domain is highly conserved among 
the TRPM subfamily.  A previous study has reported that this coiled-coil domain is essential  
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hTRPM2    MEPSALRKAGSEQEEGFEGLPRRVTDLGMVSNLRRSNSSLFKSWRLQCPFGNNDKQESLSSWIPENIKKKECVYFVESSK 80
mTRPM2    MESLDRRRTGSEQEEGFGVQSRRATDLGMVPNLRRSNSSLCKSRRFLCSFSS-EKQENLSSWIPENIKKKECVYFVESSK    79
rTRPM2    MEPLDQRRTDSDQEEGFGVQSRRATDLGMVPNLRRSNSSLCKSRRLLCSFSS-EKQENLSSWIPENIKKKECVYFVESSK    79
hTRPM2    LSDAGKVVCQCGYTHEQHLEEATKPHTFQGTQWDPKKHVQEMPTDAFGDIVFTGLSQKVKKYVRVSQDTPSSVIYHLMTQ 160
mTRPM2    LSDAGKVVCACGYTHEQHLEVAIKPHTFQGKEWDPKKHVQEMPTDAFGDIVFTDLSQKVGKYVRVSQDTPSSVIYQLMTQ    159
rTRPM2    LSDAGKVVCECGYTHEQHIEVAIKPHTFQGKEWDPKKHVHEMPTDAFGDIVFTGLSQKVGKYVRLSQDTSSIVIYQLMTQ    159
hTRPM2    HWGLDVPNLLISVTGGAKNFNMKPRLKSIFRRGLVKVAQTTGAWIITGGSHTGVMKQVGEAVRDFSLSSSYKEGELITIG    240
mTRPM2    HWGLDVPNLLISVTGGAKNFNMKLRLKSIFRRGLVKVAQTTGAWIITGGSHTGVMKQVGEAVRDFSLSSSCKEGEVITIG    239
rTRPM2    HWGLDVPSLLISVTGGAKNFNMKLRLKSIFRRGLVKVAQTTGAWIITGGSHTGVMKQVGEAVRDFSLSSSCKEGDVITIG    239
hTRPM2    VATWGTVHRREGLIHPTGSFPAEYILDEDGQGNLTCLDSNHSHFILVDDGTHGQYGVEIPLRTRLEKFISEQTKERGGVA    320
mTRPM2    VATWGTIHNREGLIHPMGGFPAEYMLDEEGQGNLTCLDSNHSHFILVDDGTHGQYGVEIPLRTKLEKFISEQTKERGGVA    319
rTRPM2    IATWGTIHNREALIHPMGGFPAEYMLDEEGQGNLTCLDSNHSHFILVDDGTHGQYGVEIPLRTKLEKFISEQTKERGGVA    319
hTRPM2    IKIPIVCVVLEGGPGTLHTIDNATTNGTPCVVVEGSGRVADVIAQVANLPVSDITISLIQQKLSVFFQEMFETFTESRIV    400
mTRPM2    IKIPIVCVVLEGGPGTLHTIYNAINNGTPCVIVEGSGRVADVIAQVATLPVSEITISLIQQKLSIFFQEMFETFTENQIV    399
rTRPM2    IKIPIVCVVLEGGPGTLHTIYNAITNGTPCVIVEGSGRVADVIAQVAALPVSEITISLIQQKLSVFFQEMFETFTENQIV    399
hTRPM2    EWTKKIQDIVRRRQLLTVFREGKDGQQDVDVAILQALLKASRSQDHFGHENWDHQLKLAVAWNRVDIARSEIFMDEWQWK    480
mTRPM2    EWTKKIQDIVRRRQLLTIFREGKDGQQDVDVAILQALLKASRSQDHFGHENWDHQLKLAVAWNRVDIARSEIFTDEWQWK    479
rTRPM2    EWTKKIQDIVRRRQLLTVFREGKDGQQDVDVAILQALLKASRSQDHFGHENWDHQLKLAVAWNRVDIARSEIFTDEWQWK    479
hTRPM2    PSDLHPTMTAALISNKPEFVKLFLENGVQLKEFVTWDTLLYLYENLDPSCLFHSKLQKVLVEDPERPACAPAAPRLQMHH    560
mTRPM2    PADLHPMMTAALISNKPEFVRLFLENGVRLKEFVTWDTLLCLYENLEPSCLFHSKLQKVLAEE-QRLAYASATPRLHMHH    558
rTRPM2    PSDLHPMMTAALISNKPEFVRLFLENGVRLKEFVTWDTLLCLYENLEPSCLFHSKLQKVLAEEHERLAYASETPRLQMHH    559
IQ-motif406
1
535
35 
 
  
 
hTRPM2    VAQVLRELLGDFTQPLYPRPRHNDRLRLLLPVPHVKLNVQGVSLRSLYKRSSGHVTFTMDPIRDLLIWAIVQNRRELAGI    640
mTRPM2    VAQVLRELLGDSTQLLYPRPRYTDRPRLSMTVPHIKLNVQGVSLRSLYKRSTGHVTFTIDPVRDLLIWAVIQNHRELAGI    638
rTRPM2    VAQVLRELLGDSTQLLYPRPRYTDRPRLSLPMPHIKLNVQGVSLRSLYKRSTGHVTFTIDPVRDLLIWAIIQNHRELAGI    639
hTRPM2    IWAQSQDCIAAALACSKILKELSKEEEDTDSSEEMLALAEEYEHRAIGVFTECYRKDEERAQKLLTRVSEAWGKTTCLQL    720
mTRPM2    IWAQSQDCTAAALACSKILKELSKEEEDTDSSEEMLALADEFEHRAIGVFTECYRKDEERAQKLLVRVSEAWGKTTCLQL    718
rTRPM2    IWAQSQDCTAAALACSKILKELSKEEEDTDSSEEMLALADEFEHRAIGVFTECYRKDEERAQKLLVRVSEAWGKTTCLQL    719
hTRPM2    ALEAKDMKFVSHGGIQAFLTKVWWGQLSVDNGLWRVTLCMLAFPLLLTGLISFREKRLQDVGTPAARARAFFTAPVVVFH    800
mTRPM2    ALEAKDMKFVSHGGIQAFLTKVWWGQLCVDNGLWRIILCMLAFPLLFTGFISFREKRLQALCRP-ARVRAFFNAPVVIFH    797
rTRPM2    ALEAKDMKFVSHGGIQAFLTKVWWGQLCVDNGLWRIILCMLAFPLLFTGFISFREKRLQALCRP-ARVRAFFNAPVVIFY    798
hTRPM2    LNILSYFAFLCLFAYVLMVDFQPVPSWCECAIYLWLFSLVCEEMRQLFYDPDECGLMKKAALYFSDFWNKLDVGAILLFV 880
mTRPM2    MNILSYFAFLCLFAYVLMVDFQPSPSWCEYLIYLWLFSLVCEETRQLFYDPDGCGLMKMASLYFSDFWNKLDVGAILLFI    877
rTRPM2    LNILSYFAFLCLFAYVLMVDFQPSPSWCEYLIYLWLFSLVCEETRQLFYDPDGCGLMKMASLYFSDFWNKLDVGAILLFI    878
hTRPM2    AGLTCRLIPATLYPGRVILSLDFILFCLRLMHIFTISKTLGPKIIIVKRMMKDVFFFLFLLAVWVVSFGVAKQAILIHNE 960
mTRPM2    VGLTCRLIPATLYPGRIILSLDFIMFCLRLMHIFTISKTLGPKIIIVKRMMKDVFFFLFLLAVWVVSFGVAKQAILIHNE    957
rTRPM2    AGLTCRLIPATLYPGRIILSLDFIMFCLRLMHIFTISKTLGPKIIIVKRMMKDVFFFLFLLAVWVVSFGVAKQAILIHNE    958
hTRPM2    RRVDWLFRGAVYHSYLTIFGQIPGYIDGVNFNPEHCSPNGTDPYKPKCPESDATQQRPAFPEWLTVLLLCLYLLFTNILL 1040
mTRPM2    SRVDWIFRGVVYHSYLTIFGQIPTYIDGVNFSMDQCSPNGTDPYKPKCPESDWTGQAPAFPEWLTVTLLCLYLLFANILL    1037
rTRPM2    SRVDWIFRGVIYHSYLTIFGQIPTYIDGVNFSMDQCSPNGTDPYKPKCPESDWTGQAPAFPEWLTVTLLCLYLLFANILL    1038
hTRPM2    LNLLIAMFNYTFQQVQEHTDQIWKFQRHDLIEEYHGRPAAPPPFILLSHLQLFIKRVVLKTPAKRHKQLKNKLEKNEEAA    1120
mTRPM2    LNLLIAMFNYTFQEVQEHTDQIWKFQRHDLIEEYHGRPPAPPPLILLSHLQLLIKRIVLKIPAKRHKQLKNKLEKNEETA    1117
rTRPM2    LNLLIAMFNYTFQEVQEHTDQIWKFQRHDLIEEYHGRPPAPPPLILLSHLQLLIKRIVLKIPAKRHKQLKNKLEKNEEAA    1118
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Figure 1.3 TRPM2 amino acid sequence alignments 
Amino acid sequence alignments of human (hTRPM2), mouse (mTRPM2) and rat (rTRPM2) TRPM2 proteins.  Different functional domains are 
highlighted in different background colours (Blue, transmembrane segments; Yellow, pore region; Orange, NUDT9-H domain; Purple, IQ-moif; 
Green, coiled-coil domain; Navy, N-x-x D motif; Pink, TRP domain).  The sequences in italics present the truncation of amino acids residues in 
splice variants.  The amino acids labelled in red are subjected to site-direct mutagenesis studies.   
 
hTRPM2    LLSWEIYLKENYLQNRQFQQKQRPEQKIEDISNKVDAMVDLLDLDPLKRSGSMEQRLASLEEQVAQTARALHWIVRTLRA    1200
mTRPM2    LLSWELYLKENYLQNQQYQQKQRPEQKIQDISEKVDTMVDLLDMDQVKRSGSTEQRLASLEEQVTQVTRALHWIVTTLKD    1197
rTRPM2    LLSWELYLKENYLQNQQYQHKQRPEQKIQDISEKVDTMVDLLDMDRVKRSGSTEQRLASLEEQVTQMGRSLHWIVTTLKD    1198
hTRPM2    SGFSSEADVPTLASQKAAEEPDAEPGGRKKTEEPGDSYHVNARHLLYPNCPVTRFPVPNEKVPWETEFLIYDPPFYTAER    1280
mTRPM2    SGFGSGAGALTLAPQRAFDEPDAELSIRRKVEEPGDGYHVSARHLLYPNARIMRFPVPNEKVPWAAEFLIYDPPFYTAEK    1277
rTRPM2    SGFGSGAGALTLAAQRAFDEPDAELSIRKKGEEGGDGYHVSARHLLYPDARIMRFPVPNEKVPWEAEFLIYDPPFYTAEK    1278
hTRPM2    KDAAAMDPMGDTLEPLSTIQYNVVDGLRDRRSFHGPYTVQAGLPLNPMGRTGLRGRGSLSCFGPNHTLYPMVTRWRRNED    1360
mTRPM2    -DVALTDPVGDTAEPLSKISYNVVDGPTDRRSFHGVYVVEYGFPLNPMGRTGLRGRGSLSWFGPNHTLQPVVTRWKRNQG    1356
rTRPM2    KDATLTDPVGDTAEPLSKINYNVVDGLMDRCSFHGTYVVQYGFPLNPMGRTGLRGRGSLSWFGPNHTLQPVVTRWKRNQG    1358
hTRPM2    GAICRKSIKKMLEVLVVKLPLSEHWALPGGSREPGEMLPRKLKRILRQEHWPSFENLLKCGMEVYKGYMDDPRNTDNAWI    1440
mTRPM2    GAICRKSVRKMLEVLVMKLPRSEHWALPGGSREPGEMLPRKLKRVLRQEFWVAFETLLMQGTEVYKGYVDDPRNTDNAWI    1436
rTRPM2    GGICRKSVRKMLEVLVMKLPQSEHWALPGGSREPGKMLPRKLKQVLQQEYWVTFETLLRQGTEVYKGYVDDPRNTDNAWI    1438
hTRPM2    ETVAVSVHFQDQNDVELNRLNSNLHACDSGASIR-------WQVVDRRIPLYANHKTLLQKAAAEFGAHY    1503
mTRPM2    ETVAVSIHFQDQNDMELKRLEENLHTHDPKELTRDLKLSTEWQVVDRRIPLYANHKTILQKVASLFGAHF    1506
rTRPM2    ETVAVSIHFQDQNDVELKRLEENLQTHDPKESARGLEMSTEWQVVDRRIPLYVNHKKILQKVASLFGAHF    1508
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Figure 1.4 The topology and structural features of the TRPM2 channel subunit  
Different functional domains are highlighted in different symbol denoted in the figure.  The amino acids presented in the figure are 
subjected to site-direct mutagenesis studies.   
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for the TRPM8 channel assembly (Tsuruda et al., 2006).  A study has revealed that the 
coiled-coil domain also plays an important role in the TRPM2 channel assembly (Mei et al., 
2006b).  Biotin labeling and Western blotting results demonstrated that there was no 
difference in the total protein expression level between the TRPM2 mutant with the C-
terminal coiled-coil domain being deleted (∆CC) and WT TRPM2 protein, whereas the cell 
surface expression level of the ∆CC mutant protein was only about half of the WT protein.  
The co-immunoprecipitation experiments also showed a dramatic reduction in the 
interaction between the ∆CC mutant proteins.  Furthermore, much smaller ADPR-induced 
currents were observed in HEK293 (human embryonic kidney 293) cells expressing the ∆CC 
mutant protein than in cells expressing the WT protein.  Thus, these observations led to the 
conclusion that the C-terminal coiled-coil domain is required in functional TRPM2 channel 
assembly.  However, low level interactions between the ∆CC mutant proteins themselves 
and between the ∆CC mutant and WT proteins were observed, suggesting involvement of 
additional regions in the TRPM2 channel assembly (Mei et al., 2006b). 
1.2.2.3 Other domains 
Besides the C-terminal coiled-coil domain, the TRPM2 protein contains another coil-coiled 
domain in the N-terminus (Fig. 1.4) with its sequence showed in Fig. 1.3.  The deletion of 
this N-terminal coiled-coil domain dramatically reduced the TRPM2 protein expression, and 
completely abolished ADPR-induced whole-cell current.  Furthermore, introduction of I658Q 
mutation in the coiled-coil domain abolished ADPR-induced current without significant 
change in the protein expression and subunit interaction (Mei and Jiang, 2009) (Fig. 1.4).  
Thus, in contrast to contribution of the C-terminal coiled-coil domain in the TRPM2 channel 
assembly, the N-terminal coiled-coil domain plays a role in the TRPM2 channel expression 
and function, with minimal involvement in the channel assembly. 
An N-x-x-D motif (amino acid 869-872) is present in the intracellular end of the S3 (Fig. 1.4).  
Substitution of Asp-872 with Asn resulted in complete loss of ADPR-induced currents, but 
caused no change in the cell surface expression level of TRPM2 protein , suggesting 
potential involvement in the TRPM2 channel gating (Winking et al., 2012). 
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Besides the functional regions mentioned above, there is a TRP domain located in the C-
terminus of the TRPM2 protein (Fig. 1.4).  However, the functional significance of this 
domain in the TRPM2 channel is unknown. 
1.2.3 Alternative splicing isoforms 
In addition to the full-length TRPM2 subunit (TRPM2-L in short), there are several 
alternative splice isoforms (Fig. 1.3).  The TRPM2-S (short TRPM2) isoform results from 
introduction of a premature stop codon (TAG) at the splice junction between exons 16 and 
17, leading to truncation of amino acid residues 847-1053; thus TRPM2-S lacks the last four 
transmembrane segments and the whole C-terminus (Fig. 1.3).  This isoform is expressed in 
human hematopoietic cells (Du et al., 2009b, Zhang et al., 2003).   Endogenous expression of 
both the TRPM2-L and TRPM2-S isoforms have been identified in human BFU-E (burst-
forming unit-erythroid)-derived cells.  Both are targeted to the plasma membrane as shown 
by immunofluorescent confocal microscopy.   Heterologous expression of the TRPM2-S 
isoform in HEK293 cells exhibits a similar subcellular localization as the TRPM2-L, but results 
in no functional channel.  Co-expression and co-immunoprecipitation showed that TRPM2-L 
and TRPM2-S isoforms can interact directly.  However, co-expression with the TRPM2-S 
isoform suppresses H2O2 (hydrogen peroxide)-induced Ca2+ responses and inhibits H2O2-
induced cell death mediated by the TRPM2-L isoform (Zhang et al., 2003).   
Another short isoform is called SSF-TRPM2, as it was originally identified in the striatum 
(Uemura et al., 2005) (Fig. 1.3).  Its transcription begins with the start codon in the fourth 
intron.  The SSF-TRPM2 protein lacks the first 214 amino acid residues in the N-terminus (Fig. 
1.3), but can still form a functional channel that mediates H2O2-induced Ca2+ influx.  
However, the Ca2+ influx amplitude is smaller than that mediated by the TRPM2-L channel.   
Additional alternative splicing isoforms have been found, including loss of part of exon 11 
and skipping of exon 27, resulting in deletion of amino acid residues 537–556 and 1292–
1325 in the N- and C-terminus, respectively, or TRPM2-ΔN and TRPM2-ΔC isoforms (Fig. 1.3).  
The TRPM2-ΔC isoform was initially identified in neutrophils and Hela cells, and cannot be 
activated by ADPR or cADPR (cyclic ADPR) (Numata et al., 2012, Wehage et al., 2002, Du et 
al., 2009a).  Using whole-cell patch clamp, Du and his colleagues have revealed that the 
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TRPM2-ΔC isoform can be stimulated by intracellular Ca2+, requiring the calmodulin (CaM)-
binding domain (the IQ-motif) in the N-terminus.  This result suggests the TRPM2 channel 
gating by Ca2+ in an ADPR-independent manner (discussed further in section 1.2.5.1.5 and 
1.2.6.2) (Du et al., 2009a).  A recent study has proposed the TRPM2-ΔC channel to mediate 
the hypertonic stress-induced currents in Hela cell as both exhibit similar I-V relationships 
and Ca2+ permeability (Numata et al., 2012).  The TRPM2-ΔN channels exhibited no 
activation by ADPR and H2O2 (Kuhn et al., 2009, Du et al., 2009a).  However, Du 
demonstrated that the whole-cell TRPM2-ΔN channel current can be evoked by intracellular 
Ca2+ (Du et al., 2009a). 
1.2.4 Subcellular location 
As mentioned above, the TRPM2 channels were thought as Ca2+-permeable cation channels.  
Many studies have provided functional evidence supporting that the TRPM2 channels are 
localized in the plasma membrane and mediate extracellular Ca2+ influx in diverse types of 
cells, such as monocyte cells (Yamamoto et al., 2008), T lymphocytes (Beck et al., 2006, 
Magnone et al., 2012), pancreatic β-cells (Togashi et al., 2008, Uchida and Tominaga, 2011), 
endothelial cells (Hecquet et al., 2008) and neurons (Chung et al., 2011, Ishii et al., 2006a, 
Ishii et al., 2006b, Kolisek et al., 2005, Olah et al., 2009, Perraud et al., 2005).  TRPM2-
mediated Ca2+ influx results in increases in the cytosolic Ca2+ concentrations ([Ca2+]c) that 
plays a role in a variety of cell functions such as cytokine generation, insulin release, and cell 
death (discussed in detail in section 1.2.7-1.2.8).   
Recent studies have reported that the TRPM2 channels are also or exclusively present in the 
membranes of intracellular organelles and function as intracellular Ca2+-release channels.  
The study by Lange and his colleagues demonstrated that, besides acting as a plasma 
membrane Ca2+ channel, the TRPM2 channel contributed to ADPR-induced intracellular 
Ca2+-release from the lysosome in TRPM2-expressing HEK293 cells and also in rat insulinoma 
cell line INS-1 endogenously expressing TRPM2 channels (Lange et al., 2009).  Lange and his 
colleagues showed using immunofluorescent confocal microscopy that the TRPM2 proteins 
were localized in the lysosome but not in the ER.  The Ca2+ storage in the lysosome is 
maintained by the proton gradient across the lysosomal membrane that is generated by 
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vacuolar-type H+-ATPase (V-ATPase).  V-ATPase is an enzyme located in the lysosomal 
membrane and pumps intracellular protons into the lysosomes, endosomes and secretory 
vesicles (Haller et al., 1996, Christensen et al., 2002).  Bafilomycin A, a type of macrolide 
antibiotic, is a specific blocker of the V-ATPase and can induce Ca2+ depletion in the 
lysosome (Kinnear et al., 2008, Kinnear et al., 2004).  Lange further showed that intracellular 
ADPR induced- Ca2+ release in INS-1 β cells can be abolished by pre-treatment with 
bafilomycin A.  These results indicate the TRPM2 channels to function as lysosomal Ca2+ 
release channels in INS-1 β cells (Lange et al., 2009).  A recent study using 
immunofluorescent confocal microscopy and Ca2+ imaging has shown the TRPM2 channel to 
be exclusively localized in the late endosomes and lysosomes, mediating Ca2+ release from 
the lysosome in mouse dendritic cells (Sumoza-Toledo and Penner, 2011).  
1.2.5 Pharmacology of TRPM2 channels 
1.2.5.1 Channel activators 
Several chemical and physical activators of the TRPM2 channels have been found over the 
past few years.  Structures of some chemical activators are shown in Fig. 1.5. 
1.2.5.1.1 ADPR 
ADPR (Fig. 1.5) activates the TRPM2 channels in a concentration-dependent manner.  The 
EC50 value varies in the range of 1-90 μM, depending on the cell types examined.  For 
instance, studies reported the EC50 to be 1.1, 7, 10 and 90 μM in neutrophils (Lange et al., 
2008), Jurkat T cells (Beck et al., 2006), TRPM2-expressing HEK293 cells (Kolisek et al., 2005, 
Starkus et al., 2007) and CRI-G1 insulinoma cells (Inamura et al., 2003), respectively.  The 
concentration for maximal activation is about 300-500 µM.  ADPR activates the TRPM2 
channels by directly binding to the above-mentioned TRPM2-specific NUDT9-H domain in 
the distal part of the intracellular C-terminus.  The binding affinity (Kd) of ADPR to the 
NUDT9-H domain, when expressed alone, is 100-130 µM (Kuhn and Luckhoff, 2004).  Using 
sited-directed mutagenesis, Kühn and his colleagues have revealed that Asn-1326, Ile-1405 
and Leu-1406 in the NUDT9-H domain (Fig. 1.3) play a crucial role in activation of TRPM2 
channel by ADPR (Kuhn and Luckhoff, 2004).  
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Figure 1.5 Structures of TRPM2 activators  
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It has been proposed that ADPR is generated from nicotinamide adenine dinucleotide (NAD) 
in the nucleus or in the mitochondria of the cells in response to ROS (reactive oxygen 
species) and reactive nitrogen species (RNS) (Fig. 1.7).  In the nucleus, ROS/RNS-induced 
DNA-damages initiate the DNA repair process, in which poly(ADPR) polymerases (PARP) are 
activated to polymerize ADPR using donor NAD into poly(ADPR) (PAR) chain on acceptor 
proteins, including PARP itself and, subsequently, the PAR chain is hydrolyzed to ADPR by 
poly(ADPR) glycohydrolase (PARG) (Kim et al., 2005).  In the mitochondria, ROS/RNS-
activated NAD nucleosidase (NADase) catalyzes hydrolysis of NAD to ADPR and nicotinamide 
(Guse, 2005, Wehage et al., 2002) (Fig. 1.7).  ADPR presumably diffuses via yet known 
mechanisms to the cytosol from either the nucleus or the mitochondria, and bind to the 
TRPM2 channels.  ADPR can be also generated extracellularly by CD38, a multifunctional 
ectoenzyme, using NAD as the substrate (Fig. 1.7).  CD38 can convert NAD to cADPR or ADPR 
(Fig. 1.7) via its ADP-ribosylcyclase and NAD glycohydrolase activities, respectively.  Cyclic 
ADPR can be further converted to ADPR by CD38 via its cADPR hydrolase activity.  In 
addition to CD38, CD38-like enzymes BST-1 and CD157 are also involved in the metabolism 
of NAD, cADPR and ADPR (Lund et al., 2006, Lund et al., 1995, Malavasi et al., 2006).  
Partida-Sanchez has shown increases in the [Ca2+]c and chemotaxis in mouse bone marrow 
neutrophils in response to cytokine and bacterial chemoattractant, formyl-methionyl-leucyl-
phenylalanine (fMLP).  Furthermore, using CD38-deficient mice, he also demonstrated that 
the deficiency of CD38 dramatically suppressed these two processes via reducing production 
of cADPR and ADPR (Partida-Sanchez et al., 2007, Partida-Sanchez et al., 2001).  However, 
the roles of CD38 and CD38-like enzymes in regulating the intracellular level of ADPR are still 
not well established, because it is unclear how ADPR generated extracellularly can be 
transported into the cytosol in order to bind the NUDT9-H domain of the TRPM2 channels 
(Hecquet and Malik, 2009, Takahashi et al., 2011). 
1.2.5.1.2 Nicotinic acid adenine dinucleotide phosphate (NAADP) 
NAADP (Fig. 1.5) elicits TRPM2 channel currents in a concentration-dependent manner in 
several types of cells, such as neutrophils (Lange et al., 2008), Jurkat T cells (Beck et al., 2006) 
and TRPM2-expressing Xenopus oocytes (Toth and Csanady, 2010).  The EC50s are 95 and 
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730 μM in neutrophils and Jurkat T cells, respectively; under the same experimental 
conditions, the EC50s for ADPR are 1.1 and 7 μM in these two types of cells, suggesting that 
the potency of NAADP is approximately 100-fold lower than that of ADPR (Beck et al., 2006, 
Lange et al., 2009).  Furthermore, NAADP induced TRPM2 channel currents in inside-out 
recording of Xenopus oocytes heterogeneously expressing the TRPM2 channels, indicating 
that NAADP can directly activate the TRPM2 channels (Toth and Csanady, 2010).  
1.2.5.1.3 NAD 
NAD, shown in Fig. 1.5, is the substrate for ADPR generation (Fig. 1.7).  An early study using 
inside-out patch clamp recording however revealed that intracellular NAD can directly 
trigger the TRPM2 channels to open but it has a low potency with an EC50 of about 1 mM in 
TRPM2-expressing HEK293 cells (Sano et al., 2001).  Activation of the TRPM2 channels by 
NAD in whole-cell patch clamp recordings exhibited a significant delay (50-150 s) (Kolisek et 
al., 2005, Sano et al., 2001).  However, another study showed failure of NAD to activate the 
TRPM2 channels (Wehage et al., 2002).  In a recent study, Toth and Csanady showed that 
commercially available NAD is contaminated with a detectable amount of ADPR using thin 
layer chromatography, and suggested the activation of the TRPM2 channels by NAD could 
be induced by the contaminated ADPR (Toth and Csanady, 2010).  Thus, the function of NAD 
as a TRPM2 activator is still an open question. 
1.2.5.1.4 cADPR 
Several studies also show activation of the TRPM2 channels by cADPR (Fig. 1.5).  
Intracellular cADPR has been shown using whole-cell patch clamp recording to induce the 
TRPM2 channel currents in a concentration-dependent manner in several types of cells, 
such as TRPM2-expressing HEK293 cells (Kolisek et al., 2005), neutrophils (Lange et al., 2009) 
and Jurkat T cells (Beck et al., 2006).  The sensitivity differs substantially with EC50s of about 
700 μM, 44 μM and 60 μM, respectively in these three cell types.  Furthermore, inside-out 
patch clamp recordings confirm direct activation of the TRPM2 channels by cADPR (Beck et 
al., 2006), but the underlying mechanism is unclear.  It has been proposed that cADPR 
interacts with a site that is different from the ADPR binding-site in the NUDT9-H domain 
(Kolisek et al., 2005).  However, several other studies have failed to demonstrate cADPR as a 
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TRPM2 channel agonist (Hara et al., 2002, Wehage et al., 2002, Heiner et al., 2006).  In a 
recent study using inside-out patch clamp recordings in TRPM2-expressing Xenopus oocytes, 
the TRPM2 channel currents can induced by the commercially sourced cADPR but not the 
purified cADPR (Toth and Csanady, 2010), supporting the notion that cADPR does not 
directly activate the TRPM2 channels on its own.   
A series of chemicals contained adenine dinucleotide group, including ADPR, NAADP, NAD 
and cADPR, have been reported to show a synergy in activation of the TRPM2 channels 
(Kolisek et al., 2005, Lange et al., 2009).  For instance, using whole-cell patch clamp 
recording in neutrophils, the EC50s of NAADP and cADPR are reduced from 95 µM to 1 μM 
and from 44 µM to 3 μM, respectively, in the presence of 100 nM ADPR (Lange et al., 2009).  
In addition, the TRPM2 channels can be activated by co-application of 300 μM NAD and 10 
μM cADPR, which cannot activate on their own, suggesting a synergistic effect (Kolisek et al., 
2005).  However, ADPR-induced TRPM2 channel currents were not enhanced by co-
application with cADPR in TRPM2-expressing Xenopus oocytes (Toth and Csanady, 2010).  
This could result from different type of cells used, or, according to the authors, from the fact 
that the ADPR contamination in the commercial cADPR samples, but not the cADPR, leads to 
TRPM2 channel activation (Toth and Csanady, 2010).     
1.2.5.1.5 Ca2+ 
ADPR-induced TRPM2 channel currents were significantly increased in the presence of 
extracellular Ca2+.  Furthermore, ADPR-induced currents in the presence of extracellular Ca2+ 
can be attenuated by intracellular application of BAPTA (1,2-bis(o-aminophenoxy)ethane- 
N,N,N',N'-tetraacetic acid), a Ca2+chelator, to lower the [Ca2+]c.  Since Ca2+ can enter into the 
cell through the open TRPM2 channels, these results suggest that intracellular Ca2+ is 
required for full activation of the TRPM2 channels.  Further whole-cell patch clamp 
recordings show that the up-regulation of the ADPR-induced TRPM2 channel currents by 
Ca2+ is concentration-dependent, with an EC50 of 340 nM and a threshold of 100 nM 
(McHugh et al., 2003).  Such a concentration-dependent activation by intracellular Ca2+ is 
confirmed in a subsequent study by inside-out patch clamp recordings of ADPR-induced 
currents in TRPM2-expressing Xenopus oocytes, with an EC50 of 22.4 μM, which is noticeably 
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higher due to perhaps the different concentrations of  ADPR used (Csanady and Torocsik, 
2009).  
Besides the enhancement of ADPR-induced TRPM2 channel activation by Ca2+, a recent 
study, using whole-cell and single-channel patch clamp recording, also showed that 
intracellular Ca2+ alone is sufficient to activate the TRPM2 channels.  In particular, the study 
showed robust Ca2+-induced TRPM2 channel currents in HEK293 cells heterologously 
expressing the ADPR-insensitive TRPM2-ΔC splice isoform, presenting compelling evidence 
to support the notion that intracellular Ca2+ can activate the TRPM2 channels independently 
of ADPR.  The same study also shows that, in cells expressing the ADPR-sensitive TRPM2 
channels, ADPR can enhance Ca2+-induced activation and that co-application of ADPR 
reduces the EC50 for Ca2+ from 16.9 µM to 0.49 μM (Du et al., 2009a). 
1.2.5.1.6 Reactive oxygen species 
The free oxygen radicals or ROS all have oxygen ion or peroxide.  There are several types of 
ROS, such as hydroxyl radical (HO•), superoxide anion (•O2
−) and H2O2.  ROS is generated by 
a variety of enzymes, including NADPH oxidase located in the plasma and ER membranes, 
xanthine oxidases and cytochrome p450 enzymes in the cytosol.  ROS can also result from 
reactions with oxygen of electrons leaked from the mitochondrial electron transport chain 
at the complex I or complex III (Bae et al., 2011).  Historically, ROS is considered as a harmful 
chemical, leading to a series of damages to DNA, RNA, lipids and proteins.  Recent studies 
have proposed ROS as a physiological signaling molecule in many cell processes, such as cell 
migration, proliferation, and apoptosis (Tsutsui et al., 2011).   ROS has been reported to be 
involved in aging and in many diseases, such as cancers, Parkinson's diseases (PD), 
Alzheimer's disease (AD) (Valko et al., 2007), myocardial infarction (Yang et al., 2006), lichen 
planus (Aly and Shahin, 2010) and fragile X syndrome (Halliwell, 2007).  
There are numerous studies showing contribution of H2O2 in the TRPM2 channel activation 
and functions.  Extracellular H2O2 can concentration-dependently induce the increase in the 
[Ca2+]c in TRPM2-expressing HEK293 cells, with an EC50 of about 30 μM (Fonfria et al., 2004, 
Hara et al., 2002, Perraud et al., 2005, Wehage et al., 2002).  H2O2-induced increases in the 
[Ca2+]c have also been observed in several types of cells, such as endothelial cells (Hecquet 
47 
 
et al., 2008), microglia (Kraft et al., 2004), neutrophils (Lange et al., 2009) and rat insulinoma 
RIN-5F cells (Ishii et al., 2006a, Ishii et al., 2006b).  While activation of the TRPM2 channels 
by H2O2 is consistently observed, the underlying mechanism remains still controversial.  
There is evidence to support direct stimulation of the TRPM2 channels by H2O2.  Using 
whole-cell patch clamp recording, Kolisek and his colleagues showed that application of 
H2O2 in the micropipette solution induced currents in TRPM2-expressing HEK293 cells but 
the current amplitude is only about 5% of that induced by ADPR.  Thus, these authors have 
proposed that H2O2 activates the TRPM2 channels independently with ADPR generation 
(Kolisek et al., 2005).  The more solid evidence for ADPR-independent activation of the 
TRPM2 channel by H2O2 came from a study by Wehage and his colleagues (Wehage et al., 
2002).  They showed that H2O2 and ADPR evoked currents in HEK293 cells heterologously 
expressing the WT TRPM2 channel, whereas H2O2, but not ADPR, can induce currents in cells 
expressing the TRPM2-ΔC channel, suggesting direct activation of the TRPM2 channel by 
H2O2 is independent of ADPR.  However, a subsequent study failed to observe H2O2-evoked 
increases in the [Ca2+]c or currents in HEK293 cells expressing the TRPM2-ΔC channels 
(Perraud et al., 2005).     
Most of the experimental results suggest that H2O2 induces activation of the TRPM2 
channels by promoting generation of ADPR in the mitochondria and nucleus, as discussed 
above (see section 1.2.1.5.1 and Fig. 1.7).  In TRPM2-expressing HEK293 cells, H2O2-induced 
increases in the [Ca2+]c can be strongly suppressed by pre-treatment with 5[H]-
phenanthridin-6-one, GPI16539 (Perraud et al., 2005), PJ34 and SB750139-B (Fonfria et al., 
2004) to inhibit PARP activation and thereby to prevent accumulation of ADPR.  H2O2-
induced TRPM2 channel currents can be also attenuated by hydrolysis of ADPR by 
overexpression of cytNUDT9, a non-compartmentalized form of the ADPR pyrophosphatase 
(Perraud et al., 2005).  These results indicate that elimination of ADPR accumulation 
prevents activation of TRPM2 channel by H2O2.  A recent study, using inside-out patch clamp 
recordings, also has shown that H2O2 cannot directly activate the TRPM2 channels 
heterogeneously expressed in Xenopus oocytes (Toth and Csanady, 2010).  All these studies 
support an indirect mechanism of TRPM2 channel activation by H2O2.   
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1.2.5.1.7 Temperature 
The TRPM2 channel is sensitive to temperature. Using fluorescent Ca2+ imaging, 
heterologous expression of the TRPM2 channels in HEK293 cells conferred significant 
increase in the [Ca2+]c in response to heat, with a threshold of about 40°C (Togashi et al., 
2006).  A recent study has also shown similar heat-evoked increases in the [Ca2+]c, with a 
higher average threshold of about 47°C in TRPM2-expressing HEK293 cells (Kashio et al., 
2012).  Such heat-evoked increases in the [Ca2+]c were also observed in pancreatic β-cells 
and insulinoma RIN-5F cells, which were  almost completely abolished by reducing TRPM2 
expression using TRPM2 siRNA (small interfering RNA) (Togashi et al., 2006).  Heat evoked 
whole-cell currents that exhibited typical linear TRPM2 I-V relationships, and further inside-
out single-channel recordings showed that heat elicited currents with a threshold of about 
34°C and maximum channel activation at 36°C in TRPM2-expressing HEK293 cells (Togashi et 
al., 2006).  The mechanism underlying TRPM2 channel activation by heat is still unclear.  
According to a recent thermodynamic study using cold-activated TRPM8 channel and heat-
activated TRPC5 channel as two examples, the thermo-sensitivity of TRP channels results 
from the conformational changes (Clapham and Miller, 2011).  However, the direct evidence 
supporting this hypothesis for the sensitivity of TRPM2 channels to heat is still lacking.  
Besides activation of TRPM2 channel by heat alone, heat also can dramatically facilitate the 
TRPM2 channel activation by agonists, such as ADPR, NAD and cADPR (Kashio et al., 2012, 
Togashi et al., 2006).  In TRPM2-expressing HEK293 cells, the currents induced by cADPR at 
body temperature (37°C) are significantly larger than those by cADPR at room temperature 
or by raising temperature from 25°C to 37°C in the absence of cADPR.  These results have 
revealed a synergistic effect of heat with agonists on the TRPM2 channel activation (Togashi 
et al., 2006).  In addition, a recent study has also demonstrated that, in macrophages, the 
threshold of temperature inducing increases in the [Ca2+]c is reduced from about 47°C to 
about 41°C or 36°C by pre-exposure of the cells to 100 µM or 3 mM H2O2, respectively 
(Kashio et al., 2012).  H2O2-induced increases in the thermo-sensitivity of the TRPM2 
channel was eliminated by substituting Met-214 with Ala in the intracellular N-terminus of 
the TRPM2 channel, leading to the proposal that Met oxidation by H2O2 has a role in 
increasing the TRPM2 channel sensitivity to temperature (Kashio et al., 2012).  However, in 
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the same study, it was shown such sensitization by H2O2 was dramatically reduced by pre-
treatment with PJ34 (Kashio et al., 2012), a PARP inhibitor; such the result seems to be 
consistent with the idea that H2O2-induced ADPR generation and the resultant synergy 
between ADPR and temperature are important in increasing the temperature sensitivity of 
the TRPM2 channels.  
1.2.5.2 Inhibitors 
Several structurally different inhibitors of the TRPM2 channels have been found over the 
past few years. Their chemical structures are shown in Fig. 1.6. 
1.2.5.2.1 N-(p-amylcinnamoyl) anthranilic acid (ACA) 
ACA belongs to the class of N-cinnamoyl-anthranilic acids (Fig. 1.6).  In TRPM2-expressing 
HEK293 cells, extracellular application of ACA suppressed H2O2-induced increases in the 
[Ca2+]c in a concentration-dependent manner with an IC50 of about 1.7 μM.  ACA at 20 µM 
fully abolished ADPR-induced currents.  The current inhibition was largely reversible upon 
washout (Kraft et al., 2004).  Single-channel patch clamp recordings showed no significant 
change in single-channel conductance by ACA, implying that the current inhibition is mainly 
due to decrease in the channel open probability.  ACA has been shown to inhibit 
endogenously expressed TRPM2 channels in DT40 B lymphocytes, human U937 cells and 
INS-1E β-cells (Bari et al., 2009, Kraft et al., 2004, Song et al., 2008).  ACA is known to inhibit 
phospholipase A2 (PLA2) (Harteneck et al., 2007).  However, two other PLA2 inhibitors, p-
bromophenacyl bromide and arachidonyltrifluoromethyl ketone showed no inhibition of 
ADPR-induced TRPM2 channel activation, suggesting that ACA-induced inhibition of the 
TRPM2 channels is not related to PLA2 inhibition (Kraft et al., 2004).  Besides the TRPM2 
channels, ACA can inhibit several other TRP channels, such as TRPC6 and TRPM8 (Harteneck 
et al., 2007, Kraft et al., 2004).   
1.2.5.2.2 Flufenamic acid (FFA) and its homologue 
FFA is a non-steroidal anti-inflammatory drug (Fig. 1.6).  Extracellular application of FFA 
inhibits ADPR-induced currents in TRPM2-expressing HEK293 cells (Chen et al., 2012, Hill et 
al., 2004a).  An early study showed that FFA inhibited the TRPM2 channels in an all-or-none 
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manner in the range of concentrations from 50 µM to 1000 µM (Hill et al., 2004a).  However, 
a recent study demonstrated that the inhibition is concentration-dependent with an IC50 of 
70 µM (Chen et al., 2012). The inhibition of ADPR-induced currents by FFA was reversible 
upon washout, but the reversibility is exposure duration-dependent in TRPM2-expressing 
HEK293 cells (Hill et al., 2004a).  In contrast, in CRI-G1 insulinoma cells endogenously 
expressing the TRPM2 channels, the inhibition by FFA was strongly reversed even after 
prolonged exposure to high concentrations (1 mM  for 3 min) (Hill et al., 2004a).  In addition 
to the TRPM2 channel, FFA can inhibit TRPM3 (Klose et al., 2011), TRPM4 and TRPM5 
channels (Ullrich et al., 2005), whereas it activates other TRP channels.  For example, TRPA1 
can be stimulated by FFA in a concentration-dependent manner with an EC50 of about 78 
µM in TRPA1-expressing Xenopus oocytes (Hu et al., 2010).  Furthermore, FFA can induce 
intracellular Ca2+ release in Aplysia Bag Cell Neurons (Gardam et al., 2008). 
A novel analogue of FFA has been reported recently, 3-aminoethoxydiphenyl borate (3-
MFA), in which the trifluoromethyl group in 2-phenylamino ring of FFA is substituted by a 
methyl.  3-MFA showed a concentration-dependent inhibition of ADPR-induced currents 
with an IC50 of 76 µM.  Furthermore, 3-MFA did not elicit Ca2+ release, suggesting 3-MFA is 
more selective than FFA (Chen et al., 2012). 
1.2.5.2.3 Clotrimazole and econazole 
1-[(2-chlorophenyl) diphenylmethyl]-1H-imidazole (clotrimazole) and 1-[2-[4-chlorophenyl) 
methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole (econazole) are imidazole related 
antifungal agents (Fig. 1.6) and are widely used in clinical and veterinary treatments of 
fungal infection (Fromtling, 1988).  Both compounds, when applied extracellularly at the 
concentrations ranging from 3 μM to 30 μM, almost completely inhibited ADPR-induced 
currents in TRPM2-expressing HEK293 cells, and also in CRI-G1 insulinoma cells. The 
inhibition of ADPR-induced currents by clotrimazole was partially reversible in CRI-G1 
insulinoma cells, but irreversible in TRPM2-expressing HEK293 cells.  The inhibition of ADPR-
induced by econazole in TRPM2-expressing HEK293 cells was also irreversible (Hill et al., 
2004b).  Econazole can also inhibit TRPM8 (Malkia et al., 2009) and P2Y2 receptors (Bahra et 
al., 2004), and clotrimazole blocks TRPV4 (Bai and Lipski, 2010) and Ca2+-activated K+ 
channels (KCa3.1) (Turner and Sontheimer, 2013). 
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Figure 1.6 Structures of TRPM2 inhibitors 
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1.2.5.2.4 2-APB 
2-APB can inhibit TRPM2 channels (Fig. 1.6).  In TRPM2-expressing HEK293 cells, 
extracellular application of 2-APB caused a rapid and reversible inhibition of ADPR-induced 
currents in a concentration-dependent manner with an IC50 of 1.2 µM.  In DRG neurons, 2-
APB at 50 μM almost completely and reversibly blocked H2O2-induced whole-cell currents 
and dramatically suppressed H2O2-induced increases in the [Ca2+]c (Naziroglu et al., 2011).  
2-APB also completely inhibited cADPR-elicited TRPM2 channel currents (Chen et al., 2012).  
2-APB is a non-specific blocker that acts on a variety of ion channels, including IP3 receptors 
(Vázquez-Martínez O, 2003), TRPV6 channel (Kovacs et al., 2012), TRPM7 channel (Chokshi 
et al., 2012) and most of the TRPC channels (Rychkov and Barritt, 2007, Harteneck and 
Gollasch, 2011).   
1.2.5.2.5 Adenosine monophosphate (AMP) 
ADPR can be hydrolyzed to AMP and ribose-5’-phosphate by ADPR pyrophosphatase 
(Bessman et al., 1996). Ribose-5’-phosphate does not have any effect, whereas AMP has 
effect on inhibition of the TRPM2 channel activation (Fig. 1.6).  Intracellular application of 
AMP inhibited ADPR-induced currents in TRPM2-expressing HEK293 cells in a concentration-
dependent manner with an IC50 of 70 µM.  AMP at 500 μM also completely abolished the 
whole-cell currents induced by NAD or cADPR (Kolisek et al., 2005).  AMP has been shown to 
bind to the NUDT9-H domain in the C-terminus of the TRPM2 protein with a Kd of about 166 
μM (Grubisha et al., 2006), and the inhibition of the TRPM2 channel by AMP is thus thought 
to be via a mechanism in which AMP competitively binds to the NUDT9-H domain and 
replaces the ADPR binding.  Since the NUDT9-H domain has the activity of ADPR 
pyrophosphatase, AMP is proposed to form a negative feedback in regulating the TRPM2 
channel activation by ADPR.   
So far specific TRPM2 channel inhibitors are still lacking but required to study the 
physiological and pathological functions of hTRPM2 channels.  Thus, chapter 4 in my thesis 
will describe our efforts to search for potential hTRPM2 channel inhibitors. 
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1.2.5.2.6 Divalent cations 
Several recent studies have examined the effects of divalent cations such as Zn2+, Cu2+ and 
Pb2+, on the TRPM2 channels.  Extracellular Zn2+ completely inhibited ADPR-induced 
currents in the range of concentrations down to 30 µM in TRPM2-expressing HEK293 cells.  
This inhibition was irreversible upon prolonged exposure, suggesting that Zn2+ induces the 
TRPM2 channel inactivation.  There are 20 residues located in the pore-forming region of 
the TRPM2 protein that may potentially interact with Zn2+, including His, Cys, Lys, Gln and 
Asn.  A site-directed mutagenesis study showed that K952A and D1002A mutations strongly 
suppressed channel inhibition caused by Zn2+.  This study further showed that the inhibition 
kinetics is concentration and species-dependent.  The mouse TRPM2 (mTRPM2) channels 
exhibit much slower response to Zn2+ than the hTRPM2 channels.   Change of Gln-992 in the 
mTRPM2 channel to His in the hTRPM2 channel dramatically accelerated the kinetics of 
Zn2+-evoked inhibition; conversely, the reciprocal mutation H995Q in the hTRPM2 channel 
decelerated the inhibition kinetics (Yang et al., 2011).  Zeng and his colleagues have 
demonstrated that extracellular application of Cu2+ inhibited ADPR-induced TRPM2 channel 
currents in a concentration-dependent manner with an IC50 of 2.59 µM (Zeng et al., 2012).  
Furthermore, Hg2+ Pb2+, Fe2+ and Se2+ also inhibited ADPR-induced currents in TRPM2-
expressing HEK293 cells (Sukumar and Beech, 2010, Zeng et al., 2012). 
1.2.5.2.7 Acidic pH 
Extracellular acidic pH has been shown to significantly inhibit the TRPM2 channel by three 
independent studies (Du et al., 2009b, Starkus et al., 2010, Yang et al., 2010).  However, the 
pattern of inhibition and the underlying mechanisms are inconsistent.  In TRPM2-expressing 
HEK293 cells, the studies by Du and Starkus using whole-cell patch clamp recordings showed 
that inhibition of ADPR-induced currents or open TRPM2 channels by acidic pH was 
concentration-dependent with IC50 values of pH 5.3 (Du et al., 2009b) or pH 6.5 (Starkus et 
al., 2010), respectively.  Differing from these two studies, the study from our lab showed 
that inhibition of the TRPM2 channel by extracellular acidic pH was state-dependent in 
whole-cell patch clamp recordings (Yang et al., 2010); ADPR-induced currents or open 
channels is completely, irreversibly and voltage-independently blocked by acidic pH in the 
range of pH 4.0–6.0, whereas exposure of the closed channels to acidic pH reduced the 
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channel activation in a pH-dependent manner with an IC50 for pH 4.7 (Yang et al., 2010).  
These results suggest two sequential steps in TRPM2 channel inhibition by extracellular 
acidic pH, which was due to initial blockage of the open channels and subsequent 
conformational changes leading to inactivation of the open channels.  Furthermore, single-
channel recordings from Du’s and Yang’ studies suggest that acidic pH decreased the single-
channel conductance (Du et al., 2009b, Yang et al., 2010).  Starkus et al examined the effects 
of acidic pH on single channel conductance in neutrophil cells endogenously expressing the 
TRPM2 channels, and found a similar effect (Starkus et al., 2010). 
In contrast to the voltage-independent inhibition (Du et al., 2009b), Starkus et al showed 
that the inhibition was voltage-dependent, with stronger inhibition at negative membrane 
potential and that the kinetics of inhibition by extracellular acidic pH was decelerated by 
holding more acidic intracellular pH (Starkus et al., 2010). They have therefore proposed 
that extracellular protons permeate the open channels into the cells and results in 
inactivation of the TRPM2 channels by binding at an intracellular site.  However, the other 
two studies suggest that the inhibition of TRPM2 channels by acidic pH is due to binding of 
protons to the extracellular pore region of the TRPM2 channels.  In Yang’s study, 
substitution with Ala of two residues in the pore-forming region, Lys-952 and Asp-1002 (Fig. 
1.4), significantly slowed down or reduced pH-induced inhibition (Yang et al., 2010).  Du et al 
showed by site-directed mutagenesis that H958Q, D964N and E994Q introduced into the 
pore-forming region, resulted in an increase in the pH sensitivity and reduction in the single-
channel conductance (Du et al., 2009a).  These results suggest that extracellular acidic pH or 
protons can interact with the extracellular vestibule of the pore to initially inhibit the open 
channel and subsequently to induce conformational changes leading to the channel 
inactivation.  
Intriguingly, several early studies showed that extracellular acidic pH accelerated the 
inhibition kinetics of other blockers (Chen et al., 2012, Hill et al., 2004a, Hill et al., 2004b, 
Kraft et al., 2004).  For instance, the inhibition of ADPR-induced current by 100 µM FFA at 
pH 6.0 was about 10-times faster than at pH 7.4 (Hill et al., 2004a).  These studies proposed 
that this phenomenon could be resulted from the change of the proportion of the charged 
form to the uncharged form of the inhibitors by pH.  However, according to the effects of 
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extracellular acidic pH revealed in the studies as discussed above, the acceleration of the 
inhibition kinetics could be in part due to the inhibition of acidic pH itself.  
Intracellular acidic pH also can block TRPM2 channels.  The inhibition of ADPR-induced 
currents by intracellular acidic pH was concentration-dependent with an IC50 of pH 6.7 (Du 
et al., 2009b).  Using inside-out single-channel recordings, Starkus and his colleagues 
showed that the channel open probability was reduced when intracellular pH was changed 
from 7.0 to 6.0 (Starkus et al., 2010).   Both studies from Du and Starkus observed no change 
in single channel conductance by intracellular acidic pH (Du et al., 2009b, Starkus et al., 
2010).  Furthermore, substitution of Asp-933 with Glu, His, Lys and Ala, reduced the IC50 
from pH 6.7 to about pH 5, suggesting that Asp-933 plays a critical role in the sensitivity to 
intracellular acidic pH (Du et al., 2009b). 
As discussed above, despite that these studies have shown that extracellular acidic pH can 
inhibit the TRPM2 channels; the underlying mechanisms are still not fully understood.  In 
chapter 3, I will conduct further experiments to study the inhibition of the human and 
mouse TRPM2 channels by extracellular acidic pH. 
1.2.6 Modulation of TRPM2 channel functions by interacting proteins 
Protein-protein interaction is a commonly used mechanism by which ion channel function is 
modulated. In this section, I will discuss several intracellular proteins that have been shown 
to interact with and regulate the TRPM2 channels. 
1.2.6.1 Protein tyrosine phosphatase-L1 (PTPL1) 
PTPL1, also called PTP-BAS (Maekawa et al., 1994), PTP1E (Banville et al., 1994) or FAP-1 
(Sato et al., 1995), is a widely expressed tyrosine phosphatase that remove the phosphate 
group from phosphorylated tyrosine residues.  PTPL1 has been reported to be involved in 
protecting Fas (folic acid synthesis)-mediated apoptosis and up-regulating Ewing's Sarcoma 
tumor genesis (Abaan et al., 2005).  Using Western blotting, Zhang and his colleagues 
showed an increased TRPM2 protein phosphorylation level in response to H2O2 or TNF-
α (Zhang et al., 2006).  Increases in H2O2 or TNF-α-induced TRPM2 phosphorylation and the 
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[Ca2+]c were significantly reduced by PTPL1 overexpression in TRPM2-expressing HEK293 
cells.  Conversely, down-regulation of endogenous PTPL1 expression by siRNA enhanced 
both TRPM2 phosphorylation and H2O2-induced increases in the [Ca2+]c.  In addition, co-
immunoprecipitation showed a direct interaction between TRPM2 and PTPL1 proteins in 
HEK293 cells heterologously co-expressing, and U937 cells endogenously expressing, these 
two proteins (Zhang et al., 2006).  These results suggest an important role of PTPL1 in 
modulating the TRPM2 channel function. 
1.2.6.2 Calmodulin and EF-hand domain-containing (EFHC) protein 1 
CaM is a small protein that is ubiquitously expressed and regulates diverse Ca2+-dependent 
cell processes (Crivici and Ikura, 1995, Hoeflich and Ikura, 2002).  CaM contains four EF-hand 
motifs, each of which provides one Ca2+-binding site with a high affinity.  As mentioned 
above, intracellular Ca2+ is important in TRPM2 channel activation.  Overexpression of wild-
type CaM cannot alter H2O2- or TNF-α-induced increases in the [Ca2+]c (Tong et al., 2006) or 
Ca2+-stimulated currents (Du et al., 2009a),  presumably because the endogenous CaM 
expression level is sufficient.  Whereas, overexpression of Ca2+-binding deficient mutant 
CaM (CaMMUT), significantly reduced both H2O2- or TNF-α-induced Ca2+ responses and 
intracellular Ca2+-induced TRPM2 channel currents (Du et al., 2009a, Tong et al., 2006).  
Furthermore, co-immunoprecipitation demonstrated a direct interaction between CaM and 
TRPM2 via the N-terminus, and such interaction strongly depended on Ca2+ (Tong et al., 
2006).  These results suggest that CaM binds with the channels, and acts as a Ca2+ sensor 
that renders the TRPM2 channel to be activated by Ca2+.   
The N-terminus of the TRPM2 protein contains an IQ-like motif (see Fig. 1.4 and section 
1.2.2).  Disruption of this motif by point mutagenesis (IQMUT) reduced the interaction of 
TRPM2 with CaM as assessed by co-immunoprecipitation and gel shift experiments (Tong et 
al., 2006).  Furthermore, IQMUT was shown to significantly reduce H2O2- or TNF-α-induced 
increases in the [Ca2+]c (Tong et al., 2006) and almost completely abolished Ca2+-stimulated 
TRPM2 channel currents (Du et al., 2009a).  These results suggested that this IQ-motif plays 
an important role in the TRPM2 channel activation.  However, binding of CaM to the TRPM2 
protein was reduced but not completely abolished by mutational disruption of the IQ-like 
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motif, suggesting that more than one CaM-binding site is present in the TRPM2 channel 
(Tong et al., 2006).  
EFHC1 has also been shown to modulate the TRPM2 channels.  Katano and his colleagues 
showed co-expression of EFHC1 and TRPM2 proteins in mouse brain using in-situ 
hybridization and direct protein-protein interaction between these two proteins by co-
immunoprecipitation (Katano et al., 2012).  In TRPM2-expressing HEK293 cells, both H2O2-
induced increases in the [Ca2+]c and ADPR-stimulated currents can be enhanced by co-
expression of EFHC1 (Katano et al., 2012).  Therefore, EFHC1 plays a role in regulating 
TRPM2 channel activation through direct binding.  However, it is unclear whether EFHC1 has 
a role in providing Ca2+-binding site to facilitate activation of the TRPM2 channels by Ca2+.  
1.2.7 Physiological functions 
In the past decade, many studies by pharmacological inhibition of the TRPM2 channel 
function and genetic manipulation of the TRPM2 protein expression, and particularly using 
TRPM2 deficient transgenic mice, provide evidence to show that the TRPM2 channels 
contribute to several physiological functions. 
1.2.7.1 Cytokine production 
Cytokines are small signal proteins or peptides, such as IL-1, IL-6, cytokine (C-X-C motif) 
ligand 8 (CXCL8) and TNF-α.  They are produced by immune cells, including lymphocytes, 
dendritic cells, monocytes and macrophages, and play an essential role in immune 
responses (Lacy and Stow, 2011).  CXCL8, the human cytokine also called IL-8, and CXCL2, 
the rodent functional homolog (Sonoda et al., 1998), are responsible for recruitment of 
inflammatory cells, such as macrophages and neutrophils, to the sites of tissue injured or 
infected.  It is well-known that H2O2 induces secretion of CXCL8 but the underlying 
mechanism remains not well established (Chiu et al., 2007, Josse et al., 2001).  Several 
recent studies have revealed that TRPM2 channels are critically involved in H2O2-induced 
CXCL8 release.  Release of CXCL8 by H2O2 in human monocyte cells was dramatically 
suppressed by siRNA knockdown of TRPM2 protein expression (Yamamoto et al., 2008). 
Consistently, H2O2-evoked CXCL2 release in monocytes isolated from TRPM2 deficient mice 
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was significantly inhibited.  Removal of extracellular Ca2+ by EGTA (ethyleneglycoltetraacetic 
acid) abolished H2O2-evoked Ca2+ influx and led to almost complete inhibition of CXCL8 
release in U937 cells.  These data suggest a critical role of TRPM2 channels in H2O2-evoked 
CXCL8 release via mediating Ca2+ influx (Yamamoto et al., 2008).  Furthermore, this study 
also showed the inhibition of H2O2-evoked CXCL8 release by pre-treatment with PD98059, a 
MEK (MAPK (mitogen-activated protein kinase) / ERK (extracellular signal-regulated protein 
kinases) kinase) inhibitor, and PDTC, a NF-κB (nuclear factor kappa-light-chain-enhancer of 
activated B cells) inhibitor.  H2O2 has been also showed to enhance the activation of ERK and 
its upstream signal molecular Pyk2 (proline-rich tyrosine kinase 2) and Ras (rat sarcoma).  
Furthermore, activation of these molecules, were all strongly suppressed by removal of 
extracellular Ca2+ or TRPM2 specific siRNA transfection, suggesting that TRPM2 channel-
mediated Ca2+ influx plays an essential role in activation of ERK pathway and nuclear 
translocation of the NF-κB by H2O2 (Yamamoto et al., 2008).  In human blood monocytes, 
mouse splenocytes and mouse paw, the production of CXCL8/CXCL2 was evoked by 
lipopolysaccharides (LPS), listeria monocytogenes (LM) and carrageenan, respectively.  Such 
LPS-induced CXCL8 generation was suppressed by TRPM2-specific siRNA transfection; and 
the LM/carrageenan-evoked CXCL2 generation was significantly decreased in the TRPM2-/- 
mice (Haraguchi et al., 2012, Knowles et al., 2011, Wehrhahn et al., 2010).  As summarized 
in Fig. 1.7, H2O2-induced CXCL8 generation results from TRPM2-mediated Ca2+ influx and 
subsequent activation of the signaling pathway engaging Pyk2 (proline-rich tyrosine kinase 
2), Ras, MEK and ERK, leading to nuclear translocation of NF-κB and initiation of expression 
of CXCL8 (Yamamoto et al., 2008). 
Besides CXCL8/CXCL2, TRPM2 channels have been reported to be involved in production of 
other cytokines.  Wehrhahn has shown that exposure of human acute monocytic leukemia 
THP-1 cells to LPS strongly enhanced both mRNA and protein expression levels of IL-6, IL-10, 
IL-12, IL-17, interferon-γ (INFγ), macrophage inflammatory peptide 2 (MIP-2) and TNF-
α,  which were partially suppressed by reducing TRPM2 expression using shRNA (short 
hairpin RNA) (Wehrhahn et al., 2010).  Another recent study has also showed that LPS 
evoked production of MIP-2, TNF-α and IL-6 from mouse lung, and release of theses 
cytokines was dramatically reduced in TRPM2-/- mice (Di et al., 2012).  In addition, LM-
induced production of INFγ and IL-12 was decreased in serum of TRPM2-/- mice (Knowles et 
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al., 2011).  Production of IL-2, INFγ and IL-17 induced by anti-CD3/CD28 from mouse CD4+ T 
cells was attenuated by pre-treatment with ACA or in TRPM2-/- mice (Melzer et al., 2012).  
Taken together, these data indicate that TRPM2 channels play an important role in 
mediating production of several types of cytokines.  However, the mechanisms underlying 
such TRPM2-mediated production of these cytokine are still not fully understood.  There are 
studies investigating the signalling mechanism underlying TNF-α production.  In THP-1 cells 
LPS-induced increases in the [Ca2+]c were strongly suppressed by TRPM2 specific shRNA and 
removal of extracellular Ca2+ led to reduction, but not complete abolition of LPS-evoked 
TNF-α production (Wehrhahn et al., 2010).  A recent study revealed sulfur mustard (SM)-
induced increases in the [Ca2+]c and production of TNF-α in human neutrophils.  In this study, 
it was further shown that the phosphorylation level of p38 MAPK was increased by SM 
treatment but such increase was abolished by removal of extracellular Ca2+ , implying an 
important role of p38 MAPK activity in SM-induced TNF-α production. Consistent with this 
idea, application of SB203580, a p38 MAPK inhibitor, was dramatically attenuated SM-
induced TNF-α production.    In addition, SM-induced elevation in the [Ca2+]c was strongly 
reduced by TRPM2 channel inhibitors, FFA, clotrimazole or econazole (Ham et al., 2012).  
These data suggest the TRPM2-mediated increases in the [Ca2+]c and Ca2+-dependent 
activation of the p38 MAPK pathway plays an important role in mediating TNF-α production. 
1.2.7.2 Insulin secretion 
Insulin, a peptide hormone, plays a central role in regulating glucose metabolism via eliciting 
absorption of blood glucose by tissues such as liver and skeletal muscles.  It is produced in, 
and released from, pancreatic β-cells.  When the level of glucose is increased in the blood 
and interstitial fluid, glucose is transported into β-cells by GluT2 (glucose transporter 2), and 
is degraded in the tricarboxylic acid cycle to generate ATP.  Elevated concentration of ATP in 
turn closes the ATP-sensitive potassium (KATP) channels on the β-cell surface, causes 
membrane depolarization leading to activation of Cav and Ca2+ influx; subsequently, increase 
in the [Ca2+]c triggers insulin secretion by exocytosis (Koster et al., 2005, Olson and Terzic, 
2010).  
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Figure 1.7 The pathway of TRPM2 channels activation and function  
The signalling pathway of TRPM2 channel activation and related cell functions.  This figure is based on the figure in a review paper 
from Takahashi (Takahashi et al., 2011).   
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Besides the classical KATP channel-dependent signaling pathway for insulin secretion, KATP 
channel-independent pathway has been documented.  Several recent studies have provided 
consistent evidence to support critical involvement of the TRPM2 channels in the KATP 
channel-independent pathway.  As described above (see section 1.2.5.1.7), heat can evoke 
TRPM2 channel activation.  In pancreatic β-cells, heat at 40°C enhanced glucose-induced 
insulin secretion that was significantly reduced by either treatment with TRPM2 channel 
inhibitors, FFA and 2-APB, or with TRPM2-specific siRNA. In addition, in the presence of 
nimodipine, a Cav blocker, glucose-induced insulin secretion was still suppressed by TRPM2-
specific siRNA, suggesting the existence of KATP channel-independent pathway in insulin 
secretion  and TRPM2 channels have a part in this pathway (Togashi et al., 2006).  In a 
recent study, glucose-induced insulin secretion was strongly attenuated in pancreatic β-cells 
from TRPM2-/- mice. Furthermore, TRPM2-deficiency reduced glucose-induced insulin 
secretion in the presence of diazoxide, KATP activator, and high concentration of extracellular 
potassium (Uchida and Tominaga, 2011). These data provide further evidence to support a 
role for the TRPM2 channels in insulin secretion via KATP-independent pathway. 
The mechanism(s) by which the TRPM2 channels mediate glucose-induced insulin secretion 
is (are) not clear.  There is evidence to imply that cAMP-PKA pathway is involved.  Glucose-
induced insulin secretion was enhanced by treatment with FSK (forskolin), an adenylyl 
cyclase activator, to increase  intracellular cAMP level, and FSK-induced enhancement of 
insulin secretion was partially reduced by TRPM2-spesific siRNA (Togashi et al., 2006). 
Glucagon-like peptide 1 (GLP-1), produced in the intestinal cells, stimulates insulin secretion 
from β-cells and suppresses glucagon secretion from α-cells (Hong et al., 2002).  Togashi 
and his colleagues also showed that exendin-4, an agonist of GLP-1 receptor, enhanced 
glucose-induced insulin secretion and such an effect was partially inhibited by TRPM2-
spesific siRNA (Togashi et al., 2006).  Consistently, enhancement of insulin secretion by 
exendin-4 was reduced by TRPM2 siRNA and TRPM2 knockout (Uchida et al., 2011, Uchida 
and Tominaga, 2011).  Taken together, these data have hypothesized that GLP-1 receptor 
activation leads to TRPM2 channel phosphorylation by cAMP-PKA and thereby increase 
glucose-induced insulin secretion from pancreatic β-cells.  However, whether the TRPM2 
channel is phosphorylated by cAMP-PKA and how this phosphorylation leads to increase in 
insulin secretion are still not unclear. 
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1.2.8 Pathological functions 
The TRPM2 channel has been reported to be involved in several pathological processes. 
1.2.8.1 ROS-induced increases in endothelial permeability 
Endothelial cells, forming the cell monolayer that lines the interior surface of the blood and 
lymphatic vessels, provide the physical barrier to prevent the transvascular movement of 
circulating cells into tissues in normal conditions. The dysfunction of endothelial barrier, 
associated with endothelial hyperpermeability, allows diffusion of pathogens and leukocytes 
into tissues, leading to infection and inflammation, respectively.  The hyperpermeability 
caused by interendothelial cell gap formation, which can be determined experimentally by 
measuring the transendothelial electrical resistance (TER), can be caused by many factors 
including oxidative stress and ischemia. 
As described above (1.2.1), TRPM2 channels are expressed in endothelial cells.  Hecquet and 
his colleague have shown that, in human pulmonary artery endothelial cells (HPAE), H2O2 
evokes whole-cell currents and concentration-dependent decreases of TER.  Both the 
current and the TER reduction can be attenuated by using siRNA to reduce TRPM2 
expression, overexpressing the non-functional isoform, TRPM2-S, or treating with DPQ (3,4-
Dihydro-5[4-(1-piperindinyl)butoxy]-1(2H)-isoquinoline), the PARP inhibitor, to suppress 
production of ADPR  (Hecquet et al., 2008).  These results indicate the involvement of 
TRPM2 channels in H2O2-induced endothelial hyperpermeability.  
Early studies have been shown that H2O2-induced increases in the [Ca2+]c plays an important 
role in endothelial hyperpermeability (Moore et al., 1998, Siflinger-Birnboim et al., 1996).  It 
has been reported that this H2O2-induced Ca2+ influx can be suppressed by TRPM2-specific 
antibody, TRPM2 siRNA and expression of TRPM2-S, suggesting that TRPM2 channels via 
mediating Ca2+ influx plays a critical role of H2O2-induced endothelial hyperpermeability 
(Dietrich and Gudermann, 2008, Hecquet et al., 2010, Hecquet et al., 2008).  
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1.2.8.2 ROS-induced cell death 
It is well known that ROS, such as H2O2, can induce cell death via a complex signaling 
transduction network.  
The TRPM2 channel is proposed to be one candidate in mediating H2O2-induced cell death in 
several types of cells, such as hippocampal neurons (Verma et al., 2012), B lymphoblast cells 
(Roedding et al., 2012), endothelial cells (Sun et al., 2012), pancreatic β-cells (Ishii et al., 
2006b), cardiomyocytes (Yang et al., 2006), as well as HEK293 cells (Hara et al., 2002, Katano 
et al., 2012) and Chinese hamster ovary (CHO) cells (Naziroglu et al., 2013) heterologously 
expressing TRPM2 channels.  For instance, in isolated striatal neurons, H2O2-induced cell 
death was dramatically suppressed by TRPM2-specific siRNA or blockage of ADPR 
generation with SB-750139, a PARP inhibitor (Fonfria et al., 2005). A recent study has 
reported that apoptotic endothelial H5V cell death induced by H2O2 was attenuated by 
knocking down TRPM2 protein expression using shRNA (Sun et al., 2012).  In insulinoma RIN-
5F cells, loss of the cell viability evoked by H2O2 was reversed by treatment with TRPM2-
specific antisense oligonucleotides (Ishii et al., 2006b).  All these results consistently provide 
evidence to support contribution of the TRPM2 channels in mediating H2O2-induced cell 
death.  
The mechanisms by which TRPM2 channels mediate cell death induced by H2O2 are still 
poorly understood. As described above (1.2.5.1.6), TRPM2 channels mediate increase in the 
[Ca2+]c induced by H2O2. This Ca2+ response is considered to be involved in H2O2-induced 
cells death.  In U937 cells, removal of intracellular Ca2+ by pre-treatment with BAPTA, a Ca2+ 
chelator, led to partial reduction of H2O2-induced cell death (Sun et al., 2012). It was 
mentioned above (1.2.5.1.5) that TRPM2 channel activation by Ca2+ is through binding to 
CaM tethered to the IQ-motif in the TRPM2 protein (Tong et al., 2006). H2O2-induced cell 
death was significantly reduced in cells expressing the TRPM2 proteins carrying mutation 
disrupting the IQ-motif.  These results implies requirement of intracellular Ca2+ via Ca2+-CaM 
binding to IQ-motif in TRPM2 proteins in TRPM2-mediated cell death. 
Furthermore, TRPM2-mediated cell death induced by H2O2 has been reported to engage the 
caspase pathway. Treatment of U937 cells with H2O2 induced increases in the level of 
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caspase-8, -9, -3 and -7 as shown using Western blotting (Zhang et al., 2006).  A recent study 
has presented similar results to show that H2O2 enhanced expression levels of caspase-9 and 
activated caspase-8 and -3 in H5V cells, which was mitigated by TRPM2 specific shRNA (Sun 
et al., 2012).  These results suggest that activation of the caspase-9 and caspase-8 pathways, 
as the signaling cascade downstream of TRPM2 channel activation and elevation in the 
[Ca2+]c, is involved in H2O2-induced cell death.  
Although the functional expression of TRPM2 channels has been identified in macrophages, 
the role of TRPM2 channels in mediating H2O2-induced cell death is still not fully understood.  
In the last results chapter, I will study the role of TRPM2 channels in H2O2-induced Ca2+-
responses and macrophage cell death. 
1.2.8.3 Cancer cell proliferation 
TRPM2 protein expression has been shown in normal prostate epithelial cells (RWPE-1), 
benign prostate cancer cells (BPH-1) and cancerous prostate cancer cells (PC-3 and DU-145), 
using immunofluorescent confocal microscopy and Western blotting (Zeng et al., 2010).  In 
RWPE-1 and BPH-1 cells, the TRPM2 proteins were mainly located closely to the plasma 
membranes.  In contrast and intriguingly, a substantial amount of the TRPM2 proteins in PC-
3 and DU-145 cells were aggregated in the nucleus. Reduction of the TRPM2 protein 
expression using siRNA strongly slowed proliferation of the cancerous cells (PC-3 and DU-
145), but not the non-cancerous cells (BPH-1 and RWPE-1).  These findings suggest that 
TRPM2 channel may play role in prostate cancer cell proliferation (Zeng et al., 2010). 
1.2.9 TRPM2 channels in diseases 
TRPM2 channels have been implied to contribute to several disease conditions. 
1.2.9.1 Alzheimer's disease 
Alzheimer's disease (AD), firstly described by Alois Alzheimer, is a type of neurodegenerative 
disorder and the most common cause of senile dementia, which affects about 36 million 
people in the world (Bergeron, 1990, Gilbert, 2013).  It manifests as gradual decline of 
memory and cognition functions (Price et al., 1993).  One of the histopathological hallmarks 
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of AD is accumulation of amyloid β-peptide (Aβ), a peptide of 36-43 amino acids, in the 
senile plaques (Gilbert, 2013).  Fonfria and his colleagues showed that Aβ induced increases 
in the [Ca2+]c, generation of ROS and cell death in rat primary striatal neurons. Furthermore, 
they showed that Aβ-induced increase in the [Ca2+]c, ROS generation and cell death were 
strongly suppressed by TRPM2 siRNA, , PARP inhibitor SB-750139  and expression of TRPM2-
S isoform (Fonfria et al., 2005).  These data imply a role for the TRPM2 channel in Aβ-
induced neurotoxicity in AD.   
1.2.9.2 Amyotrophic lateral sclerosis and Parkinsonism-dementia 
Amyotrophic lateral sclerosis (ALS) and Parkinsonism-dementia (PD) are another two types 
of neurodegenerative disorders.  ALS is caused by motor neuron death, and its clinical 
manifestations include muscle weakness and atrophy. About 120,000 ALS patients are 
diagnosed annually worldwide (Parakh et al., 2013).  PD, resulting from dopaminergic 
neuron death, is characterized by tremor, hypokinesia and rigidity.  It affects about 1 million 
individuals around the world (McGhee et al., 2013).  Hermosura has, using genotyping, 
identified P1018L mutation in the S6 of the TRPM2 protein in a subset of Guamanian ALS 
and PD cases. Functional studies have shown that, unlike the WT TRPM2 channel, the 
P1018L mutant channel exhibited rapid channel inactivation. In addition, H2O2-induced 
increases in the [Ca2+]c was almost abolished in HEK293 cells expressing the P1018L mutant 
channel (Hermosura et al., 2008).  These results imply critical contribution of loss of the 
TRPM2 channel function to the pathogenesis of ALS and PD.  
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1.3 Aim of the current study 
The overall aim of my study is to increase our understanding of theTRPM2 channels in terms 
of functional regulation, pharmacology and physiological roles.  My study is composed of 
three parts.  
The first part described in chapter 3 was to investigate how extracellular acidic pH regulate 
the TRPM2 channels using whole-cell patch clamp recording, and to elucidate the molecular 
basis determining the distinct sensitivity of the human and mouse TRPM2 channels to 
extracellular acid pH, in combination of sited-directed mutagenesis and patch clamp 
recording. 
The second part presented in chapter 4 focused on characterization of compounds as novel 
TRPM2 inhibitors.  This was achieved by examining the effects of 48 hit compounds 
identified from screening of a chemical library on H2O2-induced increase in [Ca2+]c using 
fluorescent Ca2+ imaging and ADPR-induced TRPM2 channel currents using whole-cell patch 
clamp recording.  
The last part detailed in chapter 5, was to study functional expression of the TRPM2 
channels and the role in H2O2-evoked Ca2+-response in macrophage cells, using 
immunofluorescent confocal microscopy, single cell Ca2+ imaging and whole-cell patch 
clamp recording, in conjunction of pharmacological inhibition and gene ablation.   The role 
of the TRPM2 channels in H2O2-induced macrophage cell death was also investigated by 
performing XTT and trypan blue exclusion assays.   
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2.1 Materials 
2.1.1 Mammalian cells lines 
HEK293 cells and THP-1 cells were available in our lab, and RAW264.7 cells were kindly 
supplied by Dr. J Sim (University of Manchester, UK).  The tetracycline-inducible HEK293 
cells stably expressing the hTRPM2 were kindly provided by Prof. D Beech (University of 
Leeds, UK).  
2.1.2 E.Coli strains 
Competent DH5α strains of E.Coli cells used for site-directed mutagenesis and plasmid 
amplification were purchased from BioLine. 
2.1.3 Plasmids and primers 
The cDNA encoding the hTRPM2 protein with a C-terminal FLAG epitope tag was kindly 
provided by Dr. AM Scharenberg (University of Washington, USA).  The cDNAs encoding the 
hTRPM2 subunit with a C-terminal EE- or FLAG-tag were subcloned into pcDNA3.1 vector 
(Promega) in our previous study (Mei et al., 2006a). The mTRPM2 cDNA in pCI-neo vector 
(Promega) was kindly provided by Dr. Y Mori (Kyoto University, Japan).  Primers shown in 
Table 2.3 were custom made by Geneservice.  
2.1.4 Animals 
The TRPM2+/+ (WT) C57BL/6J mice were purchased from Harlan Lab. TheTRPM2-/-transgenic 
C57BL/6J mice were generated in the lab, in collaboration with Prof DJ Beech and Dr JF 
Ainscough. The TRPM2-/- mice express non-functional TRPM2 isoform lacks amino acid 
residuals from Leu-843 to Met-931 (Zou et al., 2011, Zan et al., 2003).  All the mice were 
maintained in the Centre Biomedical Services, University of Leeds.  They were sacrificed by 
Ms Alicia Sedo according to the animal usage procedures approved by the University of 
Leeds.  
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2.1.5 Chemicals 
All the general chemicals were purchased from Sigma at the analytical reagent grade. 
All the compounds tested as the TRPM2 inhibitors in this study were provided by Dr Richard 
Foster, in the School of Chemistry, University of Leeds. The sources and full chemical 
structure information of these compounds are held in Dr Lin-Hua Jiang’s laboratory in the 
School of Biomedical Sciences (l.h.jiang@leeds.ac.uk) and also Dr Richard Foster’s laboratory 
and available upon request with prior confidentiality agreement. 
2.1.6 Antibodies 
Primary anti-TRPM2 antibody produced in rabbit and secondary FITC (fluorescein 
isothiocyanate)-conjugated anti-rabbit IgG antibody antibody were commercially obtained 
from Bethyl (catalog number: A300-413A) and Sigma (product number: F0382), respectively. 
2.1.7 Solutions 
The solutions used for whole-cell patch-clamp recording and calcium imaging were prepared 
in Milli-Q deionized water and the pH values were adjusted to pH 7.3 by 4M NaOH or to the 
pH indicated in the experiments by 4M NaOH or 37% (w:w) hydrochloric acid. The solutions 
for cell culture were commercially obtained in sterilized condition or were sterilized by 
autoclaving or filtering through 0.22 μm syringe filters. 
2.1.8 Growth medium for mammalian cells and E.Coli cells 
The growth medium for mammalian cells was prepared by adding 10% (v:v) foetal bovine 
serum (FBS) (GIBCO-BRL) and the indicated antibiotics into appropriate media (GIBCO-BRL) 
as listed in Table 2.1 and described in detail in sections 2.2.1. The medium was stored at 4°C 
prior to use. 
LB (lysogeny broth) growth medium for E.Coli cells were prepared by dilution 1.5% (w:v) LB 
powder (Sigma) into Milli-Q deionized water.  The LB medium was autoclaved and stored at 
4°C prior to use.  
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In order to make LB-agar plate, 1% (w:v) agar (Sigma) was added into the LB growth medium.  
After the solution was autoclaved and cooled down, 100 µg/ml ampicillin (Sigma) was added 
into the solution. The solution was poured into 100-mm Petri dishes and solidified at room 
temperature to form LB-agar plates.  The plates were stored at 4°C prior to use. 
2.2 Methods 
2.2.1 Mammalian cell culture 
2.2.1.1 Maintenance 
All the following cell culture operations were carried in a tissue culture hood (Wolf 
laboratories Awra-B6).  RAW264.7, THP-1 and HEK293 cells and tetracycline-inducible 
HEK293 cells stably expressing the hTRPM2 were maintained in appropriate growth media 
(Table 2.1) at 37°C in a humidified 5% CO2 incubator.   
2.2.1.2 Induction of tetracycline-inducible HEK293 cells stably expressing the hTRPM2 
HEK293 cells stably transfected with tetracycline-inducible cytomegalovirus-driven FLAG-
tagged TRPM2 were maintained at 37°C in a humidified 5% CO2 incubator in Dulbecco's 
modified Eagle's medium (DMEM)/F12 (DMEM-Ham’s F-12  growth medium containing L-
glutamax) and supplemented with 5 μg/ml blasticidin (InvivoGen) and 0.4 mg/ml zeocin 
(InvivoGen). Tetracycline (Sigma) at 1 µg/ml (Table 2.1) was applied to induce TRPM2 
protein expression 18-48 hr prior to use.  
2.2.1.3 Differentiation of THP-1 cells 
THP-1 cells were maintained at 37°C in a humidified 5% CO2 incubator in RPMI-1640 growth 
medium (Table 2.1), 100 ng/ml PMA (phorbol 12-myristate 13-acetate) (Calbiochem) was 
applied for 24 hr to induce differentiation to macrophage cells before use (Schwende et al., 
1996).  
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Table 2.1 Growth medium for mammalian cells 
Cell type Medium 
Peritoneal macrophage cells 
RPMI-1640 supplemented with 10% (v:v) FBS, 100 U/ml penicillin 
and 100 μg/ml streptomycin 
RAW264.7 RPMI-1640 supplemented with 10% (v:v) FBS 
THP-1 RPMI-1640 supplemented with 10% (v:v) FBS 
HEK293 DMEM  containing L-glutamax supplemented with 10% (v:v) FBS 
Tetracycline-inducible TRPM2-
expressing HEK293 cells 
(maintaining medium) 
DMEM/F12 supplemented with 10% (v:v) FBS, 5 μg/ml blasticidin 
and 0.4 mg/ml zeocin  
Tetracycline-inducible TRPM2-
expressing HEK293 cells 
(inducing medium) 
DMEM/F12 supplemented with 10% (v:v) FBS and 1 µg/ml 
tetracycline  
2.2.1.4 Cell passage 
All these cells were passed every 3-4 days as they became confluent. 
THP-1 cells are non-adherent cells, which were cultured in 30 ml media in 75-cm2 tissue 
culture flasks.  When the cells became confluent, 5 ml of cell suspension was moved to a 
fresh flask, and fresh growth medium was added to a final volume of 30 ml. 
RAW264.7, HEK293 and tetracycline-inducible TRPM2-expressing HEK293 cells are adherent. 
The cells were maintained in 5 ml media in 25-cm2 tissue culture flasks till they became 
confluent.  After rinsing with phosphate buffered saline (PBS), RAW264.7 cells were 
removed from the bottom of the flasks by a sterilized cell scraper.  HEK293 and tetracycline-
inducible TRPM2-expressing HEK293 cells were detached by incubating the cells in 1-2 ml 
trypsin-EDTA (ethylenediaminetetraacetic acid) at 37 °C for about 2 min.  Then, 1-2 ml fresh 
growth medium was added to inactivate trypsin.  Then, the cell suspension was transferred 
into a 15-ml centrifuge tube and the cells were collected by centrifugation at 130 × g for 5 
min.  After the supernatant was removed, the cells pellet was resuspended in 3 ml of fresh 
medium and then, 0.5 ml of cell suspension was moved into a new 25-cm2 flask.  5 ml of 
fresh growth medium was added into the flask to maintain the cells. 
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2.2.1.5 Restoration of frozen cells 
A vial of frozen cells was taken out from a liquid nitrogen cryostat and thawed quickly in a 
37°C bath for about 2 min. For adherent cells, the cell suspension was transferred into a 25-
cm2 flask with 5 ml growth medium and cultured for 24 hr to allow cells to adhere to the 
bottom of the flask before the growth medium was replaced.  For non-adherent cells, the 
cell suspension was centrifuged at 130 × g for 5 min.  Then, the cells were resuspended in 
fresh growth medium in a 25-cm2 flask.  All the cells were cultured as described above for 1-
2 weeks before use. 
2.2.1.6 Freezing cells 
Cells were cultured in 75-cm2 flasks till when they were more than 80% confluent. Then, the 
cells were detached from the bottom of the flasks as described in the section of cell passage, 
and collected by centrifugation at 130 × g for 5 min.  The cell pellets were resuspended in 3 
ml of FBS mixed with 10% (v:v) DMSO (dimethyl sulfoxide) (Sigma) and divided into three 2-
ml cryostat vials. The vials were placed in an isopropanol-containing box at -70°C overnight, 
and moved into a liquid nitrogen cryostat. 
2.2.2 Isolation of mouse peritoneal macrophage 
Mice, 4-6 weeks old, were sacrificed by cervical dislocation. The skin covering the abdomen 
was cut off and about 10 ml of ice-cold PBS was injected into the abdominal cavity using a 
syringe with 24 Ga needle.  After gentle massage, the PBS was removed from abdominal 
cavity by a syringe with 18 Ga needle, and, then, centrifuged at 130 × g for 15 min.  The cell 
pellets were resuspended in RPMI-1640 with 10% (v:v) FBS and penicillin (100 U/ml)-
streptomycin (100 μg/ml) (GIBCO-BRL) and seeded onto the 15-mm coverslips in 35-mm 
Petri dish.  After overnight culture, macrophage cells were easily purified by washing three 
times with pre-warmed PBS, because of strong adhesion of macrophage cells. 
2.2.3 Cell counting 
The counting chamber of the hemocytometer and its paired coverslip were carefully cleaned 
with ethanol and left to dry. After the coverslip was placed on the top of the 
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hemocytometer, 10 μl of cell suspension was injected into the counting chamber through 
the V-shaped well.  Using the microscope with 10× objective, the cells in 5 large squares 
(four large squares in the corner and one in the middle) and on the left and top edges of 
these squares in the counting grid were counted.  This number was multiplied by 50,000 to 
obtain the number of cells per ml.  
2.2.4 Cell preparation 
Cells were detached from the bottom of flasks as described in the section of cell passage, 
and harvested by centrifugation at 130 × g for 5 min.  Cells were added into the indicated 
container with growth medium in appropriate volume (Table 2.2) and incubated at 37°C in a 
humidified 5% CO2 incubator prior to use. 
Table 2.2 Cell preparation for different experiments 
Experiment Number of cells container 
Volume of 
medium 
Immunofluorescent 
confocal imaging 
50,000 -100,000 
35-mm Petri dish containing 4 
15-mm coverslips 
2 ml 
Whole-cell patch 
clamp recording 
40,000 - 50,000 
35-mm Petri dish containing 4 
15-mm coverslips 
2 ml 
Single cell Ca2+ 
imaging 
50,000 -100,000 
15-mm coverslip in each well 
of 24-well plates 
0.5 ml 
Flex-station 25,000-30,000 Each well of 96-well plates 0.1 ml 
XTT assay 10,000 - 20,000 Each well of 96-well plates 0.1 ml 
Trypan blue 
exclusion assay 
10,000 – 15,000 Each well of 24-well plates 0.5 ml 
2.2.5 Transient transfection 
One day before transfection, HEK293 cells were seeded in a 35-mm Petri dish in growth 
medium so that they would be 80-90% confluent at the time of transfection. The 
transfection was carried out with Lipofectin2000® reagent (GIBCO-BRL) following the 
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manufacturer’s instructions.  For each transfection, 1 μg plasmid DNA alone or with 0.1 μg 
plasmid DNA encoding green fluorescent protein (GFP), and 3 μl Lipofectin2000® reagent 
were diluted separately in 100 μl of OPTI-MEM I reduced serum medium (GIBCO-BRL).  Then 
two solutions were mixed and incubated at room temperature for 20-30 min to allow 
plasmid DNA and Lipofectin2000® reagent to form DNA-liposome complex.  The mixture 
was added into the Petri dish with HEK293 cells after removal of the old medium. Then, 800 
μl of fresh growth medium was added into each dish to a final volume of 1 ml.  The cells 
were incubated at 37°C overnight.  On the next day, the cells were detached by trypsin-
EDTA.  50 μl of cell suspension was added into a 35-mm Petri dish containing four 15-mm 
coverslips.  2 ml of fresh growth medium was added into each dish.  Cells were cultured 
overnight prior to use. 
2.2.6 Polymerase chain reaction 
Polymerase chain reaction (PCR) was performed using a thermocycler (Eppendorf) in a 
reaction volume of 25 μl.  The 25 μl reaction sample, set up in a 0.5-ml thin-wall Eppendorf 
tube, was composed of 0.75 μl of 10 μM each primer (forward and reversal primers) (Table 
2.2), 2.5 μl of 10 x Pfu Ultra reaction buffer (Stratagene), 2.5 μl of 2 mM dNTP mixture, 0.5 
μl of 0.1 μg/μl DNA template and 0.5 μl of 2.5 U/μl Pfu Ultra polymerase (Stratagene), and 
was adjusted to a final volume of 25 μl with Milli-Q water. 
The PCR sample was gently mixed and incubated at 95°C for 1 min to denature the double-
stranded DNA templates.  Then, 18 cycles of PCR were executed; each cycle was composed 
of 95°C for 50 s, 60°C for 50 s and 68°C for 20 min.  Incubation at 4°C was applied after the 
final cycle. 
2.2.7 Site-directed mutagenesis 
2.2.7.1 Primer design 
The oligonucleotide primers for site-directed mutagenesis were individually designed, 
depending on the location of mutations.  The nucleotide sequences of the forward and 
reversal primers used in this study are listed in Table 2.3 below. 
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Table 2.3 Sequences of the primers used in this study 
Primer name 5’ to 3’ Sequences 
hTRPM2 R961S forward primer 5’- CATCCACAACGAGAGCCGGGTGGACTGG -3’ 
hTRPM2 R961S reversal primer 5’- CCAGTCCACCCGGCTCTCGTTGTGGATG -3’ 
hTRPM2 H995Q forward primer 5’- CTTCAACCCGGAGCAGTGCAGCCCCAATGG -3’ 
hTRPM2 H995Q reversal primer 5’- CCATTGGGGCTGCACTGCTCCGGGTTGAAG -3’ 
mTRPM2 S958R forward primer 5’- ATACATAACGAGCGCCGCGTGGACTGG -3’ 
mTRPM2 S958R reversal primer 5’- CCAGTCCACGCGGCGCTCGTTATGTAT -3’ 
mTRPM2 Q992H forward primer 5’- TTCAGCATGGACCACTGCAGCCCCAAT -3’ 
mTRPM2 Q992H reversal primer 5’- ATTGGGGCTGCAGTGGTCCATGCTGAA -3’ 
2.2.7.2 Restriction enzyme digestion 
PCR using pair of designed primers was performed to create and amplify the plasmid 
containing mutation. The method was shown in 2.2.6. Then, each PCR sample was gently 
mixed with 0.5 μl of 10 U/μl DpnI (Promega), and incubated in a 37°C water bath for 1 hr. 
2.2.8 Agarose gel electrophoresis 
2.2.8.1 Agarose gel preparation 
Agarose gels (1%) were prepared by dissolving 1% (w:v) agarose powder (Melford) into TAE 
buffer (Table 2.4) by heating in a microwave. After the gel solution was cooled down to 50-
60°C, ethidium bromide (EB) was added to a final concentration at 0.5 μg/ml.  Then, the gel 
solution containing EB was poured into a plastic gel cast pre-assembled with a well-forming 
comb and left to solidify at room temperature. 
2.2.8.2 Gel electrophoresis 
The loading samples were made by blending the PCR sample with 1/6 volume of 6 × loading 
buffer. Then, the PCR samples and suitable DNA markers at 0.5 μg/µl were loaded into 
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individual wells side by side. Gel electrophoresis was carried out at 70 V for 90 min. Finally, 
the product was visualized and photoed using a BioRad Gel Doc system (BioRad, UK) under 
the UV light.  
2.2.9 Heat shock transformation 
Competent E. coli cells are able to take up nucleic acids including plasmid DNA in the 
presence of Ca2+ in the extracellular surroundings (Hanahan, 1983). The DH5α strain of E. 
coli cells was used for transformation; 1 μl of the PCR sample was transferred into 50 μl of 
freshly thawed competent E. coli cells and incubated on ice for 30 min. The mixture was 
shocked at 42°C for 45 s, and then returned onto ice and incubated for 2 min. The cells were 
mixed with 950 μl of LB growth medium and incubated at 37°C for 1 hr with a shaking 
incubator at 200 rpm.  The cell suspension was centrifuged at 7,000 × g for 5 min.  After 
removal of 800 μl of supernatant, the cells were resuspended and spread on LB agar plates. 
The agar plates were incubated at 37°C overnight.  On the next day, four single colonies for 
each mutation were selected and individually inoculated into 5 ml of LB medium containing 
50 μg/ml of ampicillin. The E. coli cells were incubated at 37°C with shaking at 250 rpm 
overnight. 
2.2.10 Mini-preparation of plasmid DNA 
Mini-preparations of plasmid DNA were carried out by a QIAprep®Miniprep kit (QIAGEN). E. 
coli were collected from overnight cell cultures by centrifugation at 5,000 × g for 3 min.  
After the supernatant was removed, the E. coli cells were resuspended in 250 μl of Buffer P1 
(Table 2.4) and transferred into a fresh Eppendorf tube.  After 250 μl of Buffer P2 (Table 2.4) 
was added into the tube, the cell suspension was thoroughly mixed by gently inverting the 
tubes 4–6 times, and then 350 μl of Buffer N3 (Table 2.4) was added into the cell suspension 
after the solution turned blue, and mixed thoroughly by inverting the tube 4-6 times again. 
The cell suspension was centrifuged at 13,000 × g for 10 min.  The supernatant was moved 
into a QIAprep spin column placed in a 1.5-ml Eppendorf tube, and centrifuged at 13,000 × g 
for 1 min.  The column was washed by adding 0.75 ml of Buffer PE and centrifuged at 13,000 
× g for 1 min twice to remove the residual liquid. The column was moved into a fresh 1.5-ml 
Eppendorf tube, and the DNA was eluted by adding 50 μl of Buffer EB (Table 2.4) onto the 
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spin column and centrifugation at 13,000 × g for 1 min.  The plasmid was stored at 4°C in a 
frost-free refrigerator prior to use. 
Table 2.4 Buffers for mini-preparation of plasmids 
TAE buffer 40 mM Tris-Oac, 0.114% (v:v) glacial acetic acid, and 1 mM EDTA pH 8.0 
Buffer P1 50 mM Tris·Cl, pH 8.0, 10 mM EDTA, 100 µg/ml RNAase  
Buffer P2 200 mM NaOH and 1% (w:v) sodium dodecyl sulfate (SDS) 
Buffer N3 3 M potassium acetate, pH 5.5 (adjust pH with glacial acetic acid) 
Buffer EB 10 mM Tris·Cl, pH 8-8.5 
2.2.11  DNA sequencing 
The DNA plasmids were sequenced by Geneservice in Cambridge, and the mutations were 
verified by sequence alignment to the WT human or mouse TRPM2 sequence using the 
Clustal W software (http://www.ebi.ac.uk/Tools/clustalw/). 
2.2.12  Immunofluorescent confocal imaging 
Cells were prepared as described in section 2.2.5.  After gently rinsed with PBS three times, 
the cells on the coverslips were fixed using pure methanol for 5 min at -20°C.  The cells were 
washed three times with PBS-T (Table 2.5) for 5 min each to remove methanol and enhance 
cell membrane permeability.  The cells were incubated in the blocking solution (Table 2.5) at 
room temperature for 30 min.  The primary anti-TRPM2 antibody was diluted in the 
antibody dilution buffer to the indicated concentrations detailed in chapter 5, and incubated 
with the cells at 4°C overnight.  On the next day, after washing with PBS-T three times, the 
cells were incubated with the secondary FITC-conjugated anti-rabbit IgG antibody in the 
indicated concentrations detailed in chapter 5 for 1 hr at room temperature in the dark.  
After washing three times with PBS-T, each coverslip was dried on tissue paper, mounted 
inversely on a glass slide with a 3-µl drop of anti-fade fluorescent mounting medium 
containing 4',6-diamidino-2-phenylindole (DAPI) which was used to show all of the cells in 
view, as it can pass through the cell membrane and strongly bind onto DNA, and exhibit 
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fluorescence at 461 nm.  Then, the coverslips were sealed by nail polish on the edge.  The 
slides were labelled and kept in a slide container at 4°C to be protected from light. 
The Zeiss LSM510 META upright confocal fluorescence microscope housed in the Faculty of 
Biological Science, University of Leeds was used to capture images. The 63x/1.4 oil plan-
apochromat objective was used with prior addition of immersion oil on the coverslip. A 
25mW 405 nm diode laser and a 30mW argon ion were applied to excite the DAPI at 405 nm 
and the FITC group in anti-rabbit IgG antibody at 488 nm, respectively.  After an appropriate 
cell sample was found under the microscope, the fluorescence was captured by a Zeiss 
AxioCam HRc high resolution microscope camera.  The photographing progress was 
controlled by the software Zen 2009.  Then, the data were analyzed using the Zeiss LSM 
Image software (version 4.3.0.121).   
Table 2.5 Solutions in immunofluorescent confocal imaging 
PBS 
8 g/l NaCl, 0.2 g/l KCl, 1.44 g/l Na2PO4, and 0.24 g/l KH2PO4 in water, 
pH7.4 with HCl 
PBS-T 0.4% (v:v) Trition X- 100 dissolved in PBS 
Blocking solution/ 
antibody dilution buffer 
Freshly prepared by mixing PBS-T and 10% (w:v) bovine serum albumin 
2.2.13  Patch clamp recording 
2.2.13.1 Principles 
The patch-clamp recording technique, which was developed about thirty years ago (Hamill 
et al., 1981, Hille, 1992, Neher and Sakmann, 1992), provides a research tool for ion 
transportation through membrane proteins, since it has a high resolution (Numberger and 
Draguhn, 1996) in detecting transmembrane ionic movements or currents, even through a 
single channel molecule.  
Whole-cell patch clamp recording is one configuration of the patch-clamp recording, 
together with the others, including cell-attached, inside-out and outside-out configurations.  
As illustrated in Fig. 2.1, a glass micropipette which has an open sharp tip of about one 
square micron is used. After the tip is pressed against the cell membrane, a small suction is  
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Figure 2.1  Cell-attached and whole-cell configurations of the patch-clamp recording 
This electrode is pressed against the cell surface to form a high resistance seal (gigaseal) with 
the plasma membrane by a small suction; this is cell-attached configuration.  After a further 
gentle suction is applied, the plasma membrane is rupture to form the whole-cell 
configuration. 
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Figure 2.2 The equivalent circuit of the whole-cell patch clamp recording 
The plasma membrane potential, which is equal to the voltage between the two 
electrodes in an ideal situation, is clamped at Vcommand by the differential amplifier 
connected with a feedback resistance. The change of the current flowing between the 
electrodes is detected and reflected on the current change through the feedback 
resistance.  
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applied to form a high resistance seal (in excess of GΩ) between the tip and the cell 
membrane, which is called the "gigaseal".  Then, a further suction is applied in order to 
rupture the membrane underneath the tip.   
Fig. 2.2 shows the equivalent circuit of the whole-cell patch clamp recording.  The recording 
electrode is mad e of a silver chloride-coated silver wire inserted in the micropipette, which 
is back-filled with micropipette solution. The other electrode is placed in the bath to set the 
zero level. These two electrodes are connected onto a differential amplifier that can amplify 
the difference in voltage between the two electrodes.  Through connecting a feedback 
resistance linked back onto the micropipette electrode, the differential amplifier clamps the 
voltage between the two electrodes at Vcommand and detects the shift of the current flowing 
between them, which reflects on the current change through the feedback resistance.  Since 
the plasma membrane sits between the electrodes, the membrane potential is equal to the 
voltage between the electrodes in the ideal situation. In addition, because the gigaseal 
suppresses the noise to the negligible level, the current change between the two electrodes 
is essentially composed by the variation of the transmembrane currents, such as the 
increase of the channel current when ion channel opens. 
2.2.13.2 Solutions for TRPM2 channel current recordings 
The standard external solution for whole-cell TRPM2 channel current recording is shown in 
Table 2.6 and pH was adjusted to 7.3 by 4 mM NaOH (Yang et al., 2010).  Other external 
solutions with different acidic pH indicated in chapter 3 were adjusted with 37% (w:w) 
hydrochloric acid.  ACA and test compounds were made as 20 mM and 10 mM stock 
solutions in DMSO, respectively.  All these compounds were freshly diluted to final 
concentrations in the external solution just before use, at the concentrations indicated in 
the result chapters.  DMSO alone at related concentrations was used as solvent control.  
ADPR and Na2ATP were added into the micropipette solution (Table 2.6) at the beginning of 
the day when recordings were made.  A rapid solution changer RSC-160 system (Biologic 
Science Instruments) was used to change the external solutions. 
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Table 2.6 Solutions in patch-clamp recording (in mM) 
2.2.13.3 Procedures for whole-cell TRPM2 channel current recording 
Cells were prepared as shown in section 2.2.5.  The borosilicate glass capillaries (World 
Precision Instruments) were used to the produce micropipettes using a two-stage vertical 
puller (PP-830, Narishige Scientific Instruments), and back-filled with the micropipette 
solution (Table 2.6) before it was amounted onto the probe of the amplifier.  In the external 
solution, the resistance of the micropipette was approximate 4-6 MΩ. 
ADPR-induced current recordings, from single peritoneal macrophage cells, tetracycline-
inducible TRPM2-expressing HEK293 cells, or single GFP-positive HEK293 cells transiently 
transfected with TRPM2 plasmids identified under an UV fluorescent microscope (Zeiss), 
were performed using an Axopach200B amplifier and Digidata 1332A (Axon Instruments). 
The pClamp9 software (Axon Instruments) was used to acquire and analyse the data.  The 
micropipette was moved toward and positioned on the cells using micromanipulators.  The 
membrane potential of the cells was held at -40 mV.  Recordings started, using voltage ramp 
protocols from -120 mV to 80 mV with 1-s duration applied every 5 s.  The whole-cell 
configuration was established by the small suction via a syringe connected to the 
micropipette and informed by a sudden increase in the transient capacitive currents.  
After the stable current was established, ACA at 10 μM or test compounds at 10 μM and 
acid pH indicated in the result chapter were added into the external solution. All the test 
compounds were applied up to 5 min. Acidic pH was continuously provided till the current 
became steady.  ACA was applied at the end of recordings to verify the TRPM2 current. 
Solution NaCl KCl MgCl2 CaCl2 Glucose HEPES EGTA Na2ATP ADPR 
External 
solution 
147 2 1 2 13 10    
Micropipette 
solution 
145  
 
1 0 10 0.05 1 1 
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2.2.14  Calcium imaging using fluorescent dyes 
2.2.14.1 Principle 
Calcium imaging is usually used to monitor the [Ca2+]c using fluorescent calcium indicator 
molecules, such as Fura-2.  Fura-2/AM (Fura-2-acetoxymethyl ester) is a membrane 
permeable derivative of Fura-2 and is Ca2+-insensitive.  It readily penetrates the cell 
membranes and is converted to the Ca2+-sensitive free Fura-2 in the cytosol upon removal of 
acetoxymethyl group by an endogenously expressed esterase.  Free Fura-2, can be excited 
by a light with peak value at 362 nm, and exhibits an emission peak of around 505 nm.  
Upon binding with Ca2+, the excitation peak is shifted to 335 nm, whereas the emission peak 
remains the same (Grynkiewicz et al., 1985). Thus, upon binding of Ca2+, the emission 
intensity excited by the excitation at 335 nm is enhanced and the emission intensity excited 
by 362 nm is reduced. In practice, 340 nm and 380 nm are used as excitation wavelengths, 
and the fluorescent emission intensities at 510 nm (F340 and F380) are measured.  The ratio of 
F340 to F380 (F340/F380) is used to indicate the [Ca2+]c, as it is proportional to the [Ca2+]c. The 
change of F340/F380 (∆F340/F380) is used to represent as the change in the [Ca2+]c in this study. 
2.2.14.2 Solutions 
The standard bath solution (SBS) (Table 2.7) used for Ca2+ imaging experiments was adjusted 
to pH 7.4 by 4 mM NaOH.  In some experiments, Ca2+-free SBS were used, which contained 
0.4 mM EGTA, but no CaCl2 (Table 2.7).  In some experiments, the SBS and the Ca2+-free SBS 
were preheated to 22°C or 37°C in a water bath.  The Fura-2/AM solution was prepared by 
diluting 4 μl Fura-2/AM (prepared as 1 mM stock solution in DMSO) (Calbiochem) and 1 μl 
plutonic acid (prepared as 10% (v:v) stock solution in DMSO) into 1 ml SBS before use. 
H2O2 was diluted in the SBS or Ca2+-free SBS to 0.3 mM from 30% (v:v) H2O2 stock solution 
for single cell calcium imaging,  and diluted to 4 mM for Flex-station.  ACA and test 
compounds were made as 20 mM and 10 mM stock solutions in DMSO, respectively.  PJ-34 
was dissolved in Milli-Q water to 10 mM. All these compounds were diluted in bath 
solutions to the final concentrations indicated in the result chapters. DMSO alone was used 
as solvent control. 
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Table 2.7 Solutions in Ca2+ imaging (in mM) 
Solution NaCl KCl MgCl2 CaCl2 Glucose HEPES EGTA 
SBS 134 5 1.2 1.5 8 10  
Ca2+-free SBS 134 5 1.2  8 10 0.4 
2.2.14.3 Procedures of single cell calcium imaging 
Cells were prepared as shown in section 2.2.5. After the medium was removed from the 
wells, the cells were rinsed three times with SBS, and incubated in 250 μl of 4 μM Fura-
2/AM solution.  After fully covered with aluminium foil, the plates were kept at 37°C in a 
tissue culture incubator for 1 hr.  The cells were then rinsed three times with SBS and left in 
250 μl of SBS alone or SBS containing 10 µM of PJ-34 for 30 min. The coverslip was mounted 
onto the bottom of the home-made silica gel plate with a hole in its central part, and the 
plate was placed in the recording chamber on the microscope stage and the home-made 
gravity-fed perfusion system was connected.  SBS alone or SBS containing 300 μM of H2O2 
were applied to cells after establishment of the baseline.   
The fluorescence was measured using an inverted S100 microscope with 40× objective 
(Zeiss).  The excitation light source was provided by a Xenon arc lamp (Ushio), and the 
wavelength at 340 nm or 380 nm was selected by a monochromator (Till Photonics).  The 
emission was collected via a 510-nm filter and sampled by a CCD camera (Orca ER; 
Hamamatsu). Images were taken in every 6 or 10 s by Openlab 2 software (Image Processing 
& Vision Company Ltd) as described by Zeng and his colleagues (Zeng et al., 2004).  
2.2.14.4 Procedure of Flex-station experiments 
Cells were prepared as shown in section 2.2.5.  The cells in each well were rinsed three 
times with SBS after removal of the culture medium.  Then 50 μl of 4 µM Fura-2/AM 
solution was added into each well, and the plates were wrapped with aluminium foil and 
kept at 37°C in a tissue culture incubator for 1 hr.  The cells were then rinsed three times 
with SBS, and then, kept in 120 μl of SBS with DMSO at related concentrations, or SBS 
containing ACA or test compound at the concentrations indicated in chapter 4 for 30 min.  
85 
 
The solution plate was prepared by adding 250 μl of SBS alone or SBS containing 4 mM H2O2 
into each well of the U-bottom 96-well plate. 
The fluorescence was measured using a Flex-Station II384 (Molecular Devices).  After setting 
the working temperature at 37°C and placing the pipette tip pack, solution plate and cell 
plate into the allocated chambers, the recording began following the set sampling program.  
In brief, the basal [Ca2+]c was recorded for 1 min and, subsequently, 40 μl of SBS alone or 
SBS containing 4 mM H2O2 was transferred from the solution plate into each well in the cell 
plate.  The working concentration of H2O2 was 1 mM. 
2.2.15 XTT assay 
The cell viability was assessed using XTT assay kits (Biotium). XTT, 2,3-bis-(2-methoxy-4-
nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide, can be converted to a highly water-
soluble product, which exhibits an reflection peak of around 475 nm, in the live cells by the 
active mitochondrial enzymes that become inactivated shortly after cell death (Nargi and 
Yang, 1993).  Thus, the optical density value (OD value) at 475 nm is measured to represent 
the number of live cells.  
Cells were prepared as shown in section 2.2.5. After exposure to test compounds or 10 μM 
PJ-34 for 30 min, the cells were exposed to H2O2 at the concentrations and duration detailed 
in the result chapters.  After wash once with fresh medium, 100 μl of growth medium, 50 μl 
of XTT solution and 0.25 μl of activation reagent PMS (N-methylphenazonium methyl 
sulphate) were added into each well, and three extra blank wells.  After incubation for 3 hr, 
the OD value at 475 nm in each well was measured using Varioskan Flash (Thermo Fisher 
Scientific Inc).  OD value at 650 nm was also determined as non-specific reading.  
2.2.16 Trypan blue exclusion assay 
Cells were prepared as shown in section 2.2.5.  After treatment with H2O2 at the indicated 
concentrations shown in the result chapters, cells were incubated in 0.4% (w:v) of trypan 
blue solution (Sigma) for 5min. The images in transmission light were captured using an 
Olympus IX51 microscope and software Cell^F (Olympus).  The dye-stained cells indicate the 
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necrotic cells.  ImagJ 1.43u software (National Institutes of Health, USA) was used for cell 
counting. 
2.2.17 Data analysis 
For the whole-cell current recordings, representative ADPR-induced currents at -80 mV are 
illustrated and analyzed in the result chapters.  The inhibition kinetics of the TRPM2 channel 
currents by acidic pH or test compounds was estimated by the time required to produce ≥ 
90% of the current inhibition (τ90%).  The inhibition and the current recovery from inhibition 
were determined by expressing the residual current and the currents recovered upon wash, 
as the percentage of the control currents. 
For the single cell calcium imaging, representative recordings illustrated in the result 
chapters represent the F340/F380 values that were normalized to the basal value at the time 
when in the solution perfusion started. The changes in the [Ca2+]c were estimated by the 
ΔF340/F380 before and after exposure to H2O2 at the times indicated in the result chapters. 
For the Flex-station experiments, the mean values of F340/F380 from 3-5 wells are shown in 
the result chapters.  The changes in the [Ca2+]c were estimated by the ∆F340/F380 values at 5 
min after exposure to H2O2.  The inhibition of the H2O2-induced increases in the [Ca2+]c by 
test compounds was defined as the reduction in ∆F340/F380 value in the presence of test 
compounds as percentage of the ∆F340/F380 in matched control cells. The following Hill 
equation was used to fit the concentration-inhibition data: 
y =100 × IC50n / (xn + IC50n)  
or, if there was significant residual or compound-insensitive component: 
y = (100 - A) × IC50n / (xn + IC50n) + A.   
Where n is Hill coefficient, x and y represent as the concentration of the test compound and 
the percentage of H2O2-induced increases in the [Ca2+]c in the control group in which the 
cells were exposed to SBS containing DMSO, respectively.  IC50 is the concentration 
producing 50% inhibition by the test compound.  A represents the residual component.  The 
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R value, which reflects the accuracy of the data fitting, was greater than 0.9 for all the data 
described in the result chapters. 
For the XTT assays, all the values were expressed as percentage of the average value of the 
control groups of cells that were not exposed to H2O2.  
For the trypan blue exclusion assays, the cell necrosis was defined as the percentage of 
trypan blue-positive cells in the total number of cells examined. 
Results are presented, where appropriate, as mean ± s.e.m. (standard error mean). The 
numbers shown in the brackets in the figures represent the number of cells recorded in 
whole-cell current recording, single cell calcium imaging and trypan blue exclusion assay, or 
the number of wells in Flex-station experiments and XTT assays.  Statistical significance were 
analyzed using Student's t-test between two groups and ANOVA (analysis of variance) (post-
hoc Tukey) among multiple groups, with significance at the level of p < 0.05. 
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Chapter 3                                                                                           
A residue in the TRPM2 channel outer pore is crucial in 
determining species-dependent sensitivity to extracellular 
acidic pH 
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3.1 Introduction 
As discussed in detail in the introduction chapter (section 1.2.5.2.7), acidic pH is an 
important parameter regulating ion channel activity and its biological function, including  
TRPV1 (Buijs et al., 2004), TRPV2 (Neeper et al., 2007), TRPA1 (Chen and Kym, 2009, Klionsky 
et al., 2007), P2X4 (Garcia-Guzman et al., 1997), and P2X7 (Jiang et al., 2000, Roger et al., 
2010).  Several recent studies including one from our lab have shown the inhibition of 
hTRPM2 channel by extracellular acidic pH (Du et al., 2009b, Starkus et al., 2010, Yang et al., 
2010).  However, there is significant discrepancy, particularly in terms of the reversibility of 
the inhibition and the underlying mechanisms. I conducted further experiments as 
described in this chapter to better understand the inhibition of the hTRPM2 channel by 
acidic pH. 
Mice, including transgenic mice, and the cells from them, are of paramount importance to 
infer the physiological functions of human proteins and the mechanisms responsible for 
associated pathologies and conduct preclinical testing of new therapeutic drugs (Chen and 
Kym, 2009).  Therefore I compared the effects of extracellular acidic pH on the hTRPM2 and 
mTRPM2 channels.  My results showed striking difference in the inhibition of the TRPM2 
channels by extracellular acidic pH in that the mTRPM2 channel exhibited a much lower 
sensitivity to, and slower kinetics of, inhibition, than the hTRPM2 channel.  By introducing 
reciprocal mutations of species-specific residues in the outer pore in the human and mouse 
TRPM2 channels, I have identified a crucial role for one residue in the outer pore region in 
determining such species differences.  In addition, such findings provide further evidence to 
support the conclusion that interaction of protons with the outer pore region underlies the 
inhibition of the TRPM2 channels by extracellular acidic pH (Yang et al., 2010).  Overall, 
these results help increase our understanding of how the TRPM2 channels in different 
species are functionally regulated by acidic pH.  
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3.2 Results 
3.2.1 Inhibition of H2O2-induced increases in the [Ca2+]c and ADPR-induced 
currents by ACA in HEK293 cells expressing hTRPM2 channel 
ACA has been identified as a potent TRPM2 channel inhibitor (see section 1.2.5.2.1).  Thus, I 
began with experiments studying the effects of ACA on the TRPM2 channel mediated 
responses, as it would be used as a control in the experiments that to be described later.  
Using Flex-station and tetracycline-inducible hTRPM2 channel-expressing HEK293 cells, I 
firstly investigated the effect of ACA on H2O2-induced increases in the [Ca2+]c.  As the results 
shown in Fig. 3.1A, H2O2 at 0.3 mM evoked significant elevation in the [Ca2+]c in the 
tetracycline-induced TRPM2-expressing HEK293 cells (black square), but not in the un-
induced cells (blue-triangle).  This Ca2+-response was suppressed by pre-treatment with ACA 
for 5 min in a concentration-dependent manner with an IC50 of 1.87 µM (Fig. 3.1A), which is 
similar as reported in a previous study (Kraft et al., 2004), and was completely blocked by 
ACA at 10 µM.  However, ACA at 30 μM evoked a strong increase in the basal [Ca2+]c.  ACA at 
10-20 µM also resulted in strong inhibition without altering the basal [Ca2+]c and thus was 
used to inhibit the TRPM2 channel activation in the rest of experiments described in this 
thesis.  Next, I studied whether ACA at 20 µM inhibited ADPR-induced current in the 
tetracycline-induced TRPM2-expressing HEK293 cells using whole-cell patch clamp 
recordings.  Fig. 3.1B shows the results.  ADPR at 1 mM induced a strong and sustained 
current, with the typical linear I-V relationship curve of the TRPM2 channels with the 
reversal potential at approximately 0 mV.  This ADPR-induced current was quickly and 
completely inhibited by ACA.   
Since HEK293 cells transiently transfected with WT and mutant hTRPM2 and mTRPM2 
plasmid were used in the following experiments in this chapter, I also investigated the 
inhibition of ADPR-induced current by ACA in HEK293 cells transiently transfected with the 
WT hTRPM2 plasmid.  A representative recording is illustrated in Fig. 3.1C, showing that 20 
µM ACA can rapidly and completely block the ADPR-induced current as observed in the 
tetracycline-induced HEK293 cells (Fig. 3.1B). 
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Figure 3.1 Characterization of the inhibitory effect of ACA on TRPM2 channel functions 
A, upper, the time course of the effects of ACA at different concentrations H2O2-induced increases in 
the [Ca2+]c in Ca2+-containing SBS in tetracycline-inducible hTRPM2-expressing HEK293 cell examined 
using Flex-station. The different cell preparations and ACA concentrations are indicated with different 
symbols or colours. Bottom, the concentration-inhibition relationship curve was fit to the Hill 
equation to determine the IC50.  The numbers of wells examined in each concentration are indicated 
in parenthesis. B, representative recording of 1 mM ADPR-induced currents at -80 mV (left) and the I-
V relationship curves (right) recorded from tetracycline-induced hTRPM2-expressing HEK293 cells, 
using 1-s voltage ramps of -120 to +80 mV applied every 5 s. 20 µM ACA was applied to inhibit the 
currents.  C, representative recording of 1 mM ADPR-induced current at -80 mV in HEK293 cells 
transiently transfected with the hTRPM2 plasmid. The dotted lines in B and C indicate the baseline.  
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3.2.2 Exposure duration-dependent reversibility of hTRPM2 channel 
inhibition 
In order to investigate the inhibitory effect of extracellular acidic pH on the hTRPM2 channel 
and, particularly, the mechanisms underlying the reversibility, I examined the kinetics of the 
recovery from the inhibition following various exposure durations in HEK293 cells 
transiently transfected with the hTRPM2 plasmid. Fig. 3.2A-E show representative 
recordings and the mean data for pH 5.5.  The exposure duration, denoted by the open bar 
above the recording traces, was defined as the time starting from the point when the 
complete inhibition was obtained.  Fig. 3.2F illustrates the percentage of the current 
recovery in individual cells.  While the data are scattered but still exhibit a discernible 
pattern in that the short exposure durations (0 and 30 s) led to greater current recovery 
whereas there was little or no recovery after the longer exposure durations (60, 90 and 120 
s). Fig. 3.2G plots the current recovery against the exposure duration; the data were fit 
reasonably well with exponential (R=0.7), yielding an inactivation time constant of 
approximately 30 s. Taken together, these results suggest that the early or initial inhibition 
of ADPR-induced currents by extracellular acidic pH is largely reversible, but became steady 
and irreversible after long exposure duration.  
3.2.3 Differential inhibition of the mTRPM2 and hTRPM2 channel currents by 
acidic pH 
For the reasons outlined in the introduction, it is interesting to know whether acidic pH 
inhibits the mTRPM2 channel in a similar fashion.  Therefore, I went on to investigate the 
effects of acidic pH on the mTRPM2 channel currents in HEK293 cells transiently transfected 
with the mTRPM2 plasmid.  Application of intracellular ADPR (1 mM) induced robust current 
responses, which displays a typical linear I-V relationship and complete inhibition by ACA, 
indicating that the mTRPM2 channel exhibits similar functional properties as the hTRPM2 
channel.  Similar to our previous study for the inhibition of the hTRPM2 channel currents by 
acidic pH (Yang et al., 2010), the steady-state inhibition of the mTRPM2 currents by 
extracellular acidic pH (4.5-5.5) was complete, irreversible and pH-independent (Fig. 3.3).  
The inhibition kinetics was also pH-dependent, as described for the hTRPM2 channel  
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Figure 3.2 Exposure duration-dependent reversibility of inhibition of the hTRPM2 channel 
currents by pH 5.5 
A-E, representative recordings (left) and summary (right) of the 1 mM ADPR-induced 
whole-cell currents are shown. The currents at −80 mV were recorded in HEK293 cells 
expressing the hTRPM2 channels, using 1-s voltage ramps of −120 to 80 mV applied every 5 
s in extracellular pH 7.3 before exposure to pH 5.5, after the indicated time of exposure to 
pH 5.5, recovered upon return to pH 7.3 (left).  The open bars on top of each trace show 
the duration (0, 30, 60, 90, and 120 s) from attainment of complete inhibition, and the 
black bars the total duration of exposure to pH 5.5. The dotted lines indicate the baseline. 
The ***p<0.001, **p<0.01, and *p<0.05 between the paired groups. The numbers of cells 
examined in each case are indicated in parenthesis. F, summary of the percentage of 
current recovery in individual cells (diamond symbols) and the mean values (filled squares) 
in each group as those shown in A-E. G, Relationship of the percentage of current recovery 
to the total exposure duration (denoted by the black bars in A-E). The straight line shows 
an exponential fit to the data with a time constant of approximately 30 s (R = 0.7) 
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   Figure 3.3 Characterization of the mTRPM2 and hTRPM2 channel currents induced by ADPR 
A, representative 1 mM ADPR-induced currents at −80 mV and I -V relationship curves were 
recorded from HEK293 cells transiently transfected with WT mTRPM2 (left) or hTRPM2 (right) 
plasmid, using 1-s voltage ramps of −120 to 80 mV applied every 5 s. The currents were 
inhibited by application of 20 μM ACA. The dotted lines indicate the baseline. B, summary of 
the currents before and after application of ACA as shown in A. The numbers of cells recorded 
in each case are indicated in parenthesis. ***p<0.005 between the paired groups. 
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Figure 3.4 Differential inhibition of ADPR-induced currents mediated by the hTRPM2 
and mTRPM2 channels by extracellular acidic pH 
A-B, 1 mM ADPR-induced currents are recorded from HEK293 cells transiently 
transfected with the WT hTRPM2 (A) and mTRPM2 (B) plasmid, first in extracellular pH 
7.3 and then in indicated extracellular acidic pH. The dotted lines indicate the baseline. 
C-D, summary of the residual currents in the steady state, expressed by percentage of 
the currents in pH 7.3 before solution change (C), and the kinetics of inhibition (D), 
indicated by τ90%. The numbers of cells examined in each case are indicated in 
parenthesis in C. **p<0.01 and ***p<0.005 between the paired groups, and N.S., no 
significant difference. 
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currents.  However, the inhibition kinetics was significantly slower than that of the hTRPM2 
channel currents, particularly by pH 5.5 (Fig. 3.4). Furthermore, in contrast with the 
complete inhibition of the hTRPM2 channel currents, there was little inhibition by pH 6.0 of 
the mTRPM2 channel currents.  In summary, these results provided clear evidence to 
indicate species-dependent modulation of the TRPM2 channels by acidic pH. 
3.2.4 Accelerated kinetics of, and increased sensitivity to, inhibition by acidic 
pH by His substitution of pore residue Gln-992 in mTRPM2 channel 
Our previous site-directed mutagenesis study shows that inhibition of the human TRPM2 
channel by acidic pH results from interactions of protons with residues in the outer pore 
domain (Yang et al., 2010). In order to understand the molecular mechanism that is 
responsible for the difference in inhibition of the hTRPM2 and mTRPM2 channels by acidic 
pH, I compared the amino acid sequences of the pore domain in the hTRPM2 and mTRPM2 
channels.  As shown earlier in Fig. 1.3, there are three proton-interacting candidate residues 
in the hTRPM2 protein, Arg-961, His-995 and Arg-1017, which are substituted by Ser-958, 
Gln-992 and Ala-1014 in the mTRPM2 protein. The R1017A mutation in the hTRPM2 protein 
was shown to accelerate, rather than slow down, the inhibition by acidic pH in our previous 
study (Yang et al., 2010).  I investigated the role of Ser-958 and Gln-992 in the mTRPM2 
channel by mutating them individually to the residues in the hTRPM2 channel. Both S958R 
and Q992H mutations had no effect on the amplitude of the ADPR-induced whole cell 
currents (Fig. 3.5), as well as the TRPM2 channel properties such as the linear I-V 
relationship (Fig. 3.6).  The S958R mutant mTRPM2 channel showed similar steady-state and 
kinetics of the inhibition by acidic pH, and by contrast, the Q992H mutation conferred 
dramatically accelerated inhibition kinetics or τ90% (see section 2.2.16) in response to pH 
4.5-5.5, without changing the steady-state inhibition (Fig. 3.6 and Fig. 3.8).  More strikingly, 
in contrast with the insensitivity of the WT mTRPM2 channel currents, the Q992H mutant 
mTRPM2 channel currents were completely inhibited by pH 6.0 (Fig. 3.6), as found for the 
hTRPM2 channel (Fig. 3.4). These results indicate that Gln-992 residue is crucial in 
determining the slower kinetics of, and lower sensitivity to, the inhibition of the mTRPM2 
channel by extracellular acidic pH. 
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Figure 3.5 ADPR-induced whole-cell currents in the HEK293 cells expressing WT and 
pore mutant hTRPM2 and mTRPM2 channels 
A-B, mean amplitude of 1 mM ADPR-induced currents recorded in single cells transiently 
transfected with indicated WT (gray bar) and mutant hTRPM2 (A) (open bars) and 
mTRPM2 (B) plasmid (oblique line bars). The numbers of cells recorded in each case are 
indicated in parenthesis. N.S. represents no significant difference compared to WT. 
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Figure 3.6 Accelerated kinetics of, and increased sensitivity to, inhibition by 
acidic pH by mutation of Gln-992 but not Ser-958 in the mTRPM2 channel 
A-C, 1 mM ADPR-induced currents at −80 mV and I -V relationship curves are 
recorded in HEK293 cells transiently transfected with the WT or S958R or Q992H 
mutant mTRPM2 plasmid in response to extracellular acidic pH 4.5 (A), 5.5 (B) 
and 6.0 (C). Note that the mutation Q992H greatly accelerates the inhibition by 
pH 5.5 and confers complete inhibition by pH 6.0 without change in the I-V 
relationship curves.  
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3.2.5 Decelerated kinetics of inhibition by acidic pH by reciprocal mutation of 
His-995 in the hTRPM2 channel 
To further verify the role of Gln-992 residue in the mTRPM2 channel and the equivalent His-
995 residue in the hTRPM2 channel in determining the species difference in the inhibition of 
the TRPM2 channels by acidic pH, I introduced the reciprocal mutations, R961S and H995Q, 
in the hTRPM2 channel.  Again, like the mutations in the mTRPM2 channel, both R961S and 
H995Q mutations did not alter the amplitude of ADPR-induced currents (Fig. 3.5) and the 
linear I-V relationship (Fig. 3.7).  Like the S958R mutation in the mTRPM2 channel, the R961S 
mutation in the hTRPM2 channel failed to change both the steady-state inhibition by 
extracellular acidic pH and the inhibition kinetics (Fig. 3.7 and Fig. 3.8). While the steady-
state inhibition by pH 5.5-6.0 remained unchanged, the kinetics of inhibition was remarkably 
decelerated when the H995Q mutant hTRPM2 channel was compared to the WT hTRPM2 
channel (Fig. 3.8).  These results, taken together with the results from the mTRPM2 channel, 
indicate that His-995/Gln-992 residue in the pore region is critical in determining the 
differential responses of the human and mouse TRPM2 channels to extracellular acidic pH. 
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Figure 3.7 Decelerated kinetics of, and increased sensitivity to, inhibition by acidic pH by 
mutation of His-995 but not Arg-961 in the hTRPM2 channel 
A-C, 1 mM ADPR-induced currents at −80 mV and I -V relationship curves are recorded in 
HEK293 cells transiently transfected with the WT or R961S or H995Q mutant hTRPM2 
plasmid in response to extracellular acidic pH 4.5 (A), 5.5 (B) and 6.0 (C). Note that mutation 
H995Q strikingly slows down the inhibition by pH 5.5 and pH 6.0 without change in the I-V 
relationship curves.  
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Figure 3.8 A crucial role of His-995 in the hTRPM2 channel and Gln-992 in the mTRPM2 
channel for species-dependent inhibition by acidic pH. 
A-D, summary of the residual currents induced by 1 mM ADPR in the steady state as 
percentage of the currents in pH 7.3 before solution change (left) and the kinetics of 
inhibition (indicated by τ90%; right) in extracellular pH 4.5 (A), 5.0 (B), 5.5 (C), and 6.0 (D). 
The numbers of cells examined in each case are indicated in parenthesis in the left 
panel. *p<0.05, **p<0.01, and ***p<0.005 between the paired groups, N.S., no 
significant difference, and N.D., not determined. 
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3.3 Discussion 
In this chapter I have shown that the initial inhibition of the hTRPM2 channel currents by 
extracellular acidic pH exhibited substantial reversibility but the steady-state inhibition 
became irreversible.  Similar to the hTRPM2 channel currents, the steady-state inhibition of 
the mTRPM2 channel currents was irreversible and pH-independent within pH 4.0–5.5, with 
strong pH-dependent kinetics of inhibition. However, there was a significant difference 
between the hTRPM2 and mTRPM2 channels; compared to the hTRPM2 channel currents, 
the mTRPM2 channel currents exhibited much slower kinetics of inhibition by pH 5.0–5.5 
and lack of inhibition by pH 6.0. Furthermore, the results from site-directed mutagenesis 
and functional study provide clear evidence to show that species-specific residue His-
995/Gln-992 in the outer pore region of the TRPM2 channels is crucial in determining the 
difference between hTRPM2 and mTRPM2 channels in the sensitivity to extracellular acidic 
pH. 
The finding that the reversibility of the inhibition of the hTRPM2 channel currents strongly 
depends upon the exposure duration was important in two folds. Firstly, the inhibition 
showed substantial reversibility upon returning to pH 7.3 immediately after exposure that 
just sufficed complete inhibition, but such reversibility progressively diminished as the 
exposure duration was prolonged to ≥ 60 s (Fig. 3.2A-F).  These results provide clear 
evidence to indicate that extracellular protons induces initial reversible inhibition and 
evokes conformational changes leading to subsequent irreversible inhibition or channel 
inactivation, as was proposed previously (Yang et al., 2010). Detailed analysis further 
revealed that the inactivation occurs with a time constant of 30 s (Fig. 3.2G). Secondly, as 
mentioned in the introduction, a fundamentally different mechanism had been proposed to 
account for both the reversible and irreversible inhibition of the hTRPM2 channel currents 
by extracellular acidic pH; the inhibition is thought to result from binding of extracellular 
protons, after permeating through the open channels, to an intracellular binding site 
(Csanady and Torocsik, 2009, Starkus et al., 2007).  It is also worth mentioning that there is 
no evidence for the permeability of the TRPM2 channels to protons.  This intracellular 
mechanism underlying the reversible inhibition and particularly the irreversible inhibition 
appears difficult to be reconciled with the strong dependence of the reversibility on the 
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duration, starting after no further proton influx, if one presumes that protons can permeate 
through the open TRPM2 channels (Fig. 3.2A-E). 
The steady-state inhibition of the mTRPM2 channel currents was complete, irreversible, and 
pH-independent (pH 4.0-5.5) with clear pH-dependent kinetics. These inhibitory features are 
similar to those for the hTRPM2 channel currents (Fig. 3.4A-C).  However, the kinetics of 
inhibition by pH 5.0–5.5 for the mTRPM2 channel currents was noticeably slower than that 
for the hTRPM2 channel currents (Fig. 3.4D). Furthermore, in contrast with the complete 
inhibition of the hTRPM2 channel currents, the mTRPM2 channel currents showed little or 
no inhibition by pH 6.0. Such differences in the kinetics and particularly the sensitivity to pH 
6.0 could bear significant functional implications, because the TRPM2 channels at the cell 
surface could experience extracellular acidic pH, e.g., at the site of inflammation (Lardner, 
2001), or within the lysosome where the luminal pH was highly acidic (Lange et al., 2009). In 
addition, as discussed below, the effects of extracellular acidic pH engage proton–outer 
pore interactions, and thus the species-dependence provides an indication of some local 
structural difference in the outer pore, which could have a profound impact on 
development of antagonists.  
Our previous study have identified several residues in the outer pore, including Lys-952 and 
Asp-1002, to be critical in determining the sensitivity to, and the kinetics of, the reversible 
inhibition and inactivation of the hTRPM2 channel currents, leading  to the notion that the 
effects of extracellular acidic pH originates from interactions of protons with the outer pore 
(Yang et al., 2010). Yue and her colleagues have proposed a similar molecular mechanism 
for the reversible inhibition (Du et al., 2009b) that, however, has been subsequently 
challenged (Csanady and Torocsik, 2009, Starkus et al., 2007). They introduced the H995Q 
mutation in the hTRPM2 channel but found no significant effect on the reversible inhibition 
(Du et al., 2009b). In the present study, the H995Q mutation in the hTRPM2 channel 
remarkably slowed down, and the reciprocal Q992H mutation in the mTRPM2 channel 
accelerated, the kinetics of the channel inhibition or inactivation (Fig. 3.6, Fig. 3.7 and Fig. 
3.8). Moreover, the Q992H mutation conferred complete inactivation by pH 6.0 to the 
mTRPM2 channel, which was otherwise insensitive (Fig. 3.6). We simply failed to produce 
such opposing effects by introducing reciprocal mutations of another pair of residues, Arg-
961 in the hTRPM2 channel and Ser-958 in themTRPM2 channel (Fig. 3.8), supporting that 
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the mutational effects of H995Q in the hTRPM2 channel and Q992H in the mTRPM2 channel 
is specific. Taken together, the results described in this chapter suggest that His-995 confers 
greater sensitivity to and faster kinetics of inactivation of the hTRPM2 channel by 
extracellular acidic pH. One simple and plausible interpretation of the striking differences 
between the hTRPM2 and mTRPM2 channels and the opposing effects from reciprocal 
mutations of His-995/Gln-992 is that protonation at His-995 in the WT hTRPM2 channel, or 
the His residue engineered in the equivalent position of the Q992H mutant mTRPM2 
channel, introduces electrostatic interactions with other charged residues nearby such as 
Asp-1002 (Yang et al., 2010) and particularly Asp-987 (Wehrhahn et al., 2010), and thereby 
evokes conformational changes leading to inactivation of the ion-conducting pore. Such an 
interpretation is consistent with a previous study proposing that the P1018L mutation in the 
outer pore, identified in Guamanian Western Pacific amyotrophic lateral sclerosis and 
Parkinsonism dementia patients, renders the hTRPM2 channel to inactivate via 
conformational changes in the outer pore (Hermosura et al., 2008). 
In summary, I have shown in the study described in this chapter that extracellular acidic pH 
induces initial reversible inhibition and subsequent irreversible inactivation of the human 
TRPM2 channels. I have also revealed the strong difference of the sensitivity to, and kinetics 
of, the inhibition by extracellular acidic pH between the human and mouse TRPM2 channels, 
and have identified residue His-996 in the outer pore of the hTRPM2 channel and equivalent 
Gln-992 in the mTRPM2 channel as a crucial determinant for such species difference. These 
findings provide new insight into the responses of the TRPM2 channels to extracellular 
acidic pH. 
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Chapter 4                                                                                       
Characterization of novel TRPM2 channel inhibitors 
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4.1 Introduction 
As discussed in detail in the introduction chapter, many compounds have been 
demonstrated to inhibit the TRPM2 channels, such as ACA, FFA and 2-APB (section 1.2.5.2). 
In the previous chapter, I have also presented evidence to show that acidic pH can also 
inhibit the TRPM2 channels.  However, all of these chemicals are able to have various 
effects on a range of ion channels. For example, ACA acts as an inhibitor of calcium-
activated chloride channels and 2-APB inhibit the IP3 receptors and other TRP channels 
(Diver et al., 2001, Gwanyanya et al., 2010, Xu et al., 2005).  Besides these non-specific 
TRPM2 channel inhibitors, some other chemicals can indirectly influence the TRPM2 
channel activation, such as PJ-34 which is an inhibitor of PARPs and thus suppresses the 
TRPM2 channel activation by blocking PARP-mediated generation of ADPR (Fonfria et al., 
2004, Kashio et al., 2012).  Currently, there is no specific blocker for the TRPM2 channels, 
which makes difficulties if it is impossible to study the physiological functions of the hTRPM2 
channel.  In addition, several recent studies show that transgenic TRPM2 deficient mice are 
fertile and exhibit no significant detrimental phenotype but such mice show strong 
protection from oxidative stress-induced colitis (Knowles et al., 2011), and mitigate obesity 
and metabolic disorders (Zhang et al., 2012), suggesting development of hTRPM2 channel 
specific inhibitors is a promising therapeutic strategy.  In order to develop new TRPM2 
inhibitors, our lab has collaborated with Dr. R Foster, Medicinal Chemistry and Chemical 
Biology (MCCB) Technology Group Leader in the School of Chemistry in the University of 
Leeds.  They have screened 14,000 compounds by testing the effects on H2O2-induced 
increases in the [Ca2+]c in the tetracycline-induced hTRPM2-expressing HEK293 cells and 
identified 48 hit compounds.  In this chapter, I will describe a detailed characterization of 
the effects on H2O2-induced Ca2+ responses and ADPR-induced currents by these 
compounds. I have shown that several compounds can inhibit the TRPM2 channels with a 
micromolar or submicromolar potency.  
112 
 
4.2 Results 
4.2.1 Inhibition of H2O2-induced increases in [Ca2+]c by the TRPM2 inhibitor 
candidates 
I began with examining the effects of 48 compounds at 10 µM on the increases in the [Ca2+]c 
induced by 1 mM H2O2 in the tetracycline-induced HEK293 cells expressing the hTRPM2 
channels. The cells were loaded with Fura-2/AM, and the fluorescence intensity, excited 
with 340 nm and 380 nm and emitted at 510 nm, was measured using Flex-station (see 
section 2.2.13).  After 1 min recording to establish the baseline, cells were exposed to H2O2, 
and the recording continued for 5min.  As shown in Fig. 4.1, for the cells in the control group 
(treated with the solvent DMSO) in Ca2+-containing SBS, H2O2 evoked, with a delay of about 
1 min, strong increases in the [Ca2+]c that reached the steady-state level within 1-3 min.  
Pre-treatment with 10 µM ACA for 30 min substantially inhibited H2O2-induced increases in 
the [Ca2+]c.  Similar pre-treatment with each of the 48 compounds exhibited various effects. 
Some of the compounds, including No.13, No.35, No.37, No.42, No.02 and No.07, 
completely or almost completely eliminated H2O2-induced increases in the [Ca2+]c, many 
other compounds, such as No.15, No.17, No.34 and No.09, had partial inhibition, whereas 
some compounds, such as No.18 and No.44, showed little or no inhibition. Fig. 4.2 
summarizes the mean inhibitions of all 48 compounds, arranged in a descending order.  
Of notice, several compounds such as No.31 and No.12 substantially altered the baseline 
before addition of H2O2 (Fig. 4.1), which prevents or complicates accurate determination of 
the inhibition by such compounds.  The baseline shift could be caused by many reasons, for 
example, alteration in the membrane permeability to allow extracellular Ca2+ influx or 
release of intracellular Ca2+, or interference of the fluorescent properties of Fura-2.  To 
mitigate the effect on the baseline, these compounds at 1 µM were tested for their effects 
on H2O2-induced Ca2+ responses.  The time course of the effects and the mean inhibition are 
shown in Fig. 4.3 and Fig. 4.4, respectively.  The shifts in the basal [Ca2+]c by most of the 
compounds tested, such as No.04, No.10 and No.33, were reduced or completely abolished. 
In addition, some of these compounds, including No.22 and No.45, still exhibited substantial, 
but attenuated, changes in the basal [Ca2+]c, but elimination of the increases in the [Ca2+]c by  
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Figure 4.1 Effects of hit compounds at 10 µM on H2O2-induced increases in the [Ca2+]c 
The time courses of the effects on H2O2-induced Ca2+ responses by individual compounds 
(indicated in the figure) in tetracycline-induced hTRPM2-expressing HEK293 cells in Ca2+-
containing SBS using Flex-station.  Cells were pre-treated with DMSO (black square), 10 µM ACA 
(navy diamond) or 10 µM compounds (red circle) for 30 min, and then exposed to 1 mM H2O2 
for 5 min.  The compounds are arranged according to the percentage of inhibiting H2O2-induced 
Ca2+ responses in a descending order.  The data show mean ± sem; the number of wells 
examined for each compound are indicated in parenthesis in Fig.4.2. 
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Figure 4.2 Summary of inhibition of H2O2-induced increases in the [Ca2+]c by compounds 
at 10 µM 
Summary of the inhibition of 1 H2O2-induced Ca2+ responses by individual compounds 10 
µM in tetracycline-induced hTRPM2-expressing HEK293 cells as illustrated in Fig. 4.1.  The 
compounds are arranged according to their percentage of inhibiting H2O2-induced Ca2+ 
responses in a descending order.  The dotted-line shows 50% inhibition.  The compounds 
before the double-line induce >50% inhibition.  The oblique line bars indicate that the 
compounds cause a substantial change in the basal [Ca2+]c. The data show mean ± sem; the 
number of wells examined for each compound are indicated in parenthesis. 
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Figure 4.3 Effects of hit compounds at 1 µM on H2O2-induced increases in the [Ca2+]c 
A-B, the time courses of the effects on H2O2-induced Ca2+ responses by individual 
compounds (indicated in the figure) in tetracycline-induced hTRPM2-expressing HEK293 
cells in Ca2+-containing SBS using Flex-station.  Cells were pre-treated with DMSO (black 
square) or 1 µM indicated compounds (grey circle) for 30 min, and then exposed to 1 mM 
H2O2 for 5 min. Panel B shows the compounds which exhibited modest or no effects on 
the basal [Ca2+]c and no inhibition of H2O2-induced Ca2+ responses.  The compounds are 
arranged according to the percentage of inhibiting H2O2-induced Ca2+ responses in a 
descending order.  The data show mean ± sem; the numbers of wells examined for each 
compound are indicated in parenthesis in Fig. 4.4. 
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Figure 4.4 Summary of inhibition of H2O2-induced increases in the [Ca2+]c by compounds at 
1 µM 
Summary of the inhibition of 1 mM H2O2-induced Ca2+ responses by 1 µM individual 
compounds in tetracycline-induced hTRPM2-expressing HEK293 cells.  The compounds are 
arranged according to the percentage of inhibiting H2O2-induced Ca2+ responses in a 
descending order. The dotted-line shows 50% inhibition.  The oblique line bars indicate that 
the compounds cause a substantial change in the basal [Ca2+]c.  The data show mean ± sem; 
the number of wells examined for each compound are indicated in parenthesis. 
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these compounds at 1 µM suggested a high potency of inhibiting the TRPM2 channels.  In 
contrast, some other compounds (Fig 4.3B), No.01, No.12, No.20 and No.47, at 1 µM 
showed modest or no effects on the basal [Ca2+]c and at the same time they lost their 
inhibition of H2O2-induced increases in the [Ca2+]c.  Thus, 24 compounds, which showed 
strong inhibition of H2O2-induced Ca2+responses with modest or no effect on the basal 
[Ca2+]c were subjected to further characterization (showing in black in Fig.  4.2). 
4.2.2 Potency of select TRPM2 inhibitor candidates 
I next examined the potency of the 24 compounds by determining the inhibition of H2O2-
induced increase in the [Ca2+]c at more than 5 different concentrations and fitting the data 
to Hill equation (section 2.2.16) to derive the IC50.  Fig. 4.5 shows the mean data and the 
fitting curves, and Fig. 4.6 summarizes the derived IC50s.  Three compounds (No.30, No.17 
and No.15) exhibited a relatively low potency with an IC50 of higher than 5 µM.  The IC50s of 
all other compounds were lower than 5 µM, suggesting a high sensitivity of H2O2-induced 
increase in the [Ca2+]c to these compounds; among them, six compounds (No.03, No.40, 
No.10, No.13, No.22 and No.45) have a very high potency, with an IC50 of less than 1 µM.  
However, two compounds, No.41 and No.43, were ineffective, resulting in partial inhibition 
of H2O2-induced Ca2+ response at 10 µM, and thus, their IC50s were not calculated.  
4.2.3 Inhibition of ADPR-induced currents by TRPM2 inhibitor candidates 
The whole-cell patch-clamp recording was performed to investigate whether the 
suppression of H2O2-induced increases in the [Ca2+]c by these compounds were due to direct 
inhibition of the hTRPM2 channel activation.  I focused on the 19 compounds, whose IC50s 
were lower than 5 µM (Fig. 4.6), and determined their effects at 10 µM on the currents 
induced by 1 mM ADPR in the tetracycline-induced HEK293 cells stably expressing the 
hTRPM2 channels. The individual compound was applied to the patched cells for up to 5 min 
after stable ADPR-induced currents were established (Fig. 4.7).  ACA at 20 µM was applied 
to any residual currents at the end of the recordings to verify that the currents were 
mediated by the TRPM2 channels.  The representative currents at -80 mV and the mean 
data are shown in Fig. 4.7 and Fig. 4.8, respectively.  The effects of these compounds on the  
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Figure 4.5 Concentration-dependent inhibition of H2O2-induced increases in the [Ca2+]c 
For each compound are shown the time courses of the concentration-dependent effects on H2O2-induced Ca2+ response (left) and the 
concentration-inhibition relationship curve (right) in tetracycline-induced hTRPM2-expressing HEK293 cells using Flex-station.  The red lines 
represent the fitting curves to Hill equation.  Cells were pre-treated with SBS containing DMSO at related concentrations (black square) or the 
indicated compound at different concentrations (indicated by the symbols on the top of each panel) for 30 min, and then exposed to 1 mM H2O2 
for 5 min.  The numbers of wells examined for each compound are indicated in parenthesis.        
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Figure 4.6 IC50 values of the tested compounds inhibiting H2O2-induced increases in the [Ca2+]c 
A, summary of the IC50s of compound tested in Fig. 4.5.  The compounds are arranged according to their IC50 in a descending 
order. The dotted-lines show 5, 10 and 15 µM.  The chemicals on the right of the double-line exhibit IC50s lower than 5 µM. B, 
the mean data of IC50s for compounds No.07, No.13, No.39 and No.42.  The data show mean ± sem value from three 
independent experiments.  
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TRPM2 channel currents were noticeably various from almost complete abolition (No.07, 
No.13, No.39, and No.42) to modest inhibition (Fig. 4.8).  The mean inhibition by No.07, 
No.13, No.39 and No.42 was 100% ± 0.6%, 98% ± 0.7%, 97% ± 1.7% and 92% ± 1.8%, 
respectively. The inhibition by all these four compounds was similar at positive and negative 
membrane potentials, indicating voltage-independent inhibition (Fig. 4.7B-E).  However, 
there were significant differences in the inhibition kinetics and reversibility among these 
four compounds.  The inhibition by No.07 and No.42 (Fig. 4.7B and Fig. 4.7C) was similar; 
the inhibition was relatively fast, with τ90% of 77.0 ± 39.5 s and 121.3 ± 38,3 s, respectively 
(Fig. 4.8C). The inhibitions by No.07 and No.42 were substantially reversible (75.3% ± 13.6% 
and 81.2% ± 4.3%, respectively) (Fig. 4.8B).  In contrast, the inhibition by No.39 (Fig. 4.7D) 
was quick, with τ90% of 32.5 ± 6.0 s, but the recovery from the inhibition was slow, and only 
partial current (31.2% ± 7.2%) recovered after washout for 5 min.  The inhibition by No.13 
(Fig. 4.7E) was also slow, with τ90% of (196.4 ± 45.8 s) (Fig. 4.8C) and virtually irreversible (1.3% 
± 1.0%) (Fig. 4.8B).  I repeated the above-described Flex-station experiments for No.07, 
No.13 and No.39 and No.42. The results from three independent experiments (Fig. 4.6B) 
confirm the potency of inhibiting the hTRPM2 channels, with mean IC50 values of 0.35 ± 0.07 
µM, 2.5 ± 0.7 µM, 2.3 ± 0.06 µM and 2.3 ± 0.9 µM, for N0.13, No.07, No.39 and No.42, 
respectively. Of notice, the IC50 of No.13 was nearly 10-fold lower than that of No.07, No.42 
and No.39, indicating that this compound is more potent than the other three (Fig. 4.6B).  
Taken together, the results from the Flex-station and patch-clamp recording show that 
No.07, No.42, No.13 and No.39 are potent TRPM2 channel inhibitors and particularly No.13 
is the first compound to be identified so far that inhibits the hTRPM2 channel with a 
submicromolar potency.   
4.2.4 Derivatives of No.13 and No.07 
Thirteen compounds, eleven of which are structurally related to No.13 and two to No.07 
were synthesized by Dr. Foster’s group to better understand the structure-activity 
relationship of No.13 and No.07 compounds.  The key structural characteristics of these 
derivative compounds are highlighted in Fig. 4.9, with an exception of CG-050, a derivative 
of No. 07 whose structure has not been fully determined. 
127 
 
  
 
A
CB
E
a
b
c
8
0
-10
-120 80
nA
mV
ACA
b
a c
0
-9
Cu
rr
en
t (
nA
)
0                                           10
Time (min)
a
b
dc e
12
0
-15
-120 80nA
mV
No.39
a
b
c
d
e
0
-9
Cu
rr
en
t (
nA
)
Time (min)
0                                           10
No.42
a
b
dc e
10
0
-15
-120 80
nA
mV
a c
b d
e
0
-10
Cu
rr
en
t (
nA
)
0                                           10
Time (min)
a
b
d
c e
7
0
-9
-120 80
nA
mV
No.7
a
b
c
d
e
0
-8
Cu
rr
en
t (
nA
)
0                                           10
Time (min)
a
b
d c
6
0
-9
-120 80
nA
mV
No.13
a
b
c d
0
-12
Cu
rr
en
t (
nA
)
0                                           16
Time (min)
D
128 
 
  
 
        Figure 4.7 Effects of tested compounds on ADPR-induced TRPM2 channels currents  
A-E, representative recordings of 1 mM ADPR-induced currents before and after application of 
20 µM ACA (A) or 10 µM No.07, No.42, No.39 and No.13 (B-E) at −80 mV ( left) and I–V 
relationship curves (right) in tetracycline-induced hTRPM2-expressing HEK293 cells using 
whole-cell patch clamp recording.  The chemicals were washed for up to 5 min after maximum 
inhibition was observed. F, representative recordings for ADPR-induced currents before and 
after application of each indicated compounds at 10 µM.  The TRPM2 channel currents were 
verified by the complete inhibition by application of 20 μM ACA (grey bar).  
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Figure 4.8 Inhibition of ADPR-induced whole cell currents by tested compounds   
A, summary of the inhibition of 1 mM ADPR-induced whole cell currents by 20 µM ACA (open 
bar) and 10 µM indicated compounds, which almost completely (black bar) or partially (grey 
bar) blocked ADPR-induced currents in tetracycline-induced hTRPM2-expressing HEK293 cells. 
The compounds are arranged according to their percentage of inhibition in a descending order. 
B, the mean currents recovered after removal of the compounds for up to 5 min.  C, the mean 
data of τ90%.  The data show mean ± sem; numbers of cells examined for each compound are 
indicated in parenthesis.   
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The eleven No.13 derivatives can be divided into 4 groups, according to the substitutions 
introduced to the three key functional groups (R1, R2 and R3) in the molecule of No.13.  CG-
046 and CG-045, belong to group 1.  In these two compounds, R2 is substituted by 2-
methylalkoxy-3-hydroxyphenyland; meanwhile the cyclopentyl in R1 in No.13 is changed 
into cyclohexyl and butly in CG-046 and CG-045, respectively.  Group 2 has five members, 
CG-006, CG-013, CG-036, CG-008 andCG-040, in which R1 is all replaced by amino, and R2 is 
substituted by functional groups detailed in Fig. 4.9A.  There are three compounds in group3, 
CG-011, CG-038 and CG-039; R1 is replaced by neobutly, and R2 is substituted by 3-pyridyl, 
2-thienyl and 2-Furyl in CG-011, CG-038 and CG-039, respectively.  CG-001 is the only one 
member belonging to group 4.  In this compound, R1, R2 and R3 are changed into 
phenylmethylamino, 2-methylalkoxy-3-hydroxyphenyl and pyridobismdiazole, respectively. 
Using Flex-station and hTRPM2-expressing HEK293 cells, the inhibition of H2O2-induced 
increases in the [Ca2+]c by these compounds at more than six different concentrations were 
determined. The time courses and the concentration-inhibition relationship curves are 
shown in Fig. 4.10A, and the derived IC50s are summarized in Fig. 4.11.  GC-045 and GC-046, 
the compounds in group1, exhibited slightly lower IC50s than that of No.13 (Fig. 4.11).  The 
IC50s of the five compounds in group 2 were similar or 10-fold lower than that of No.13 (Fig. 
4.11).  In addition, almost no or little change in the basal [Ca2+]c was induced by any of these 
compounds (Fig. 4.10A).  Among the compounds in group 3, the IC50s of GC-038 and GC-039 
were similar to that of No.13 and no change in the basal [Ca2+]c by these two compounds 
was observed, and, by contrast, the potency of GC-011 was strongly reduced and this 
compound significantly altered the basal [Ca2+]c (Fig. 4.10A and Fig. 4.11).  Finally, 
compound GC-001 exhibited a reduced potency and introduced dramatic change in the 
basal [Ca2+]c (Fig. 4.10A and Fig. 4.11). 
The results of examining CG-058 and CG-050, the derivatives of No.07, are shown in Fig. 
4.10B and Fig. 4.11.  CG-058, exhibited about 10-fold higher potency than No. 07, with an 
IC50 of 0.17 µM.  CG-050 was ineffective, resulting in partial inhibition of H2O2-induced 
increases in the [Ca2+]c at even 30 µM, and thus, its IC50 of CG-050 was not calculated. 
Taken together, four derivatives of No.13 (CG-013, CG-036, CG-040 and CG-008) and one of 
No.07 (CG-058) show improved potency than their parent compounds.   
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Figure 4.9 The chemical structures of the derivatives of compounds No.13 
and No.07 
A, the derivatives of compound No.13, which are divided into four groups 
depending on the substitutions introduced to the R1, R2 and R3 functional 
groups in No.13.  B, compound No.07 and its derivative CG-058.  The boxes 
represent the parts of No.13 and No.07 whose structures are not revealed.   
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Figure 4.10 The effects of the derivatives of No.13 and No.07 on H2O2-induced Ca2+ responses 
A-B, H2O2-induced Ca2+ responses in the absence (control) and presence of indicated 
concentrations of compounds related to No.13 (A) or No.07 (B) in tetracycline-induced 
hTRPM2-expressing HEK293 cells using Flex-station. The concentration-inhibition 
relationship curves are shown at the bottom or on the right for each chemical and the solid 
red lines represent the fitting curves to the Hill equation to calculate the IC50. The cells were 
pre-treated with SBS with DMSO at related concentrations (black square) or compounds at 
indicated concentrations (shown by the symbols) for 30 min, and then exposed to 1 mM 
H2O2 for 5 min.  The derivatives of No.13 are divided into 4 groups depending on their 
chemical structures (shown in Fig. 4.9). The numbers of wells examined for each compound 
are indicated in parenthesis 
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Figure 4.11 The IC50 values of the derivatives of compounds No.13 and No.07 in inhibiting H2O2-
induced increases in the [Ca2+]c 
Summary of the IC50s of No.13 and No.07 derivatives, obtained from the data shown in Fig. 4.10. 
The derivatives of No.13 are divided into four groups according to their R1, R2 and R3 groups 
(details shown in figure 4.9).  The oblique line bars show that the compounds alone cause a 
substantial change in the basal [Ca2+]c at high concentrations. 
 
IC
50
(µ
M
)
30
10
1
0.1
0.03
Group 1 Group 2 Group 3 Group 4
>>
 3
0 
µM
137 
 
4.3 Discussion 
In the study described in this chapter, the effects of 48 hit compounds initially identified by 
screening chemical libraries on H2O2-induced increases in the [Ca2+]c in tetracycline-induced 
hTRPM2-expressing HEK293 cells were investigated using Flex-station. Nineteen compounds 
exhibited potency with IC50s lower than 5 µM.  Subsequent experiments using whole-cell 
patch clamp recordings showed that four compounds, No.13, No.07, No.39 and No.42, 
almost completely abolished ADPR-induced currents, confirming them as novel TRPM2 
channel inhibitors.  Furthermore, the results in the structure-activity study demonstrated 
that four derivatives of No.13, CG-013, CG-036, CG-040 and CG-008, and one of No.07, CG-
058, exhibited improved potency.  
In whole-cell patch clamp recordings, No.07, No.42, No.13 and No.39 were verified to be the 
TRPM2 channel inhibitors, since they almost abolished ADPR-induced currents (Fig. 4.7 and 
Fig. 4.8).  The inhibition by all of these four compounds was voltage-independent.  However, 
they exhibited remarkable differences in the inhibition kinetics and reversibility.  The 
inhibitions by No.07, No.39 and No.42 were relatively fast, in contrast to the slow and 
gradual inhibition caused by No.13.  In addition, the inhibitions by No.07 and No.42 were 
almost completely reversible, whereas No.39 exhibited very slow and partially reversible 
inhibition, and No.13 induced a completely irreversible blockage. The mechanism underlying 
their actions is different but remains currently unclear.  Further investigations are required.   
The effects of eleven derivatives of No.13 and two of No.07 on H2O2-induced increases in 
the [Ca2+]c were examined to better understand the structure-activity relationships (Fig. 4.9 
and Fig. 4.10).  The derivatives of No.13 resulted from substitutions of the key functional 
groups R1, R2 and R3 and accordingly are divided into four groups (Fig. 4.9).  Group 1 
containing two compounds, CG-046 and CG-045.  In these two compounds, R2 is substituted 
by 2-methylalkoxy-3-hydroxyphenyl and, and the cyclopentyl in R1 in No.13 is changed into 
cyclohexyl and butly in CG-046 and CG-045, respectively (Fig. 4.9A).  According to the data 
showing in Fig. 4.11, the IC50s of CG-046 and CG-045 are only slightly smaller than that of 
No.13, implying that such substitutions in these two compounds have no or little effect on 
the potency of the inhibition of H2O2-induced Ca2+-response.  The results for group 2 are 
most remarkable.   Group 2 has five members, CG-006, CG-013, CG-036, CG-008 and CG-040, 
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in which R1 is all replaced by amino, and R2 is substituted by functional groups detailed in 
Fig. 4.9A.  Four of the five compounds, CG-013, CG-036, CG-040 and CG-008, exhibited a 
potency that is about 10-fold higher than that of No.13 (Fig 4.11).  These results suggest an 
important role of amino in determining the potency.  The other compound, CG-006, which 
also contains an amino in R1, exhibited a similar IC50 as that of No.13.  This could result from 
the strongly reduction of the potency by the R2 in CG-006.  The results for group 3 are also 
informative.  There are three compounds in group 3, CG-011, CG-038 and CG-039; R1 is 
replaced by neobutly, and R2 is substituted by 3-pyridyl, 2-thienyl and 2-Furyl in CG-011, CG-
038 and CG-039, respectively (Fig 4.9).  GC-038 and GC-039 showed similar IC50s as that of 
No.13, whereas GC-011 exhibited strongly reduced potency (Fig 4.10 and 4.11).  These 
results imply the expectation of the improved potency by five-member rings, such as thienyl 
and furyl in GC-038 and GC-039, but not by the six-member rings, such as the pyridyl in GC-
011.   CG-001 is the sole member in group 4.  In this compound, R1, R2 and R3 are changed 
into phenylmethylamino, 2-methylalkoxy-3-hydroxyphenyl and pyridobismdiazole, 
respectively (Fig. 4.9).  CG-001 exhibited a dramatically reduced potency and significant 
alteration in the basal [Ca2+]c (Fig. 4.11).  CG-046 and CG-045, the compounds in group 1, 
which contain the same R2 as in CG-001, exhibit similar effect as compound No.13 on H2O2-
induced Ca2+ response.  Thus, the phenylmethylamino in R1 and/or pyridobismdiazole R3 
could crucially result in the reduction of the inhibition potency of the compound.  CG-058, 
the derivative of No.07, exhibited approximately 10-fold higher potency than No. 07 (Fig. 
4.11).  As the structure showing in Fig. 4.9B, there is a large difference between the 
molecular structure of CG-058 and No.13.  Thus, the contribution of the functional groups in 
CG-001 to the inhibition potency is complex or difficult to determine.  The other derivative 
of No. 07, CG-050, was ineffective, since it induced only partial inhibition of H2O2-induced 
increases in the [Ca2+]c at even 30 µM (Fig. 4.11).  However, the structure-activity cannot be 
analyzed, because structure of CG-050 has not been fully determined.  Due to time 
constraint, patch clamp recording was not carried out to examine the effects of these 
compounds on ADPR-induced currents. Thus it is still unknown whether these derivatives 
can directly inhibit the TRPM2 channels as No.13. Such studies are clearly needed to better 
understand whether and how these compounds inhibit the hTRPM2 channels.  
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Besides No.07, No.42, No.13 and No.39, 15 other compounds also strongly and potently 
inhibited H2O2-induced increases in the [Ca2+]c (Fig 4.6),  but they induced partial inhibition 
of ADPR-induced currents (Fig. 4.8).  From the discussion described in the introduction 
chapter (see section 1.2.5.1.6), H2O2 activates the TRPM2 channels via several indirect 
signalling mechanisms including ADPR generation that requires activation of PARP and CD38. 
For these compounds that completely blocked the H2O2-induced increases in the [Ca2+]c but 
not ADPR-induced currents, it is possible that they inhibit the signalling pathways engaged 
in generation of ADPR, as well as directly blocking the TRPM2 channels.  
The results from measuring H2O2-induced increases in the [Ca2+]c using Fura-2 as the Ca2+ 
indicator show noticeable or even dramatic changes the basal value of F340/F380 by some of 
the compounds (Figs. 4.1 to 4.6). The exact causes are not known and there are several 
factors that may contribute to such changes.  For example, the changes may result from 
alterations in properties of Fura-2, include the binding affinity for Ca2+ and the excitation or 
emission fluorescence.  It also remains possible that the compounds changing the basal 
intracellular [Ca2+]c by altering the cell membrane permeability to increase or reduce Ca2+ 
influx or intracellular Ca2+ release or Ca2+ refilling in the ER.   
In summary, the results in this chapter identified four structurally different compounds as 
four novel TRPM2 channel inhibitors with a potency of micromolar or submicromolar 
concentrations. Furthermore, five structurally related compounds exhibited improved 
potency.  Further experiments are required to determine whether these novel inhibitors are 
specific to the TRPM2 channels and can inhibit the TRPM2 channels in different species such 
as human and rodent TRPM2 channels.  If this is the case, it is interesting to know whether 
they provide the eagerly-awaited pharmacological tools to study TRPM2-mediated 
physiological or pathological functions and new therapeutics treating TRPM2-related 
diseases.  
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Chapter 5                                                                                 
Expression of TRPM2 channels and their role in H2O2-
induced Ca2+ responses and cell death in macrophage cells 
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5.1 Introduction 
As described in the introduction chapter (section 1.2.5.1.6, section 1.2.7 and section 1.2.8), 
ROS and particularly H2O2 are important signalling molecules that trigger or regulate a 
diversity of physiological functions and also potent agents causing oxidative damages 
associated with inflammatory, cardiovascular, and neurodegenerative diseases (Forman et 
al., 2010, Forstermann, 2008, Giorgio et al., 2007).  One common cellular event during the 
early responses to ROS is the increase in the [Ca2+]c, resulting from activation of not yet fully 
characterized mechanisms leading to intracellular Ca2+ release and, more frequently and 
significantly, extracellular Ca2+ influx. 
Macrophages play an important role in both innate and adaptive immunity. Their functions 
are to engulf and digest the pathogens and cellular debris, and generate ROS or pro-
inflammatory mediators, such as IL-1β and TNF-α, to regulate the immunity response 
(Giorgio et al., 2007, Kashio et al., 2012, Kregel and Zhang, 2007).  It is well-known that ROS 
produced by macrophages can in turn stimulate ROS generation to form positive feedback, 
and furthermore, regulates macrophage cell functions in diverse physiological and 
pathological conditions (Kregel and Zhang, 2007).   
As also discussed in the introduction chapter (section 1.2.5.1.6), TRPM2 channel exhibits 
substantial Ca2+ permeability (Togashi et al., 2006, Xia et al., 2008) and strong sensitivity to 
activation by ROS via mechanisms primarily promoting ADPR generation (Perraud et al., 
2005), and thus it is an important cellular sensor for ROS (Jiang et al., 2010).  The most well-
known role of TRPM2 channel is to mediate ROS-induced cell death, as shown in pancreatic 
β-cell (Lange et al., 2009), monocytic cell (Hara et al., 2002) and endothelial cell (Sun et al., 
2012).  Nonetheless, the exact contribution of the TRPM2 channel in ROS-induced cell death 
has not been well defined.  It is known that ROS regulates macrophage functions by 
inducing cell death via stimulating PARP (Xu et al., 2006). PARP activation and ADPR 
generation represent the primary mechanism underlying activation of the TRPM2 channel 
by ROS (Buelow et al., 2008, Perraud et al., 2005).  However, the role of the TRPM2 channel 
in mediating ROS-induced macrophage cell death is largely unclear. 
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In addition, many previous studies have reported that TRPM2 channel function as a cell 
surface Ca2+-permeable cationic channel. However, it has become increasingly clear that 
TRPM2 also form as a Ca2+ channel mediating intracellular Ca2+ release.  This study aimed to 
investigate the contribution and mechanisms of the TRPM2 channels in macrophage cells in 
mediating Ca2+ signaling and cell death during early response to biologically relevant 
concentrations of H2O2. Our results show that the TRPM2 channels operate as a cell surface 
Ca2+-permeable channel that mediates Ca2+ influx and constitutes the principal Ca2+ signaling 
mechanism but has a limited, albeit significant, role in cell death. 
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5.2 Results  
5.2.1 Optimization of the working conditions of anti-TRPM2 antibody 
Immunofluorescent confocal imaging together with anti-TRPM2 antibody was used to 
investigate whether TRPM2 proteins were expressed in macrophage cells. I started with 
optimization of the working conditions of antibodies in HEK293 cells transiently transfected 
with the TRPM2 plasmid, because only a subset of HEK293 cells were expected to be 
transfected and thus express the TRPM2 proteins.  Only these cells should exhibit 
immunofluorescence.  I initially kept the dilution of primary anti-TRPM2 antibody at 1:500, 
and used 1:200 to 1:1000 dilution of the FITC-conjugated secondary antibody.  In the second 
set of experiments, I used a dilution of the secondary antibody at 1:400 or 1:600, and the 
dilution of primary antibody changed from 1:200 to 1:1000.  As the results shown in Fig. 5.1, 
under the conditions where the primary and secondary antibody antibodies were 1:500-
1:1000 and 1:400-1:600, respectively, only some cells exhibited strong immunofluorescence, 
whereas the other cells were weakly or not stained.  Thus, these antibody dilutions were 
used in the following immunofluorescent confocal imaging to examine TRPM2 protein 
expression in macrophage cells. 
5.2.2 TRPM2 protein expression in RAW264.7, PMA-differentiated THP-1 and 
peritoneal macrophage cells 
In order to examine TRPM2 protein expression in macrophage cells, I used two macrophage 
cell lines, RAW264.7 cells and PMA-differentiated THP-1 cells, two widely-used model cells 
to study macrophage cell functions and also peritoneal macrophage cells isolated from WT 
(TRPM2+/+) mice.  Representative images are shown in Fig. 5.2. There was strong 
immunostanining of RAW264.7, PMA-differentiated THP-1 and peritoneal macrophage cells 
(up), whereas no staining was observed in the absence of the primary antibody in all these 
three types of cells (bottom). These results suggest that the TRPM2 proteins are expressed 
in these three types of macrophage cells.  
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Figure 5.1 Immunofluorescence in HEK293 cells transiently transfected with hTRPM2 plasmid 
Representative confocal images of HEK293 cells transiently transfected with hTRPM2 plasmid 
and stained with primary anti-TRPM2 antibody produced in rabbit (1°) and secondary goat 
anti-rabbit IgG-FITC antibody (2°).  The dilution of primary and secondary antibody is indicated 
on the left and top, respectively. For each condition, the left image presents the fluorescence; 
right image presents the merged image of fluorescence and white light, with the cells 
highlighted in white dotted circles.  
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             Figure 5.2 Expression of TRPM2 proteins in macrophage cells  
A-C, representative immunofluorescent confocal images of RAW264.7 (A), PMA-
differentiated THP-1 (B) or peritoneal macrophage cells (C).  Cells were treated with (up) or 
without (bottom) of primary anti-TRPM2 antibody produced in rabbit. Each panel is 
accompanied with a DAPI-stained image showing all the cells (right). Similar results were 
obtained in at least three independent experiments. 
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5.2.3 H2O2-induced increases in the [Ca2+]c in macrophage cells mainly result 
from extracellular Ca2+ influx and are temperature dependent 
I next used single cell imaging to monitor the changes in the [Ca2+]c in response to H2O2 at 
biologically relevant concentrations (300 µM) in RAW264.7, PMA-differentiated THP-1 and 
peritoneal macrophage cells.  H2O2 at 300 µM induced consistent and robust increases in 
the [Ca2+]c. Noticeably, in peritoneal macrophage cells, the H2O2-induced Ca2+ responses 
occurred relatively earlier and took relatively shorter times to reach the maximum than in 
RAW264.7 and PMA-differentiated THP-1 cells (Fig. 5.3).  In some experiments, cells were 
exposed to 5 μM ionomycin in the end of experimentation to compare H2O2-induced Ca2+ 
responses to ionomycin-induced Ca2+ responses. 
To further elaborate whether the H2O2-induced increases in the [Ca2+]c resulted from 
extracellular Ca2+ influx, intracellular Ca2+ release, or both, I used the Ca2+ add-back protocols 
(Fig. 5.4).  In extracellular Ca2+-free solution, H2O2 induced no consistent change in the 
[Ca2+]c. Subsequent introduction of extracellular Ca2+-containing solution resulted in no or a 
small increase in the [Ca2+]c in cells that were not treated with H2O2, and in striking contrast, 
there were rapid and robust increases in the [Ca2+]c in H2O2-treated cells (Fig. 5.4). These 
results taken together indicate that extracellular Ca2+ influx represents a predominant 
mechanism for elevation in the [Ca2+]c in macrophage cells in response to H2O2.  
The TRPM2 channel is thermosensitive with an activation threshold of ≥40°C but can open 
at body temperature in the presence of subthreshold concentrations of agonist (Kashio et 
al., 2012, Togashi et al., 2006). We were interested in whether H2O2-induced increases in 
the [Ca2+]c in macrophage cells were enhanced at body temperature. For this, I compared 
H2O2-induced Ca2+ responses at room temperature (22°C) and body temperature (37°C).  As 
shown in Fig. 5.5, H2O2-induced increases in the [Ca2+]c at 37°C were significantly greater 
than at 22°C. Furthermore, such responses were strongly inhibited by pre-treatment with 
10 µM PJ-34, a PARP inhibitor known to block H2O2-induced TRPM2 channel activation 
(Fonfria et al., 2004).  These results are consistent with the idea that the TRPM2 channel has 
a role in mediating H2O2-induced Ca2+ influx.  
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        Figure 5.3 Exposure to H2O2 elevates the [Ca2+]c in macrophage cells.  
Left, representative single cell Ca2+ imaging recordings of individual RAW264.7 (A), PMA-
differentiated THP-1 cells (B), and peritoneal macrophage (C) in response to perfusion with 
extracellular Ca2+-containing solution alone or containing 300 µM H2O2. Right, cells were 
exposed to 300 µM H2O2 and then 5 µM ionomycin in extracellular Ca2+-containing solutions. 
Dashed lines indicate the basal [Ca2+]c when the solution perfusion started. Mean changes in 
the F340/F380 under indicated conditions are also shown. Number of cells examined in each 
case is shown in parentheses. ***P < 0.005, significant difference. 
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Figure 5.4 H2O2-induced increases in the [Ca2+]c in macrophage cells primarily results from 
extracellular Ca2+ influx.  
Representative single cell Ca2+ imaging recordings of individual RAW264.7 (A), PMA-
differentiated THP-1 cells (B), and peritoneal macrophage (C) in response to perfusion initially 
with extracellular Ca2+-free solutions and then with extracellular Ca2+-containing solutions 
without (top) and with 300 µM H2O2 (bottom).  Dashed lines indicate the basal [Ca2+]c when the 
solution perfusion started.  The mean changes in the F340/F380 during the periods in 
extracellular Ca2+-free solutions (-) or Ca2+-containing solutions (+), respectively, are shown.  
The number of cells examined in each case is shown in parentheses. ***p < 0.05 and ***p < 
0.005, significant difference between cells in the absence and presence of extracellular Ca2+. 
†††p < 0.005, significant difference between untreated and H2O2-treated cells in the presence 
of extracellular Ca2+. 
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Figure 5.5 H2O2-induced increases in the [Ca2+]c in macrophage cells are facilitated by body 
temperature.  
A–C, representative single cell Ca2+ imaging recordings of individual RAW264.7 (A), PMA-
differentiated THP-1 (B), and peritoneal macrophage cells (C) in response to perfusion with 300 
µM H2O2 in extracellular Ca2+-containing solution at room temperature (left) and body 
temperature (right). In each set of experiments, some cells were pre-treated with 10 µM PJ-34. 
Dashed lines indicate the basal [Ca2+]c when the solution perfusion started. D, mean changes in the 
F340/F380 in experiments shown in A–C, Number of cells examined in each case is shown in 
parentheses. *P < 0.05 and ***P < 0.005, significant difference for the paired groups. 
A RAW264.7
at 22⁰C 
F 3
40
/F
38
0
0.75
2.5
0 64Time (min)
at 37⁰C 
0 64Time (min) 0 64Time (min)
+ PJ34 at 22⁰C 
0 64Time (min)
H2O2
+ PJ34 at 37⁰C 
H2O2 H2O2H2O2
B
2.0
F 3
40
/F
38
0
0.75
0 22Time (min) 0 22Time (min) 0 22Time (min) 0 22Time (min)
at 22⁰C + PJ34 at 22⁰C at 37⁰C + PJ34 at 37⁰C 
H2O2 H2O2 H2O2H2O2
MacrophageC
0.75
at 22⁰C 
F 3
40
/F
38
0
2.5
0 64Time (min)
at 37⁰C 
0 64Time (min)
+ PJ34 at 37⁰C 
0 64Time (min)
+ PJ34 at 22⁰C 
0 64Time (min)
H2O2 H2O2 H2O2H2O2
Differentiated THP-1 
0
T⁰C  22  37   22    22      37    37
PJ34  - - - +    - +
∆
F 3
40
/F
38
0
1.2
(14)
(15)
(26)
(15)
(28)
***
******
(14)
RAW264.7
T⁰C   22    37    22 22    37 37
PJ34   - - - + - +
0
0.6
∆
F 3
40
/F
38
0
(19)
(14)
(44)
(37)(12)
(14)
*
***
***MacrophageD
0
T⁰C  22    37    22  22   37    37
PJ34 - - - +   - +
∆
F 3
40
/F
38
0
(22)
(43)
(22)
(50) (16)
(26)***
****
0.8 Differentiated THP-1 
150 
 
5.2.4 Functional expression of the TRPM2 channels in peritoneal 
macrophage cells 
Currently, there is no TRPM2 specific inhibitor as described above (see section 1.2.5.2). To 
provide defining evidence for the role of the TRPM2 channels in H2O2-induced Ca2+ 
responses in macrophage cells, I introduced the generated transgenic mice, TRPM2-/- mice, 
which were well established in our lab previously.  These mice express mutated alleles 
without exons 17 and 18 of the Trpm2 gene. The remaining sequence encodes an internally 
deleted TRPM2 protein lacking the Leu-843-Met-931 segment.  
I compared H2O2-induced increases in the [Ca2+]c in macrophage cells from the WT 
(TRPM2+/+) and TRPM2-/- mice.  The H2O2-induced increases in the [Ca2+]c in extracellular 
Ca2+-containing solution observed in the TRPM2+/+ macrophage cells were completely lost in 
the TRPM2-/- macrophage cells (Fig. 5.6A and C), clearly indicating a key role for the TRPM2 
channels in mediating H2O2-evoked increases in the [Ca2+]c in macrophage cells.  Similarly, 
the Ca2+ add-back experiments showed that H2O2 induced no change in the [Ca2+]c in the 
TRPM2-/- macrophage cells in the absence or presence of extracellular Ca2+ (Fig. 5.6 B). 
These results clearly indicate that TRPM2-mediated Ca2+ influx is the principal Ca2+ signalling 
mechanism in macrophage cells during initial response to H2O2.  I was interested in whether 
PJ-34-insensitive PARPs contributed to H2O2-induced TRPM2 channel activation.  For this, I 
compared H2O2-induced increases in the [Ca2+]c in the TRPM2+/+ and TRPM2-/- macrophage 
cells that were pre-treated with PJ-34.  The residual H2O2-induced Ca2+ responses in the WT 
macrophage cells were significantly higher than those in the TRPM2-/- macrophage cells (Fig. 
5.6 B and E), suggesting involvement of the PJ-34-insensitive PARPs in H2O2-induced TRPM2 
channel activation. 
Then, I investigated ADPR-induced currents in peritoneal macrophages from TRPM2+/+ and 
TRPM2-/- mice.  According to the results showing in Fig. 5.7, there were large ADPR-induced 
currents with a typical linear current-voltage relationship for the TRPM2 channels in 
macrophage cells isolated from the TRPM2+/+ mice but such currents were undetectable in 
macrophage cells from the TRPM2-/- mice.  Taken together with the study in single cell Ca2+ 
imaging, the data provide compelling evidence for functional expression of the TRPM2 
channels in macrophage cells. 
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        Figure 5.6 TRPM2 channel mediates H2O2-induced extracellular Ca2+ influx in macrophage cells.  
A and B, representative single cell Ca2+ imaging recordings of individual peritoneal macrophage from trpm2+/+ and trpm2-/- 
mice, in responses to perfusion with extracellular Ca2+-containing solution alone or containing 300 µM H2O2 (A) or perfusion 
initially with extracellular Ca2+-free solutions and then with extracellular Ca2+-containing solutions alone or containing 300 µM 
H2O2 (B). C, representative single cell Ca2+ imaging recordings of individual peritoneal macrophage from TRPM2+/+ and TRPM2-
/- mice in response to perfusion with 300 µM H2O2 in extracellular Ca2+-containing solutions at room temperature and body 
temperature. All cells were pre-treated with 10 µM PJ-34. Dashed lines indicate the basal [Ca2+]c when the solution perfusion 
started. D–F, mean changes in the F340/F380 under indicated conditions. Number of cells examined in each case is shown in 
parentheses. **p < 0.01, ***p < 0.005, and †††p < 0.005, significant difference for the paired groups; N.S., no significant 
difference for the paired groups. 
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     Figure 5.7 ADPR-induced whole-cell currents in peritoneal macrophage cells 
A, representative ADPR-induced whole cell currents at −80 mV ( left) and the I–V relationship 
curves (right) in peritoneal macrophage isolated from TRPM2+/+ (top) and TRPM2-/- (bottom) 
mice. 1-s voltage ramps from −120 mV to +80 mV were applied in every 5 s.  Arrows indicate 
the transition from cell-attached to whole cell configurations. 20 µM ACA was used to inhibit 
ADPR-induced currents. B, mean ADPR-induced peak currents at -80 mV. The data show 
mean ± sem; the number of cells examined in each case is shown in parentheses.  *** p< 
0.005 significant difference for the paired groups 
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5.2.5 Contribution of TRPM2 channel in H2O2-induced cell death in RAW264.7, 
PMA-differentiated THP-1 and peritoneal macrophage cells 
I conducted the XTT cell viability assay to determine macrophage cell death during early 
response to H2O2. Exposure to 300 µM H2O2 for up to 60 min reduced the cell viability by 50% 
for RAW264.7 and peritoneal macrophage cells, and 20–30% for PMA-differentiated THP-1 
cells, indicating significant macrophage cell death (Fig. 5.8).  The relatively high viability for 
PMA-differentiated THP-1cells may relate to the difference in the level of macrophage 
differentiation and the resistance to cell death (Daigneault et al., 2010).  The effects of 
exposure to H2O2 on the cell viability exhibited strong dependence on duration (5–60 min) 
and H2O2concentration (30 µM-3 mM) (Fig. 5.8). 
To gain an insight into the role of the PARP activation and potential TRPM2 channel 
activation in H2O2-induced cell death, I examined the effect of PJ-34.  Pretreatment with PJ-
34 resulted in a general tendency of attenuating H2O2-induced reduction in the cell viability; 
the protective effect varied among the three cell types and reached statistical significance 
for exposures with relatively long durations or to relatively high concentrations of H2O2 
(denoted by the symbol + in Fig. 5.8). In addition, PJ-34 prevented significant reduction in 
the viability of RAW264.7 and THP-1 cells by low concentrations of H2O2 (30–100 µM; Fig. 
5.8).  These results support that PARP activation and TRPM2 channel activation contribute 
to, but are not fully responsible for, macrophage cell death during initial exposure to H2O2. 
A recent study has shown that the protective effects of PARP inhibition on H2O2-induced 
cardiomyocyte death can arise from TRPM2-independent mechanisms (Yang et al., 2006).  
To further define the role of the TRPM2 channels in H2O2-induced macrophage cell death, I 
finally compared the effects of H2O2 on the viability of TRPM2+/+ and TRPM2-/- macrophage 
cells (Fig. 5.9). The TRPM2 channel deficiency conferred a general and consistent tendency 
of decreasing H2O2-induced reduction in macrophage cell viability; the effects were 
significant under most of the conditions examined (denoted by the symbol + in Fig. 5.9). The 
overall protective effects resulting from the genetic ablation of the TRPM2 channel function 
were similar to but noticeably more salient than those from pre-treatment with PJ-34 (Fig. 
5.8); this is not surprising, considering that PJ-34-insensitive PARPs are involved in H2O2-
induced TRPM2 channel activation (Fig. 5.6). There was a modest but statistically significant 
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increase in cell viability in response to 30-min exposure to 30 µM H2O2 (Fig. 5.9). It was also 
noted that the reduction in the cell viability by 1-3 mM H2O2, which are of less or no 
biological relevance, remained significantly different inTRPM2+/+and TRPM2-/-macrophage 
cells, but the difference diminished (Fig. 5.9), suggesting that the TRPM2 channel has a less 
or no significant role in macrophage cell death induced by such high concentrations of H2O2. 
There was strong and persistent H2O2-induced cell death in cells pre-treated with PJ-34 (Fig. 
5.8) or TRPM2 channel-deficient macrophage cells (Fig. 5.9), consistently indicating a limited 
role for the TRPM2 channel in H2O2-inducedcell death in striking contrast with the key role 
in mediating H2O2-induced Ca2+ responses. 
Cells die through either necrosis or apoptosis. The membrane integrity of necrotic cells is 
lost, so the trypan blue can enter into the necrotic cells, in contrast to the living and 
apoptotic cells that cannot be dyed because of the intactness of the cell membrane.  Thus, I 
examined whether the H2O2-induced macrophage cell death is due necrosis or apoptosis, 
using trypan blue exclusion assay.  As shown in Fig. 5.10, exposure to 300 µM H2O2 for 60 
min induced a small necrosis in RAW264.7 cells, PMA-differentiated THP-1 cells and 
peritoneal macrophage cells.  In RAW264.7 and peritoneal macrophage cells, there was 
substantial necrosis with 32.1% and 36.9% of dye-stained cells, respectively, after exposure 
to 3 mM H2O2 for 60 min.  However, necrosis in PMA-differentiated THP-1 cells induced by 3 
mM H2O2 was very low (5.4%).  These results suggested that the macrophage cell death 
induced by relatively short exposure (≤ 60 min) to H 2O2 at low concentration (≤300 µM) is 
mainly due to apoptosis, but not necrosis. 
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Figure 5.8 PJ-34 attenuates  H2O2-induced reduction in macrophage cell viability.  
Summary of the viability of RAW264.7, PMA-differentiated THP-1 and peritoneal macrophage cells after exposure to 300 µM H2O2 for 
indicated durations (A) for untreated cell (hatched columns) and cells pre-treated with 10 µM PJ-34 (black columns) or after exposure to 
indicated  H2O2 concentrations (B) for 30 min for untreated cells (hatched columns) and cells pre-treated with 10 µM PJ-34 (grey and black 
columns). Dashed lines indicate the 50 and 100% levels. Data were obtained from 18 wells from three independent experiments, and 
expressed as percentage of the control without PJ-34 treatment. *P < 0.05, **P < 0.01, and ***P < 0.005, denote difference compared with 
their respective control. Grey bars indicate no difference from the control. †P < 0.05 and †††P < 0.005, denote difference for the paired 
groups. 
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Figure 5.9 TRPM2 deficiency suppresses H2O2-induced reduction in macrophage cell viability.  
Summary of the viability of macrophage cells from TRPM2+/+ (hatched columns) and TRPM2-/- 
mice (grey and black columns), after exposure to 300 µM H2O2 for indicated durations (A) or 
after exposure to indicated concentrations of H2O2for 30 min (B). Dashed lines indicate the 50 
and 100% levels. Data were obtained from 18 wells from 3 independent experiments, and 
expressed as percentage of the respective control. *P < 0.05 and **P < 0.001, difference 
compared with their respective control. Grey bars indicate no difference from the control. ††P 
< 0.01 and †††P < 0.005, difference for the paired groups. 
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Figure 5.10 H2O2-induced necrosis in macrophage cells 
A, representative images of H2O2-induced necrosis in RAW264.7 (A), PMA-
differentiated THP-1 cells (B), and peritoneal macrophage (C) in trypan blue exclusion 
assays. Cells were pre-treated with H2O2 at indicated concentrations for 60 min. B, 
mean percentage of dye-stained RAW264.7 (D), PMA-differentiated THP-1 cells (E), 
and peritoneal macrophage (F) under the indicated conditions.  The data show mean ± 
sem; the number of cells examined in three independent experiments in each case is 
shown in parentheses. *** p< 0.005 significant difference for the paired groups. 
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5.3 Discussion 
The results from the study described in this chapter have provided evidence to support 
functional expression of the TRPM2 channels and a crucial role in mediating H2O2-induced 
increases in the [Ca2+]c in macrophage cells.  More specifically, the TRPM2 channels function 
as a cell surface Ca2+-permeable channel that mediates extracellular Ca2+ influx and 
constitutes the principal mechanism elevating the [Ca2+]c during early response to H2O2 at 
biologically relevant concentrations. The study has also shown that the TRPM2 channel or 
TRPM2-mediated Ca2+ influx has a limited role in H2O2-induced macrophage cell death.  
It has become increasingly clear from numerous recent studies using transgenic TRPM2 
deficient mice that theTRPM2 channels in immune cells plays a crucial role in immune 
responses and inflammatory diseases. However, the current picture with respect to the 
subcellular localization of the TRPM2 channels and associated Ca2+ signaling mechanisms 
and cell functions in these cells is intriguing; the TRPM2 channels on the one hand function 
as a Ca2+-permeable channel in the plasma membrane mediating Ca2+ influx in monocytes, 
macrophages and microglia (Yamamoto et al., 2008) and, on the other, operate as a 
lysosomal Ca2+ release channel in dendritic cells (Sumoza-Toledo et al., 2011). In this study, 
we showed that H2O2 increased the [Ca2+]c in macrophage cells and such responses were 
strongly attenuated by inhibiting the TRPM2 channel activation by PJ-34 (Fig. 5.5), 
prevented by removing extracellular Ca2+ (Fig. 5.4) or by genetically deleting the TRPM2 
channel function (Fig. 5.6). These results provide consistent evidence to indicate that the 
TRPM2 channels in macrophage cells functions as a cell surface Ca2+-permeable channel and 
TRPM2-mediated extracellular Ca2+ influx constitutes the principal mechanism elevating the 
[Ca2+]c in early response to H2O2. Such information helps to fully understand the TRPM2-
mediated disease mechanisms and the molecular mechanisms determining cell type-specific 
subcellular compartmentalization of the TRPM2 channels and thereby to identify druggable 
targets and develop therapeutics.  
One interesting and physiologically relevant finding from this study is that the TRPM2-
mediated H2O2-induced increases in the [Ca2+]c in macrophage cells were significantly 
greater at body temperature than at room temperature (Fig. 5.5).  TRPM2 channels 
heterologously expressed in HEK cells and endogenously expressed in insulin-secreting cells 
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are temperature-sensitive with an opening threshold of 40°C and thus remains closed at 
body temperature in the absence of agonist but can open in the presence of subthreshold 
concentrations of agonist, such as cADPR (Kashio et al., 2012, Togashi et al., 2006). Our 
results suggest that activation of the TRPM2 channel by H2O2 in macrophage cells is strongly 
facilitated at body temperature (Fig. 5.5). A recent thermodynamic study has postulated 
that the thermosensitivity of the TRP channels is in principle governed by temperature-
dependent conformational changes (Clapham and Miller, 2011). As one plausible 
interpretation, the temperature induced potentiation of activation of the TRPM2 channel by 
H2O2 observed in this study may result from a synergy between ADPR and temperature in 
promoting the conformational transitions that lead to channel opening. The higher PARP 
activities and thus more ADPR generation at body temperature may also contribute. A 
recent study has shown that prior exposure to H2O2 increases the thermosensitivity of the 
TRPM2 channel (Kashio et al., 2012). Such H2O2-induced sensitization, despite being in a 
large part prevented by pre-treatment with PJ-34, has, however, been attributed to TRPM2 
protein oxidation. Regardless, the synergy between H2O2 and body temperature is 
important for TRPM2-mediated macrophage cell functions in vivo. 
TRPM2-mediated cell death is largely characteristic of cell death caused by oxidative, 
ischemic, and inflammatory damage (see section 1.2.8). The present study has revealed a 
significant but limited role for the TRPM2 channel in macrophage cell death induced by 
biologically relevant concentrations of H2O2 within 1 hr (Fig. 5.8 and 5.9), in contrast with 
the principal role in Ca2+signaling. These findings are consistent with the idea that TRPM2-
mediated Ca2+ signaling plays a more critical role in other macrophage cell functions in 
responses to early or initial exposure to ROS, for example, inflammasome activation and 
cytokine generation (Kashio et al., 2012, Zhong et al., 2013). Intriguingly, brief exposure to 
30 µM H2O2 increased macrophage cell viability (Fig. 5.9). The reason for this is currently 
unclear. The increase in cell viability could result from increased cell proliferation as 
previously reported for microglia (Mander et al., 2006). A recent study has reported that 
TRPM2 expression renders SH-SY5Y cells to be less prone to cell death induced by 6- to 24-
hr exposure to 50–100 µM H2O2 due to enhanced expression of FOXO3a (forkhead box O3) 
and SOD2 (superoxide dismutase 2) (Zhang et al., 2012).  Further investigation is required. 
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In conclusion, the TRPM2 channel in macrophage cells functions as a Ca2+-permeable 
channel in the plasma membrane and constitutes the principal Ca2+ signaling mechanism 
responsible for the increases in the [Ca2+]c and has a significant but limited role in cell death 
during early response to H2O2. Such knowledge will help to evolve a full understanding of 
the TRPM2 channel in ROS-related immune responses and inflammatory diseases. 
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Chapter 6                                                                            
Summary and conclusions 
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6.1 Summary of findings 
6.1.1 The crucial contribution of a pore residue in determining species-
dependent inhibition of TRPM2 channels by extracellular acidic pH 
Several recent studies have shown the inhibition of hTRPM2 channel by extracellular acidic 
pH (Du et al., 2009b, Starkus et al., 2007, Starkus et al., 2010, Yang et al., 2010).  However, 
there is significant discrepancy in the reversibility of the inhibition and the underlying 
mechanisms.  In the previous study of our group, the state-dependent inhibition of hTRPM2 
channel by extracellular acidic pH was postulated to result from initial reversible inhibition 
and subsequent conformational changes leading to largely irreversible TRPM2 channel 
inactivation (Yang et al., 2010).  
Using whole-cell patch clamp recordings, I further investigated the reversibility of the 
inhibition of ADPR-induced TRPM2 channel currents by extracellular acidic pH 5.5 in HEK293 
cells transiently transfected with hTRPM2 plasmid.  The results showed that short exposure 
duration caused strong reversible inhibition of ADPR-induced currents; whereas the 
inhibition became irreversible after long exposure duration. These results are consistent 
with the two sequential steps hypothesis for the inhibition of hTRPM2 channels by 
extracellular acidic pH. 
Studies using mice are important to infer the physiological functions proteins and the 
mechanisms responsible for associated pathologies and conduct preclinical testing of new 
therapeutic drugs, but species difference between humans and rodent animals may bear 
significant limitations (Chen and Kym, 2009).  I conducted experiments to determine how 
the mouse TRPM2 channels respond to acidic pH.  For this, I investigated the effects of 
extracellular acidic pH on both hTRPM2 and mTRPM2 channels at range of pH 4.0-6.0.  The 
results showed that the steady-state inhibition of both hTRPM2 and mTRPM2 channels 
were complete and pH-independent.  In addition, the lower acidic pH induced quicker 
inhibition of both hTRPM2 and mTRPM2 channel currents, indicating that the inhibition 
kinetics is pH-dependent.  However, the inhibition kinetics at the mTRPM2 channels by 
acidic pH was significantly slower than that at the hTRPM2 channels. Strikingly, where 
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completely abolishing the hTRPM2 channels pH 6.0 hardly suppressed the mTRPM2 channel 
currents.  These results demonstrated clear species-dependent sensitivity of the human and 
mouse TRPM2 channels in response to extracellular acidic pH. 
In the further study of the molecular basis and mechanism of this species-dependent 
inhibition, residues Arg-961 and His-995 in the outer pore region of the hTRPM2 channel 
were substituted individually by Ser-958 and Gln-992, their equivalent residues in the 
mTRPM2 channel.  The reciprocal mutations were also introduced in the mTRPM2 channel. 
Then, the effects of extracellular acidic pH on the inhibition of ADPR-induced current in 
these mutants have been investigated.  The data show that H995Q mutation in the hTRPM2 
channel strongly slowed down, and its reciprocal mutation Q992H in the mTRPM2 channel 
dramatically accelerated the inhibition kinetics, as anticipated if this residue is critical.  In 
contrast, the R961S and S958R mutations resulted in no significant effect on the inhibition 
kinetics.  Thus, these results has shown a crucial role for residue His-995/Gln-992 in the 
outer pore region in determining such species differences of TRPM2 channels in response to 
extracellular acidic pH.  These results also provide further evidence to support the notion 
that extracellular acidic pH inhibit the TRPM2 channels by interacting with the ion-
conducting pore (Yang et al., 2010).   
6.1.2 Identification of novel and potent TRPM2 channel inhibitors 
Currently, there is a lack of specific TRPM2 channel inhibitors, which makes it difficult to 
study the functions of the hTRPM2 channel.  In order to search for novel TRPM2 inhibitors, 
screening of 14,000 compounds on H2O2-induced increases in the [Ca2+]c in hTRPM2-
expressing HEK293 cells have led to identification of 48 hit compounds that may inhibit the 
hTRPM2 channel.  Using Flex-station and tetracycline-induced hTRPM2-expressing HEK293 
cells, the effects of these 48 compounds on H2O2-induced increases in the [Ca2+]c were 
investigated in detail.  24 compounds have been verified to strongly inhibit H2O2-induced 
Ca2+ responses and 19 of them exhibit a micromolar or submicromolar potency in inhibiting 
H2O2-induced Ca2+ responses. However, whole-cell patch clamp recording show four 
compounds, No.07, No.42, No.13 and No.39 at 10 µM can completely inhibit ADPR-induced 
TRPM2 channel currents.  Their inhibition in terms of kinetics and irreversibility is noticeably 
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different.  The inhibition by No.07 and No.42 was relatively quick and largely reversible. The 
inhibition by NO.39 is fast but hardly reversible, whereas the inhibition by No.13 was slow 
and irreversible.  These results may indicate despite potent inhibition of the TRPM2 
channels, mechanisms of actions of these four compounds appear different. Further 
investigations are required to understand how they inhibit the hTRPM2 channels. 
In the further efforts to better the structure-activity relationships, eleven and two 
derivatives of No.13 and No.07, respectively, were tested for their inhibition of H2O2-
induced increases in the [Ca2+]c.  The results based on the IC50s showed that four derivatives 
of No.13, CG-013, CG-036, CG-040 and CG-008, and one of No.07, CG-058, exhibited about 
10-fold higher potency then No.39 and No.07, respectively.  
Taken together, these results identified four novel and structurally different TRPM2 
channels inhibitors. Further studies are required to determine their specificity and 
metabolically stability. Nonetheless, identification of such compounds may provide new 
tools to better understand the physiological and pathological functions of the human 
TRPM2 channels and develop therapeutics to treat TRPM2-related diseases. 
6.1.3 Expression of TRPM2 channels and their role in H2O2–induced Ca2+ 
responses and cell death in macrophage cells 
ROS, particularly H2O2, is important signaling molecule that regulates a diversity of 
physiological functions and is related to several diseases, such as inflammatory, 
cardiovascular, and neurodegenerative diseases.   TRPM2 channel is an important cellular 
sensor for ROS.  The early event of TRPM2 channel activation by H2O2 is to increase the 
[Ca2+]c.  The most well-known role of the TRPM2 channel is to mediate ROS-induced cell 
death.  However, the function expression of TRPM2 channel and its role in mediating H2O2-
induced Ca2+ signaling and cell death in macrophage cells is not well understood.  This study 
investigate the contribution and mechanisms of the TRPM2 channel in macrophage cells in 
mediating Ca2+ signaling and cell death during early response to biologically relevant 
concentrations of H2O2. 
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The TRPM2 protein expression was detected in RAW264.7 cells, PMA-differentiated THP-1 
cells and peritoneal macrophage cells, using anti-TRPM2 antibody and immunofluorescent 
confocal imaging.  The results showed the expression of TRPM2 proteins in all these three 
types of macrophage cells both on the cell surface and inside the cells.  H2O2 induced robust 
increases in the [Ca2+]c in RAW264.7 cells, PMA-differentiated THP-1 cells and peritoneal 
macrophage cells using single cell Ca2+ imaging. The role of TRPM2 channels in mediating 
these H2O2-induced Ca2+responses were supported by their sensitivity to inhibition to PJ34, 
a PARP inhibitor known to prevent H2O2-induced TRPM2 channels, their sensitivity to 
facilitation by temperature.  Furthermore, H2O2-induced Ca2+ responses were virtually lost in 
macrophages isolated from TRPM2-/- mice, providing compelling evidence to support the 
functional expression of TRPM2 channels in macrophage cells.  In addition, H2O2-induced 
increases in the [Ca2+]c almost exclusively result from extracellular Ca2+ influx, suggesting 
that TRPM2 channels function as a Ca2+-permeable channel at the cell surface, which is 
different from the lysosomal location of TRPM2 channels as an intracellular Ca2+ release 
channel in dendrite cells. .  
The role of TRPM2 channels in H2O2-induced macrophages cell death in RAW264.7 cells, 
PMA-differentiated THP-1 cells and peritoneal macrophage cells were investigated using the 
XTT assays. The data show that H2O2 at biologically relevant concentrations induced 
macrophage cell death in both exposure duration- and H2O2 concentration-dependent 
manner in all three types of macrophage cells.  Further experiments using trypan blue 
exclusion assays show that H2O2-induced cell death by mainly due to the apoptosis, but not 
necrosis.  Both pre-treatment with PJ-34 and TRPM2 channel deficiency partially reduced 
but not prevented H2O2-induced cell death. Taken together, these results indicate that the 
TRPM2 channels play a crucial role in mediating H2O2-induced increases in the [Ca2+]c in 
macrophage cells and contributed to  cell death.  
6.2 General discussion 
Inflammation is a complex response to the infection and tissue injury, which is characterized 
by redness, swelling, heat and pain. The leukocytes, such as macrophages, neutrophils and 
lymphocytes, are activated and recruited to the sites of infection and injured tissues to 
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eliminate the pathogens in the immune response.  However, the leukocyte population 
needs to be controlled; otherwise the excessive immune response will damage the healthy 
cells and tissues and result in the inflammation. 
Macrophage plays an important role in phagocytosis, antigen presentation and cytokine 
release in the immune response. Its population is reduced by apoptosis to prevent 
inflammation.  TRPM2 channels have already been identified in macrophages. My study 
demonstrates that, although TRPM2-independent mechanism exists, the TRPM2 channel is 
involved in mediating the apoptosis in macrophage cell induced by biologically relevant 
concentrations of H2O2. My study also shows the essential role of TRPM2 channel in 
mediating the H2O2-induced Ca2+ influx in macrophage cells.  These results indicate the 
limited contribution of TRPM2 channel to macrophage cell apoptosis through Ca2+-
depended pathway, and imply the role of TRPM2 channel in preventing of the induction of 
inflammation in the physiological condition.  
However, several studies have reported the contribution of TRPM2 channel to promote the 
inflammation in the pathological condition, although the underlying mechanism is not fully 
understood (Melzer et al., 2012, Haraguchi et al., 2012, Yamamoto et al., 2008). The 
reduced pH is one of the characteristics in the inflammation. My study in TRPM2 channel-
expressing HEK293 cells shows that extracellular acidic pH can induce TRPM2 channel 
inhibition, which is mainly caused by the channel inactivation when the exposure to acidic 
pH is prolonged. In addition, the inhibition kinetics is pH-dependent. The acidic pH-induced 
inhibition of TRPM2 channel results in a reduction of Ca2+ influx, which could further 
regulate the downstream cellular functions in the inflammatory condition.  
Since TRPM2 channel has been reported to be involved in inflammation, it may be a target 
for development of therapy treating inflammatory diseases. In addition, as shown in my 
study, the hTRPM2 and mTRPM2 channel exhibit different sensitivity to, and slower kinetics 
of, inhibition in response to extracellular acidic pH. These results imply the distinct features 
of TRPM2 channels in two different species. Thus, the specific TRPM2 inhibitors are eagerly 
required in the research because of the limitation of the animal models. In my study, four 
novel TRPM2 inhibitors have been identified. These inhibitors can provide pharmacological 
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tools to study TRPM2 channel functions and new therapeutics treating TRPM2-related 
diseases, including inflammation. 
6.3 Conclusions 
The studies described in this thesis provide evidence to support the following conclusions: 
(1) State-dependent and irreversible inhibition of the TRPM2 channels by extracellular acidic 
pH results from initial reversible inhibition and subsequent irreversible inactivation. The 
human and mouse TRPM2 channels exhibit species- difference in the sensitivity to 
extracellular acidic pH. Residue His-996/Gln-992 in the pore region is an important 
molecular determinant for such species difference.   
(2) Four structurally different compounds No.13, No.07, No. 39 and No.42, have been 
identified as novel TRPM2 channels inhibitors, that with a micromolar and sub-
micromolar potency.  
(3) The TRPM2 channel is functionally expressed in macrophage cells and functions as a 
Ca2+-permeable channel at the cell surface which play an essential role in mediating 
H2O2-induced Ca2+ influx and thereby contributing to H2O2-induced increases in the 
[Ca2+]c. The TRPM2 channel has also contributed to H2O2-induced macrophage cell death, 
but its role is limited.    
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